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Abstract 
 
Neisseria meningitidis is a bacterium that colonises the human nasopharyngeal mucosal 
surface. Occasionally, it can migrate from the nasopharynx to cause potentially life-
threatening meningitis and septicaemia. In contrast, closely related bacteria such as 
Neisseria lactamica, colonise the nasopharynx but do not cause invasive disease. 
Interaction differences between N. meningitidis and N. lactamica with the human host 
at the colonisation stage are poorly defined. I hypothesise that early interactions of N. 
meningitidis and N. lactamica with respiratory epithelial cells are associated with 
differential host cell responses, and that these may be capable of altering the outcome 
of the interaction. Experiments were undertaken to describe the interactions of N. 
meningitidis and N. lactamica with a human bronchial epithelial cell line. Association 
and invasion studies indicated a similar extent of association and invasion of N. 
meningitidis and N. lactamica. Human epithelial gene expression profiles in response to 
N. meningitidis and N. lactamica were determined using a genome wide microarray 
platform. Comparison of live and dead bacteria enabled the identification of host 
responses specifically to live Neisseria while comparison of the N. meningitidis cap- 
and pilE- mutants allowed the identification of host responses to non-capsule and pili 
factors, such as secreted proteins. Selected genes were further verified at the transcript 
and protein level. Host metabolic and energy production processes were associated with 
both neisserial species, suggesting that both N. meningitidis and N. lactamica utilise 
host resources for energy. In contrast, the data indicated that while N. meningitidis 
down-regulates host defence genes, N. lactamica initiates a proinflammatory response, 
suggesting specific colonisation processes that may lead to different clinical outcomes. 
Treatment of the epithelial cells with neisserial secreted proteins showed that they may 
be directing some of these differential responses, suggesting novel mechanisms for 
modulation of the host response. 
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1.1 Colonisation of the human host by bacteria 
Bacteria interact with mucosal surfaces such as those of the gastrointestinal, respiratory 
and urogenital tracts very early on in life. The interaction of bacteria with the host can 
lead to harmless colonisation of mucosal epithelial surfaces (commensals), which has 
been most studied in the human gut. For example, commensal gut bacteria such as 
Bacteroides thetaiotaomicron do not cause disease in the human host and is part of the 
normal human gut microflora (Kelly et al., 2004). There are, however, commensals 
which can behave as opportunistic pathogens as they occasionally cause disease 
(accidental pathogens). For example, the non-pathogenic gut bacterium Enterococcus 
faecalis can cause colitis in hosts with immunoregulatory and mucosal barrier deficits 
(Packey and Sartor, 2009). At the other end of the spectrum are pathogenic bacteria 
which can express virulence factors that enable them to subvert host defences and cause 
disease. For example, Shigella is an intestinal pathogenic bacterium which possesses 
virulence factors that modulate host cell cycling, so as to influence epithelial cell 
renewal to maintain infection (Iwai et al., 2007). 
 
Despite the fact that commensal bacteria, like their pathogenic counterparts, express 
components such as lipopolysaccharide (LPS) that can be readily be detected by 
membrane bound Toll like receptors (TLRs), they are thought not to provoke 
inflammatory responses characteristic for infection with a pathogen (Steinhoff, 2005). 
This has been particularly studied in the gut, where large numbers of bacteria colonise. 
It was traditionally thought that the intestinal epithelium serves as a barrier to prevent 
the entry of potential pathogens and commensals into the internal milieu of the host 
(Hecht, 1999). In addition, TLR expression is compartmentalised in order to avoid 
stimulation by the normal flora (Artis, 2008).  
 
There is however, increasing evidence that the intestinal epithelium is not just a 
physical barrier to prevent the detection of commensals by the host. Instead, 
interactions between the host and commensal bacteria are found to be important as 
well. Commensal bacteria possess a variety of strategies for successful colonisation, 
which in turn can evoke different host epithelial responses. There is evidence to suggest 
that some commensals can adopt active mechanisms to manipulate the host response 
and keep the immune response in a limited activated state, where they drive the 
attenuation of proinflammatory signalling and evade the innate host defence system to 
Chapter 1 
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maintain colonisation. For example, the anaerobe B. thetaiotaomicron was shown to 
attenuate proinflammatory cytokine expression by promoting the export of NF-κB 
subunit RelA from the nucleus (Kelly et al., 2004). Incubation of epithelial cells with 
non-pathogenic Salmonella strains has been shown to inhibit the NF-κB pathway (and 
thus inflammation) through the stabilisation of IκBα (Neish et al., 2000). 
 
On the other hand, there are also studies which show that the host can recognise 
commensals. Recognition of commensal bacterial components by the host via TLRs 
represents a critical component of the symbiosis between the host and indigenous 
microflora and is important for protection against gut injury and associated mortality 
(Magalhaes et al., 2007). Rakoff-Nahoum et al. (2004) demonstrated that TLR 
mediated signalling by the commensal microflora is crucial for protection against 
dextran sodium sulphate mediated intestinal colitis. It is therefore, likely that different 
commensals exert different effects on the host during colonisation either to induce 
tolerance or even to benefit the host. 
 
Like the gut, the respiratory tract is exposed to a myriad of environmental stimuli 
consisting of pathogenic and commensal bacteria. Airway epithelial cells not only serve 
a barrier function against invading pathogens such as Pseudomonas aeruginosa but 
they also possess TLRs which can be activated to not only induce chemokine 
expression to recruit polymorphonuclear leukocytes (PMNs), but also to initiate 
cleavage of junctional proteins to accommodate the transmigration of the recruited 
PMNs into the airway (Chun and Prince, 2009). In contrast, during normal conditions, 
the respiratory tract possesses several mechanisms to prevent inflammation to 
innocuous antigens or commensal bacteria. For example, alveolar macrophages secrete 
anti-inflammatory cytokines like IL10 and TGF-β. They also suppress T cell activation 
and inhibit the antigen presentation function of interdigitating dendritic cells in the 
airways (Wissinger et al., 2009). The expression of TLRs like TLR2 in bronchial 
epithelial cells can also be tightly regulated so as to limit uncontrolled activation by 
commensal bacteria (Mayer et al., 2007). In contrast to the gut however, less is known 
about the interactions of the respiratory tract with colonising commensal bacteria, and 
how this may contribute to the colonisation of the host at mucosal epithelial surfaces. It 
is thought that commensals like Neisseria lactamica interact and induce responses in 
the host as N. lactamica colonisation has been shown to induce bactericidal antibodies 
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and result in the development of a cross-protective immunity against Neisseria 
meningitidis (Gold et al., 1978). 
 
The various mechanisms that allow commensals to successfully colonise their hosts are 
poorly defined in the respiratory tract but are likely to involve both host and bacterial 
factors. In this thesis, N. meningitidis and N. lactamica have been used as models, as in 
the different commensal bacteria in the gut, to gain insights into host-interactive 
biology of the respiratory tract. 
 
1.2 The genus Neisseria 
The genus Neisseria consists of Gram-negative proteobacteria that all colonise mucosa. 
Hosts range from humans to animals (Barrett and Sneath, 1994; Dent, 1982). Neisseria 
species that may be isolated from animals include Neisseria macacae (from monkeys), 
Neisseria animalis (from guinea pigs) and Neisseria canis (from dogs). Neisserial 
species associated with humans do not colonise other animals and are mostly present in 
the nasopharynx, except for Neisseria gonorrhoeae, which resides predominantly in the 
urogenital tract. The two main species of Neisseria that colonise the human 
nasopharyngeal mucosa are N. meningitidis and N. lactamica. The others include 
Neisseria cinerea, Neisseria polysaccharea, Neisseria subflava, Neisseria sicca, 
Neisseria mucosa, Neisseria flavescens and Neisseria elongate. They are asymptomatic 
colonisers of the nasopharyngeal mucosa, with N. meningitidis occasionally causing 
invasive disease (van Deuren et al., 2000). 
 
1.3 Neisseria meningitidis 
N. meningitidis is an aerobic Gram-negative diplococcus, non-motile, non-spore 
forming, and oxidase positive bacterium. Like other Gram-negative bacteria, it is 
surrounded by an outer membrane containing outer membrane proteins (OMPs), and 
endotoxic lipooligosaccharides (LOS). Humans are the only natural host for 
meningococci, where it is a commensal that colonises the nasopharynx. Occasionally 
however, it can penetrate the mucosal surface and cause invasive infection resulting in 
meningitis and/or septicaemia (van Deuren et al., 2000). 
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1.3.1 Classification 
Traditionally, meningococcal strains have been classified by serological typing based 
on the antigenic variation of the capsular polysaccharide (serogroup); the PorB OMP 
(serotype); the PorA OMP (serosubtype) and the LOS (immunotype) (Frasch et al., 
1985). N. meningitidis have been divided into 13 serogroups: A, B, C, D, 29E, H, I, K, 
L, W135, X, Y and Z. A majority of disease isolates are encapsulated and five of these 
serogroups (A, B, C, W135 and Y) cause more than 90% of invasive disease worldwide 
(Yazdankhah and Caugant, 2004).  
 
The drawback of such a classification system is that recognition is limited to 
serological variants included in the panel of monoclonal antibodies used. In addition, 
there is a high variability of the OMPs due to high frequency phase and antigenic 
variation. The use of molecular genetic methods, such as polymerase chain reaction-
restriction fragment length polymorphism (PCR-RFLP), have been demonstrated to be 
more reliable than serological methods (Zhu et al., 1995). In addition, a genetic typing 
system based upon polymorphisms in multiple housekeeping genes called multilocus 
sequence typing (MLST) is widely used. It is based on the sequencing of internal 
fragments of seven housekeeping genes, followed by assignment of each sequence to a 
specific allele (Maiden et al., 1998). More recently, the use of matrix-assisted laser 
desorption/ionisation time of flight mass spectrometry (MALDI-TOF MS) was 
introduced as a new sequencing method for microbial typing. It was shown that 98% of 
all the N. meningitidis strains tested were correctly identified (as compared to classical 
dideoxy sequencing), validating the method for automated high-throughput microbial 
DNA sequence analysis (Honisch et al., 2007).  
 
1.3.2 Epidemiology 
1.3.2.1 Asymptomatic carriage 
N. meningitidis is an obligate commensal that exclusively colonises the nasopharynx of 
humans. The bacterium survives only very shortly in the environment; thus, 
transmission between hosts requires the spread of upper respiratory secretions from an 
infected, but, most of the time, symptom-less, individual to his/her close contacts 
(DeVoe, 1982). It is likely that, at one time or another during life, most individuals will 
harbour the bacterium asymptomatically, a phenomenon known as carriage (Broome, 
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1986). While carriage rates are variable among human populations, point-prevalence 
carriage rates in Europe and the United States have been estimated to range from 10 to 
35% in young adults (Cartwright et al., 1987; Caugant DA, 1994; Claus et al., 2005; 
Stephens, 1999). 
 
In Europe and North America, meningococcal carriage is an age-dependent 
phenomenon, with rates increasing sharply in teenagers, reaching a peak in young 
adults aged between 20 to 24 (Caugant and Maiden, 2009). Carriage rates tend to be 
high in institutional settings, for example, in military recruits and university students 
(Yazdankhah and Caugant, 2004). Carriage prevalence of N. meningitidis is generally 
higher among household contacts of meningococcal patients (Cardenosa et al., 2001; 
Cooke et al., 1989; Olcen et al., 1981) than in the general population. The duration of 
the carrier state is highly variable, from days to months, probably depending on the 
characteristics of the colonising strain (Caugant et al., 2007).  
 
1.3.2.2 Invasive disease 
Relative to their high carriage prevalence, meningococci rarely cause disease. The 
overall incidence of meningococcal disease in Europe and North America is 1 to 3 per 
100,000 population, with the highest age-specific incidence rates seen in children under 
5 (Stephens et al., 2007). Close contact with patients who have meningococcal disease 
increases the risk of meningococcal disease 500 to 2000 fold (Peltola, 1983). The 
highest incidence rates are found in countries of sub-Saharan Africa, in the so-called 
‘‘meningitis belt’’ which extends from Ethiopia in the East to Senegal in the West 
(Lapeyssonnie, 1963). In these countries, large outbreaks mainly caused by N. 
meningitidis serogroup A occur about every 5 to 10 years during the dry season, with 
annual incidence rates of as much as 1000 per 100,000 being recorded during the most 
severe epidemics (Stephens et al., 2007). Serogroup B meningococci, which are 
generally absent in sub-Saharan Africa, are primarily responsible for invasive disease in 
industrialised countries in Europe and America (Caugant and Maiden, 2009). 
Serogroup C meningococci also cause invasive disease worldwide, especially in 
adolescents and young adults (Caugant, 2008) while serogroup Y meningococci have 
emerged as an important cause of disease in the United States since the mid 1990s 
(Stephens et al., 2007). Serogroup W-135 has emerged as a cause of outbreaks 
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associated with the Hajj pilgrimage in 2000 (Aguilera et al., 2002) and in Burkina Faso 
in 2002 (Teyssou and Muros-Le Rouzic, 2007). 
 
1.3.3 Meningococcal disease 
Occasionally, shortly after the onset of colonisation, usually less than 10 days from first 
exposure (Caugant and Maiden, 2009), N. meningitidis may penetrate the mucosal 
membrane and gain access to the bloodstream, where they can survive and multiply 
intravascularly. Progression to severe meningococcal disease can occur very rapidly. 
The most important factors predisposing individuals to invasive meningococcal disease 
known to date are the lack of circulating protective bactericidal antibodies and defects 
in the complement system (Stephens et al., 2007). From the blood stream, the 
bacterium is then disseminated to various organs and more than half of the patients 
developing a systemic meningococcal infection will present with clinical symptoms of 
meningitis (Brandtzaeg, 2006). This is when the bacteria cross the blood brain barrier 
and infect the meninges and cerebrospinal fluid. N. meningitidis is thus a major 
infectious cause of disability and death in children in the world with about 10% 
mortality (van Deuren et al., 2000) and survivors are left severely disabled through 
neurological damage or loss of limbs, the result of severe vascular damage, thrombosis 
and gangrene (Stephens et al., 2007). 
 
1.4 Neisseria lactamica 
N. lactamica is a commensal that most commonly colonises the nasopharynx of infants 
and young children (Blakebrough et al., 1982; Gold et al., 1978). It can be 
distinguished from all other Neisseria by the production of acid from lactose (Hollis et 
al., 1969). N. lactamica is carried mainly by infants and young children in the seven 
months to three year age group with up to 50% colonisation rates at any one time (Gold 
et al., 1978; Olsen et al., 1991). MLST of N. lactamica isolates from infants show that 
they are genetically diverse, with 69 distinct genotypes recovered from the subjects. 
Carriage was generally long-lived, with 15% (11 of the 75 infants) carrying more than 
one genotypically unique isolate during the course of the study (Bennett et al., 2005).  
 
N. lactamica carriage has been shown to induce cross reactive antibodies against 
meningococcal strains of different serogroups (Gold et al., 1978). The antibody induced 
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is not directed against the capsule, as N. lactamica is not encapsulated (Kim et al., 
1989).  Immunisation with live N. lactamica has been shown to provide protection 
against lethal meningococcal challenge and elicit serum bactericidal antibodies in mice 
(Li et al., 2006). OMVs derived from a strain of N. lactamica (Y92-1009) are currently 
being evaluated as a vaccine for meningococcal disease. In the phase 1 trial, it has been 
shown that the vaccine is safe and induces a broad humoral immune response to N. 
meningitidis. IgG against meningococcal OMVs were induced and serum bactericidal 
and opsonophagocytic activities were observed against six diverse strains of serogroup 
B N. meningitidis (Gorringe et al., 2009). 
 
N. lactamica behaves as a commensal and is not known to cause invasive disease in 
immunocompetent individuals. In fact, the only rare times that N. lactamica has been 
found to cause disease are in immunocompromised individuals (Zavascki et al., 2006).   
 
1.5 Colonisation of the human host  
For both N. meningitidis and N. lactamica, the first step of interaction with the human 
body occurs with the colonisation of the upper respiratory tract. Several studies have 
investigated how N. meningitidis interact with host epithelial cells in a multi step model 
during colonisation.  
 
Using human polarised epithelial colonic cells (T84 cells) as a surrogate colonisation 
model, Pujol et al. (1997) have indicated that the initial contact of meningococci with 
host epithelial cells is mediated by type IV pili, which are composed mostly of pilin 
encoded at the pilE locus. Type IV pili also mediates bacterial adherence to other 
human epithelial cells such as Chang cells (human conjunctival epithelial cells), Hep-2 
cells (human larynx carcinoma cells),  nonciliated columnar epithelial cells (using a 
human nasopharyngeal organ culture model) and also endothelial cells like human 
umbilical vein endothelial cells (HUVECs) (Stephens et al., 1983; Virji et al., 1993b).  
Interaction of type IV pili with CD46 on some host epithelial cells has been shown to 
be involved in bacterial attachment. When antibodies against CD46 were used, binding 
of piliated N. meningitidis FAM20 to ME180 epithelial cells (from cervical carcinoma) 
was blocked (Kallstrom et al., 1997). In contrast, other studies using polarised Calu-3 
human bronchial epithelial cells have found that CD46 is not involved in the adhesion 
of N. meningitidis to these cells, as addition of purified CD46 or anti-CD46 antibodies 
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did not inhibit bacterial attachment (Sutherland et al., 2010). It is likely that the 
interaction of CD46 with type IV pili is one of several components that facilitate 
bacterial adherence to human epithelial cells.  
 
The pilus-mediated adhesion phase is called localised adhesion and occurs within the 
first 6 hours after infection. During this process, meningococci proliferate on the 
surface of the epithelial cells, forming small microcolonies at the site of initial 
attachment (Figure 1.1, a) (Pujol et al., 1997). In addition to pilin, PilC1 protein is also 
required for adhesion as mutation of the gene results in the inability of meningococci to 
adhere to epithelial cells (Backman et al., 1998; Nassif et al., 1994; Pron et al., 1997; 
Rahman et al., 1997; Rudel et al., 1995; Ryll et al., 1997; Virji et al., 1995a). Pilin 
mediated binding of the meningococcus to CD46 receptor of the host has been shown 
to trigger a cytosolic calcium flux which in turn reinforces the initial, weak attachment 
via CD46 (Kallstrom et al., 1998).  
 
After initial adherence, between 6 to 18 hours, the pili disappear and individual 
diplococci become intimately associated with the host plasma membrane, exhibiting a 
diffuse pattern of adherence on the epithelial cells (Figure 1.1, b) (Pujol et al., 1997). A 
follow up study using meningococci with a mutation in its PilT protein resulted in loss 
of piliation, dispersal and subsequent intimate attachment of the bacteria (Pujol et al., 
1999). Close adherence of meningococci to the host epithelial cells can be mediated by 
the bacterial opacity proteins, Opa and Opc, which interact with carcinoembryonic 
antigen-related cell adhesion molecule 1 (CEACAM 1) (Opa) and heparan sulphate 
proteoglycans (HSPGs) (Opa and Opc). Opa and Opc proteins are transmembrane 
molecules that form β-barrel structures in the outer membrane of the bacteria (Virji, 
2009). Together, the pili, Opa and Opc proteins are considered major adhesins of N. 
meningitidis. 
 
In contrast, little information is known about how commensal bacteria like N. lactamica 
can adhere and invade epithelial cells. There are two classes of type IV pili which are 
structurally distinct. They are encoded by different genes, have different subunit 
molecular masses and react to different monoclonal antibodies (Diaz et al., 1984). 
Some strains of N. meningitidis such as MC58 possess class 1 pili while other strains 
such as FAM18 possess class 2 pili. In contrast,  N. lactamica only possess class 2 pili 
(Fowler et al., 2006; Hardy et al., 2000; Snyder et al., 2005). Although it is not known, 
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N. lactamica is also thought to use its pilus for the initial association with host 
epithelial cells as part of the colonisation process. Comparative genome hybridisation 
experiments determined the presence and absence of pilC in N. meningitidis and N. 
lactamica strains, respectively (Snyder and Saunders, 2006). Therefore, PilC (or a 
homologue) does not appear to be involved in the adhesion of N. lactamica to host 
epithelial cells.  
 
A gene encoding Opc was not present in two strains of N. lactamica strains (L13 and 
L18) (Stabler et al., 2005) but was present in 70% of the strains of N. meningitidis 
tested (Seiler et al., 1996). This suggests that Opc is not involved in the interaction of 
N. lactamica with epithelial cells. However, further work is required to determine 
whether the lack of an Opc homologue in N. lactamica is a species trait or is only 
confined to a subset of strains. On the other hand, Opa is present in several strains of 
both N. meningitidis and N. lactamica (Snyder and Saunders, 2006; Toleman et al., 
2001). It has been shown in in vitro studies using human epithelial cells that 
meningococcal Opa proteins can play a central role in colonisation by mediating 
intimate attachment between the bacteria and the human nasopharyngeal mucosa (Virji 
et al., 1993a). 
 
 
(a)        (b)   
 
Figure 1.1: Scanning electron microscope examination of human polarised epithelial cells with 
meningococci, taken from Pujol et al. (1997) 
(a) Localised adherence at 4 hours which is pilus mediated and leads to the formation of small colonies 
on the surface of the apical membrane. 
(b) At a later time-point of 9 hours, bacteria express a diffuse pattern of adherence and the apical surface 
is covered by a single monolayer of diplococci instead of localised clumps. 
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1.6 Differences between N. meningitidis and N. lactamica 
1.6.1 Capsule 
Comparative genome hybridisation experiments with a pan-Neisseria array showed that 
genes for the biosynthesis of capsular polysaccharides were only found in N. 
meningitidis but not in N. lactamica. (Stabler et al., 2005). N. meningitidis is classified 
into 13 serogroups dependent on capsule type. Five of them, A, B, C, Y and W135 
account for more than 90% of invasive disease worldwide. Successful polysaccharide 
and polysaccharide-protein conjugate vaccines based upon four of these 
polysaccharides (A, C, Y and W135) are now available. Strains of serogroup B are a 
particular problem because they are a major cause of invasive disease in Europe and the 
United States (Jones, 1995), and there is currently no effective vaccine as this capsular 
serogroup mimics human antigens and is a poor immunogen (Stephens et al., 2007). 
The capsule is an importance virulence factor which can protect N. meningitidis against 
phagocytosis (Read et al., 1996), complement mediated lysis (Schneider et al., 2007) 
and prevent desiccation during transmission (Virji, 1996).  
 
1.6.2 Lipooliogosaccharide (LOS) 
Another important component of N. meningitidis is the LOS located in the bacterial 
outer cell membrane. Meningococcal LOS lacks the repeating O antigens of enteric 
LPS but maintains a conserved inner core of membrane-associated lipid A (Kulshin et 
al., 1992) to which variable α- and β-chains attach (Kahler and Stephens, 1998). Lipid 
A is the active moiety through its ability to up-regulate the inflammatory response. 
LOS has been implicated in meningococcal interaction with host cells such as epithelia 
and peripheral blood monocytic cells. For example, a stimulation of 1 ng/ml of LOS 
from H44/76 strain of N. meningitidis resulted in the secretion of proinflammatory 
cytokines such as IL1 and TNF-α by human peripheral blood mononuclear cells 
(Sprong et al., 2001). LOS is a major factor contributing to the human proinflammatory 
response in meningococcal sepsis and meningitis (Kahler and Stephens, 1998; van 
Deuren et al., 2000). Clinically, LOS values up to 500 ng/ml and bacterial numbers up 
to 5 X 108 colony forming units (cfu)/ml in cerebrospinal fluid during meningococcal 
meningitidis have been detected (Bingen et al., 1990; Brandtzaeg et al., 1992b; 
Mariani-Kurkdjian et al., 1999). Genomic bacterial load quantified by real time 
polymerase chain reaction of ctrA (a single copy gene) indicate a median concentration 
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of log10 5.29 copies of the bacteria/ml in whole-blood samples of patients who died 
from meningococcal disease (Darton et al., 2009). Fulminant meningococcal sepsis is 
characterised by high plasma concentrations of endotoxin that range from 0.75 to 170 
ng/ml (Brandtzaeg et al., 1992a; Brandtzaeg et al., 1989a; Brandtzaeg et al., 1989b; 
van Deuren et al., 2000; van Deuren et al., 1992). Furthermore, the morbidity and 
mortality of meningococcal sepsis are directly correlated with levels of circulating 
meningococcal LOS (Brandtzaeg et al., 1992a; Brandtzaeg et al., 1989a).  
 
In addition, LOS contributes to the pathogenicity of N. meningitidis by helping the 
bacteria avoid complement-mediated lysis (Schneider et al., 2007). LOS contributes to 
N. meningitidis resistance to the human antimicrobial peptide, LL-37 by limiting its 
interaction with the bacterial surface (Jones et al., 2009).  
 
In contrast, there is little information on the contribution of LOS from N. lactamica on 
the host response. N. lactamica shares LOS structures and epitopes with strains of N. 
meningitidis (Kim et al., 1989). N. meningitidis and N. lactamica share cross-reactive 
carbohydrate antigens (part of the LOS) and this may indicate that glycoconjugate 
antigens found on commensal Neisseria like N. lactamica might be involved in the 
development of natural immunity to meningococcal endotoxins. 
 
1.6.3 Genome and proteome comparisons of N. meningitidis and N. lactamica 
The whole genome sequences of three disease causing strains of N. meningitidis have 
been determined. They are strains Z2491 (serogroup A) (Parkhill et al., 2000), MC58 
(serogroup B) (Tettelin et al., 2000) and FAM18 (serogroup C) (Bentley et al., 2007). 
Each sequenced genome consists of a single circular chromosome with an average size 
of 2.2 Mb. The genome sequence of N. lactamica (ST640) has been completed at the 
Sanger Institute with a similar genome size. However, the sequences have not yet been 
properly annotated or published.  
 
With the availability of annotated genome sequences from N. meningitidis, several 
groups tried to identify genes specific to N. meningitidis, for example, pathogen 
specific virulence genes (Perrin et al., 2002; Perrin et al., 1999; Snyder and Saunders, 
2006; Stabler et al., 2005). It is thought that such analyses may identify genes that are 
associated with the virulence of N. meningitidis. The whole genome sequences were 
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used to produce microarrays and comparative genome hybridization experiments using 
genomic DNA from both N. meningitidis and N. lactamica were carried out. The 
majority of potential virulence genes in N. meningitidis have some role on the bacterial 
cell surface, including secretion system proteins, capsule modification and adhesion 
and invasion. There were also comparisons between N. meningitidis and N. lactamica 
which focused on genes encoding specific classes of molecules like secreted proteins 
and components in OMVs (Abel et al., 2007; van Ulsen and Tommassen, 2006; 
Vaughan et al., 2006). The following sections focus on some of these genes and the 
effects on the host by the encoded proteins. 
 
1.6.3.1 Secreted proteins 
A review by van Ulsen and Tommassen (2006) used the available genomes of N. 
meningitidis and of N. lactamica (ST640) to identify genes encoding secreted proteins 
using sequence homology to known genes encoding bacterial secreted proteins.  From 
this, both N. meningitidis and N. lactamica specific secreted proteins can be identified 
although the number of strains used for N. lactamica are still limited. For example, iga 
genes are identified in N. meningitidis strains belonging to serogroups A (Z2491), B 
(MC58) and C (FAM18) as well as a strain of N. gonorrhoeae (FA1090). However, it 
was not found in the genome of N. lactamica (ST640). In contrast, ata-1, ata-2 and ata-
3 which encode homologues of known secreted proteins in other bacteria (such as 
Escherichia coli, Shigella flexneri and Bordetella pertussis) are found in the genome of 
N. lactamica (ST640) but not in any of the genomes of N. meningitidis. 
 
1.6.3.1.1 IgA1 protease 
The gene encoding IgA1 protease is present in the A, B and C serogroups of N. 
meningitidis (Z2491, MC58 and FAM 18) but not in N. lactamica (ST640) (van Ulsen 
and Tommassen, 2006). In Southern hybridisation experiments, no homology to the iga 
gene was detectable in the chromosomal DNAs of several commensal Neisseria species 
(Jose et al., 2003). IgA1 protease seems to be an important virulence factor by cleaving 
IgA1, which is present on the human mucosal surface. This in turn can prolong 
bacterial extracellular survival (Virji, 2009). IgA1 protease can also cleave the 
lysosomal/phagosomal protein LAMP1, which is thought to promote the intracellular 
survival of N. meningitidis (Ayala et al., 2001; Lin et al., 1997). When added to 
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peripheral blood mononuclear cells, IgA1 induces expression of proinflammatory 
cytokines such as TNF-α, IL6 and IL8. Therefore, together with LOS, IgA1 may also 
contribute substantially to the overwhelming proinflammatory responses seen during 
invasive disease in the blood (Lorenzen et al., 1999). In particular, comparisons of 
IgA1 protease activity between invasive isolates (including MC58) and colonising 
strains of N. meningitidis indicate a higher activity in the former, showing that not only 
the presence, but also the activity level of IgA1 protease is a virulence determinant that 
contributes to the pathogenic phenotype of some N. meningitidis strains (Vitovski et al., 
1999). 
 
1.6.3.2 Outer membrane proteins (OMPs) and outer membrane vesicles 
(OMVs)  
Neisseria possess OMPs which can mediate interaction with host cells. Some of these 
OMPs can be part of OMVs (together with LOS and periplasmic proteins) which are 
shed by live bacteria (blebbing). The latter process in N. meningitidis has been 
associated with fatal meningococcal septicaemia, characterised by an extremely high 
level of endotoxin (Namork and Brandtzaeg, 2002). Genomic and proteomic studies of 
N. meningitidis and N. lactamica have compared the OMPs in these two species of 
Neisseria. 
 
Perrin et al. (1999) compared the genome of N. meningitidis (serogroup A Z2491), N. 
gonorrhoeae (FA1090) and N. lactamica (strains 8064, 9764) using subtractive and 
representational difference analysis to identify genes specifically present in N. 
meningitidis and N. gonorrhoeae. Sequences present in N. lactamica were physically 
subtracted from the N. meningitidis Z2491 and also from the N. gonorrhoeae FA1090 
sequences. The clones obtained from each subtraction were tested by Southern blotting 
for their reactivity with the three species, and only those which reacted with both N. 
meningitidis and N. gonorrhoeae were further investigated. Clones were mapped onto 
the chromosome and functional identification of genes carried out using homology of 
open reading frames. Genes encoding OMPs such as PorA is present in N. meningitidis 
but not in N. lactamica. The same results were obtained with a follow up study by 
Perrin et al. (2002). An array was designed from N. meningitidis serogroup A Z2491 
DNA sequence and reacted with genomic DNA from eight strains of N. meningitidis (a 
panel of virulent meningococci chosen to represent the major phylogenetic groups 
Chapter 1 
30 
causing disease), as well as three N. gonorrhoeae and two N. lactamica strains. Genes 
specific to N. meningitidis and not in N. lactamica (such as those encoding PorA) could 
also be identified. 
 
The release of four complete pathogenic Neisseria species annotated genome sequences 
(serogroup A Z2491, serogroup B MC58, serogroup C FAM18 and N. gonorrhoeae 
FA1090) allowed the comparisons between potential pathogenic Neisseria with other 
commensal Neisseria species like N. lactamica. The DNA array technology was 
expanded to allow the construction of a pan-Neisseria microarray with every gene in all 
four genomes represented. Stabler et al. (2005) hybridised the pan-Neisseria microarray 
with 26 other N. meningitidis strains and other commensal neisserial strains, including 
two of N. lactamica (L13 and L18). They managed to identify 55 genes that were 
absent from all the commensals (and from the N. lactamica ST640 sequencing project) 
but present in all N. meningitidis serogroup B strains tested. Some of the genes encode 
OMPs such as TonB-dependent receptor proteins and OpcB. TonB has a function in the 
transport of iron from receptors on the outer membrane to the bacterial cytoplasm while 
OpcB mediates adhesion and invasion. 
 
Proteomic analysis of N. lactamica and N. meningitidis OMV components have been 
carried out by two groups (Abel et al., 2007; Vaughan et al., 2006) in a bid to identify 
proteins specific to either bacteria. Vaughan et al. (2006) compared the OMVs of N. 
lactamica Y92-1009 with that of N. meningitidis K454 using mass spectrometry. 
Proteins specific to either bacteria were identified by matching the mass spectrometry 
data to the respective sequenced genomes. They found that both N. meningitidis and N. 
lactamica possess common OMPs such as PorB, RmpM and NspA. In contrast, 
surface-associated proteins like PorA, NadA, FrpA and TonB-dependent receptor were 
specific to N. meningitidis. In addition, some cytoplasmic proteins like ribonuclease E 
were also present in the OMVs of N. lactamica and N. meningitidis.  
 
Abel et al. (2007) compared the OMVs from N. meningitidis disease isolates (strains 
B16B6, M982, Nm30) with that from N. lactamica strains isolated from the oropharynx 
of volunteers. Western blotting techniques, mass spectrometry and bioinformatic 
comparisons using protein homology to known OMPs in other bacteria allowed the 
identification of the proteins. Similar to Vaughan et al. (2006), they found that both N. 
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meningitidis and N. lactamica possess common OMPs such as RmpM, while surface-
associated proteins like PorA is specific to N. meningitidis.  
 
In summary, genomic comparisons of N. meningitidis and N. lactamica as well as 
proteomic analysis of the OMVs of these two bacteria indicate differences and 
similarities in the OMP composition. Both N. meningitidis and N. lactamica possess 
common OMPs such as Por B, RmpM and NspA. NspA is also a major component in 
the OMVs of the two neisserial species. PorA however, is specific to N. meningitidis.  
 
Host responses to neisserial OMPs and OMVs have been described, but mainly in N. 
meningitidis. For example, a study by Humphries et al. (2005) demonstrated that 
components in the meningococcal outer membrane induced secretion of 
proinflammatory cytokines like IL8 and IL6 by meningioma cells, and that LOS was 
only a small contributor to this effect. These data suggested that meningococcal OMPs 
contributed to the induction of proinflammatory cytokines.  In addition, meningococcal 
porins are not only strong immune adjuvants and B cell activators but N. meningitidis 
PorB interacts with mitochondria and protects host cells from apoptosis (Massari et al., 
2000). Besides a role in adhesion, Opa is present in neisserial OMVs and can bind 
CEACAM 1 and suppress CD4+ T lymphocyte function (Lee et al., 2007). 
 
1.6.4 Host responses to N. meningitidis  
The host response to a wide variety of meningococcal strains both in vitro and in vivo 
has been described (Bonnah et al., 2004; Linhartova et al., 2006; Plant et al., 2004; 
Waage et al., 1989; Waage et al., 1987). At the in vitro level, the cell types used have 
differed dependent on whether the investigation was focused on the colonisation or 
invasive stages of disease. The following sections describe studies on host responses to 
N. meningitidis representing different stages of interactions with the human host. 
 
1.6.4.1 Colonisation of the human respiratory tract 
Neisseria colonise nasopharyngeal epithelium, where the bacteria adhere and/or invade. 
There are several papers which have detailed the interaction of meningococci with the 
host as described in the earlier sections. Host expression studies at the epithelial level, 
however, are few and focus mainly on studying host genes involved in inflammation, 
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adhesion and iron homeostasis (Bonnah et al., 2004; Plant et al., 2004). Plant et al. 
(2004) undertook microarray experiments using a commercially available cDNA array 
aimed at studying genes involved in inflammation and adhesion in response to N. 
meningitidis. ME-180, an epithelial-like human cell line from a cervical carcinoma was 
infected with N. meningitidis FAM20 strain (serogroup C). Most of the host genes 
induced early in infection (2 hours) were chemokine receptors and cytokines such as 
CXCR4, CXCR5, IL1A, IL1B, IL18 and IFN-γ. Bonnah et al. (2004) used a human 
epidermoid carcinoma line (A431) to show that mRNA expression of several host 
genes involved in iron homeostasis is altered upon infection with meningococci. 
 
1.6.4.2 Invasion into the blood 
1.6.4.2.1 Vascular endothelial cells 
N. meningitidis occasionally causes disease when it enters into the systemic circulation 
and multiplies in the host. For this, it requires passage across the respiratory epithelial 
barrier as well as vascular endothelial cells to enter into the blood. In vitro studies using 
HUVECs have been carried out to determine how the presence of meningococci can 
affect the host transcriptional response in the endothelial cells (Linhartova et al., 2006). 
Their results indicated that pilus-mediated adhesion and growth of meningococci in 
microcolonies on the host cell surface results in alterations of expression levels of 
human genes known to regulate apoptosis, cell proliferation, inflammatory response, 
adhesion and genes for signalling pathway proteins such as TGF-β/Smad, Wnt/β-
catenin and Notch/Jagged. Expression of these proteins increases the ability of host 
cells to withstand apoptotic signals induced by infection allowing the maintenance of 
normal cell function. Genes that responded to meningococcal infection independent of 
bacterial adherence were involved in apoptosis, stress response, hypoxia, cytoskeletal 
protein reorganization, cell adhesion and cytokine, chemokine and other inflammatory 
mediator production. It is thought that these responses could be involved in human 
vascular cell damage that appears to play a key role in the pathogenesis of invasive 
meningococcal disease. 
 
The host response to meningococci in vivo in the blood has also been described. Serum 
samples from patients with meningococcal septic shock were collected and cytokines 
levels recorded in an attempt to determine the cause of fatal outcome in meningococcal 
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disease (Waage et al., 1989; Waage et al., 1987). These studies indicate that a complex 
pattern of cytokines exists in serum from patients with meningococcal septic shock, and 
that the release of IL6 and IL1, in addition to TNF-α, is associated with fatal outcome. 
 
1.6.4.2.2 Complement system  
Once in the blood, N. meningitidis faces host innate immune defence mechanisms, one 
of which is the complement system. The latter is required for protection against 
meningococcal disease, being mediated through bactericidal antibodies and 
complement. Human genetic studies have identified the complement system as an 
important defence mechanism against meningococcal disease. Patients with 
deficiencies in certain components of the complement system, such as C3 and C5 to 
C9, as well as those with immunoglobulin deficiencies are more susceptible to 
developing meningococcal disease (Emonts et al., 2003). Complement is activated on 
the surface of the meningococcus by one or more of the three initial complement-
activating pathways; the classical, alternative or lectin pathway (Schneider et al., 2007). 
The classical pathway is initiated by the binding and activation of the C1 complex, 
consisting of C1q, C1r and C1s. C1q can bind bactericidal antibodies bound on the 
surface of the bacteria. When C1q binds, its associated proteases, C1r and C1s, become 
activated and form the activated C1 complex, which cleaves C4 and C2 to generate 
C4b2a; this functions as a C3 convertase. This antibody-dependent classical pathway is 
responsible for most of the complement mediated killing of meningococci 
(Goldschneider et al., 1969). The lectin pathway is initiated when mannose binding 
lectin (MBL) bind Opa and PorB on the meningococcal surface (Estabrook et al., 
2004). MBL can form complexes with MBL-associated serine protease-2 (MASP-2), 
which cleaves C4 and C2 to yield C3 convertase. MBL deficiency and specific 
sequence polymorphisms in the gene encoding MBL have been associated with 
meningococcal disease (Bax et al., 1999; Hibberd et al., 1999), which suggest that the 
lectin pathway is also important for defence against the meningococcus. C3 convertase 
generated by all the pathways cleaves C3 to liberate C3b. C3b itself can also interact 
directly with complement factor B forming C3bBb, the C3 convertase of the alternative 
pathway. Properdin, a positive regulator of the alternative pathway, stabilises C3bBb 
and prolongs its activity. Individuals with deficiencies in properdin are more 
susceptible to meningococcal disease and have more severe symptoms, suggesting that 
the alternative pathway is important in protection against the meningococcus (Sprong et 
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al., 2006). C3b is an essential component of both convertases, C4b2a3b and C3bBb3b, 
which cleave C5 into C5a and C5b, which then participates in the complement cascade 
involving the formation of the C5b to C9 complex (membrane attack complex [MAC]). 
The MAC inserts in the outer membrane of the bacteria and results in its lysis. The 
polysaccharide capsule protects the meningococcus from the correct insertion of MAC, 
and so prevents the efficient lysis of the bacteria. In addition, C3b and iC3b (a 
breakdown product of C3b) act as opsonins on bacterial surfaces, allowing the uptake 
of the bacteria by phagocytotic cells (opsonophagocytosis) through complement 
receptor 1 (CR1) (for C3b) (Ehlenberger and Nussenzweig, 1977), as well as through 
CR3 and CR4 (for iC3b).  
 
Meningococci modulate steps in the complement cascade by binding negative 
regulators. This allows the bacteria to subvert host complement defences. N. 
meningitidis binds C4bp, an inhibitor of both the classical and lectin pathways in a 
PorA dependent manner (Jarva et al., 2005). Factor H (fH), a negative regulator of the 
alternative pathway, has been shown to interact with a meningococcal surface 
lipoprotein known as factor H binding protein. It has been recently shown that N. 
meningitidis mimics the mechanism by which host cells regulate complement activation 
on their surface by using amino acid side-chains instead of charged sugars, and in doing 
so is able to recruit fH to its surface (Schneider et al., 2009). By binding fH, the 
meningococci is more resistant to complement mediated killing and is associated with 
increased survival in the blood (Haralambous et al., 2006; Schneider et al., 2006).  
 
Complement can also contribute to the proinflammatory response of the host through 
the production of C5a, an anaphylotoxin. Stimulation of immune cells in the blood like 
PMNs and monocytes or macrophages with C5a results in an up-regulation of 
proinflammatory cytokines and chemokines, such as IL1, IL6, IL8 and TNF-α. 
 
1.6.4.2.3 Toll-like receptors (TLRs) 
Another way in which the human host defends itself against N. meningitidis is via 
TLRs, which can recognise evolutionarily conserved microbial associated molecular 
patterns on the surface of the bacteria. Upon ligand recognition, TLRs signal to the 
intracellular milieu and stimulate expression of inflammatory and antimicrobial genes 
(Akira and Takeda, 2004; Akira et al., 2006). N. meningitidis is recognized by TLR2 
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and 4 on immune cells in the blood, which recognize bacterial porins (PorB) and LOS, 
respectively (Massari et al., 2002; Zughaier et al., 2004). Rare heterozygous missense 
mutations of TLR4 were significantly over-represented among patients with systemic 
meningococcal disease, suggesting that a deficiency in the sensing of meningococcal 
LOS increases the risk of meningococcal disease (Smirnova et al., 2003). In addition, 
using a mouse model for meningococcal sepsis (Sjolinder et al., 2008), it has been 
reported that TLR9 is also essential for optimal host defence against N. meningitidis 
and contributes to the production of cytokines by plasmacytoid dendritic cells. Mice 
deficient in TLR9 are more susceptible to meningococcal sepsis, suggesting that this 
receptor is essential for bacterial clearance. Although TLRs are important in innate host 
defences, uncontrolled proinflammatory activation is detrimental for the host and is one 
of the hallmarks of fulminant sepsis. The release of IL6, IL1, and TNF-α is associated 
with fatal outcome in meningococcal sepsis (Waage et al., 1989; Waage et al., 1987). 
 
1.6.4.3  Host-bacterial interactions during meningitis 
Bacterial meningitis results from the entry of N. meningitidis into the cerebrospinal 
fluid, which involves the adhesion and translocation of brain endothelial cells (via Opc) 
and subsequent interactions with cells of the leptomeninges. These processes have been 
mimicked in vitro using endothelial and more recently meningeal cells (Christodoulides 
et al., 2002; Sokolova et al., 2004; Wells et al., 2001). It has been observed that these 
meningeal cells are capable of producing proinflammatory mediators such as IL6, IL8 
and TNF-α, and are thought to be one of the main sources of cytokines detected within 
the cerebrospinal fluid of patients with meningitis. Besides inflammation, a human 
cDNA microarray study on the response of human brain endothelial cells to N. 
meningitidis (Schubert-Unkmeir et al., 2007) found activation of genes involved in 
other functions such as cytoskeletal reorganisation, which is thought to be involved in 
bacterial uptake. 
 
1.6.5 Host responses to N. lactamica 
Compared to N. meningitidis, there are few studies that describe the host response to 
commensal N. lactamica. It has been shown that immunisation with live N. lactamica 
protects mice against meningococcal challenge and can elicit serum bactericidal 
antibodies (Li et al., 2006). Fowler et al. (2006) compared the inflammatory responses 
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of human meningeal cells following challenge with N. lactamica and N. meningitidis to 
understand how different species of Neisseria interact with cells derived from the 
leptomeninges and concluded that cells from the meninges can participate in innate host 
immune responses to both N. lactamica and N. meningitidis. There was a differential 
regulation of cytokines, where N. meningitidis induced a significantly higher amount of 
IL6 compared to N. lactamica, which led the authors to suggest that this is one of the 
reasons why N. meningitidis may be able to induce a much greater and more damaging 
proinflammatory response compared to N. lactamica during bacterial meningitis. 
 
1.7 Host cell models representative of the respiratory tract 
Many of the studies investigating interactions between N. meningitidis and the human 
host involve the use of cell lines representing different bodily locations of the host, 
depending on which stage of the interaction (either colonisation or invasive disease). 
As described in the previous sections, human epithelial cell lines used to represent host 
cells during neisserial colonisation at the nasopharynx include ME-180 (an epithelial-
like human cell line from a cervical carcinoma) (Plant et al., 2004) and T84 cells 
(human polarised epithelial colonic cells) (Pujol et al., 1997). ME-180 cells were used 
to study genes involved in inflammation and adhesion upon interaction with N. 
meningitidis while T84 cells were used to investigate the adherence and traversal of 
cellular monolayers by N. meningitidis. 
 
There are, however, other studies which have used human organ culture models 
representative of the upper airway environment that N. meningitidis is thought to 
encounter during colonisation. Human nasal turbinate mucosa tissue was used to 
investigate and compare the invasion of different strains of N. meningitidis (Townsend 
et al., 2002). Explants of human nasopharyngeal tissue were used to identify 
meningococcal genes necessary for colonisation (Exley et al., 2009). In contrast to a 
cell line which consists of a single cell type, upper airway organ culture models present 
the bacteria with the physical epithelial barrier (made up of polarised columnar cells 
joined by tight junctions) and subepithelial layer present in the upper respiratory tract. 
In addition, mucociliary transport is maintained by active cilia present on the apical 
epithelial surface. However, although human organ culture models permits the study of 
the interaction of Neisseria in an environment close to the in vivo state compared to cell 
lines, they are difficult to handle and are present in limited amounts. In this thesis, the 
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16HBE14 cell line was used to investigate interactions of N. meningitidis and N. 
lactamica with the host during colonisation. It is a non-carcinoma cell line derived from 
primary human bronchial epithelial cells and transformed by SV40 large T antigen. In 
addition, it has been shown to retain differentiated epithelial morphology and functions 
(Cozens et al., 1994). Unlike the other cell lines such as those derived from cervical 
carcinoma (ME-180) and colon epithelium (T84), it is an epithelial cell line derived 
from bronchial epithelium and so may closer represent the human respiratory tract.  
 
1.8 Using human microarrays to investigate host-pathogen interactions 
With the sequencing of the human genome, there has been a deluge of human 
microarrays constructed and used to improve our understanding of the gene expression 
changes in host cells in response to pathogens. One of the first applications of global 
gene expression methods to investigate host-pathogen interactions was the use of 
oligonucleotide arrays to monitor gene expression in primary human fibroblasts 
infected by human cytomegalovirus (Zhu et al., 1998). Total RNA was converted into 
cDNA, which then undergoes in vitro transcription to produce single stranded 
biotinylated RNA for hybridisation on to the DNA arrays. In this case, there were only 
about 6600 genes on the array. In these initial arrays produced by Affymetrix, the 
probes are fabricated by in situ synthesis of oligonucleotides (each about 25 nucleotides 
long). These Affymetrix GeneChip arrays are constructed in a specific layout, with 
each probe synthesised at a predefined location. Samples are processed separately as 
each array can hold one sample (Barnes et al., 2005).  
 
Closer to the neisserial-host interaction field, Schubert-Unkmeir et al. (2007) utilised a 
cDNA microarray to investigate gene expression of human brain microvascular 
endothelial cells in response to N. meningitidis (MC58). Total RNA was converted into 
cDNA, which was radiolabelled and hybridised onto plastic human microarrays 
containing oligonucleotides representing about 12,000 genes. Although representing 
more genes than the Affymetrix GeneChip, these arrays were still not covering all the 
genes encoded by the human genome. New approaches to human gene expression 
arrays by Illumina include the introduction of long oligonucleotides bead-based arrays 
which contain probes (each about 50 nucleotides long) against a majority of genes 
encoded by the human genome (approximately 20,591 genes). In addition to the 
increased number of probes, the Illumina HumanRef-8 BeadChip has 30 copies of the 
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same oligonucleotide within the array, which provide an internal technical replication 
which is lacking in the Affymetrix arrays. By having eight arrays on a chip and more 
probes in an array, the Illumina HumanRef-8 BeadChip provides a fast and high 
throughput method to look at the expression of several genes in many samples in a 
single process (Barnes et al., 2005). In this thesis, the Illumina HumanRef-8 BeadChip 
was used to investigate the whole genome wide expression of human cells to Neisseria. 
 
1.9 Hypothesis and aims 
Despite there being a large amount of data available on how N. meningitidis interacts 
with various types of host cells at different disease stages, as well as how N. 
meningitidis is different from N. lactamica, it is still not understood why these two 
bacteria differ in their clinical outcome potential. Investigations in the gut have 
suggested an important role of bacterial-host interactions whereby commensals may 
possess a variety of strategies for successful colonisation, which in turn can evoke 
different host responses (Section 1.1). 
 
In contrast, the various mechanisms that allow N. meningitidis and N. lactamica to 
successfully colonise their hosts in the respiratory tract are poorly defined but are also 
likely to involve both host and bacterial factors. In this thesis, N. meningitidis and N. 
lactamica have been used as model organisms to determine whether, as observed for 
different commensal bacteria in the gut, they differentially affect host cell responses 
during colonisation.  
 
I hypothesise that early interactions of N. meningitidis and N. lactamica with 
respiratory epithelial cells are associated with differential host cell responses, and that 
these may be capable of altering the outcome of the colonisation process. This may 
ultimately lead to the identification of new processes that can point the way towards an 
understanding of how commensals can become pathogens. To enable the hypothesis to 
be tested, the host responses of 16HBE14 human bronchial epithelial cells to N. 
meningitidis MC58 and N. lactamica Y92-1009 have been evaluated. Host responses 
were determined using a genome-wide microarray platform, with selected genes being 
verified both at the transcript and protein level. Furthermore, the role of specific 
bacterial components on host response has been evaluated through mutant (capsule and 
pili) or the use of isolated preparations (secreted proteins) studies.  
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Aims 
• Determine the extent of  N. meningitidis and N. lactamica adherence and invasion 
of 16HBE14 human bronchial epithelial cells 
• Determine the differential gene expression of 16HBE14 human bronchial epithelial 
cells in response to N. meningitidis and N. lactamica 
• Identify bacterial components involved in the differential host response to N. 
meningitidis and N. lactamica 
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Chapter 2 : Materials  and methods. 
Materials and methods 
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2.1 Bacterial strains and growth conditions  
2.1.1 Bacterial strains 
Bacterial strains utilised during this work are described in Table 2.1. Live and 
inactivated bacteria were used. Formaldehyde inactivation of wild type (WT) N. 
meningitidis MC58 and N. lactamica Y92-1009 was carried out by a modification of 
the procedure described by Uronen-Hansson et al. (2004). In brief, bacterial strains 
were grown overnight and harvested by centrifugation. Approximately 4 X 108 cfu of 
bacteria were killed by overnight incubation at 4°C in 5 ml of phosphate buffered saline 
(PBS) pH 7.4 (Invitrogen, UK) containing 2.5% formaldehyde (Merck, USA). The 
bacteria were washed three times with PBS to remove excess formaldehyde. No growth 
was observed on plate cultures confirming bacterial killing. 
 
Table 2.1: Bacterial strains 
a) N. lactamica strains 
N. lactamica strains Source 
WT Y92-1009 Centre for Applied Microbiological Research 
Y92-1009 nspA- Dr Cliona O’ Dwyer 
 
b) N. meningitidis strains 
N. meningitidis  Genotype / Phenotype Source 
WT MC58 B:15:P1.7.16b Virji et al., 1991 
MC58 cap- B:15:P1.7.16b Virji et al., 1995b 
MC58 pilE- B:15:P1.7.16b Virji et al., 1993b 
MC58 cap- nspA- B:15:P1.7.16b Dr Cliona O’ Dwyer 
 
2.1.2 Bacterial growth conditions 
Neisseria were routinely propagated on GC (gonococcal) agar supplemented with 1% 
Vitox (sGC) or on BHI (brain heart infusion) agar (BD Diagnostics, USA) at 37°C in 
5% CO2. All media were sterilised by autoclaving at 121oC for 15 minutes. All 
experiments with N. meningitidis strains were carried out in a containment level 3 
laboratory. Antibiotics were used at the following concentrations for selective growth 
of the N. meningitidis cap- and pilE- mutants: kanamycin 150 µg/ml and erythromycin 
5 µg/ml. 
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2.2 Cell culture 
All solutions and media for cell culture were prepared under aseptic condition in a 
laminar flow hood. All media were sterilised by autoclaving at 121oC for 15 minutes. 
Heat labile reagents were manually filter-sterilised or filtered using a vacuum manifold 
and 0.2 µm polyethersulfone filters (Acrodisc, Nalgene, USA). The 16HBE14 
epithelial cells were grown in sterile plastic tissue culture flasks (BD Biosciences, 
USA). They were cultured in Dulbecco’s Modified Eagle Medium (DMEM) 
(Invitrogen, UK) supplemented with 2 mM L-glutamine, 1% penicillin and 
streptomycin (Invitrogen, UK) and 10% heat inactivated foetal bovine serum (HIFBS) 
(Invitrogen, UK) in a humidified incubator at 37°C with 5% CO2. Briefly, confluent 
cells were passaged in a ratio of 1:3 every 2 to 3 days by washing them in a 0.02% 
mixture of ethylenediaminetetraacetic acid (EDTA) and PBS (Sigma, UK). Trypsin-
EDTA (Sigma, UK) solution was then added to the cells and incubated at 37°C with 
5% CO2 for 10 to 20 minutes until the cells were trypsinised. The cell suspension was 
spun in Falcon tubes at 290 g for 10 minutes before suspending the resultant cell pellet 
in fresh media. 
 
2.3 Epithelial association and invasion assays  
The SV40 large T-antigen transformed human bronchial epithelial cell line 16HBE14 
was used. Cells were seeded in 24-well plates (Nunc, Thermo Fisher Scientific, USA) 
and grown to a confluent monolayer (with approximately 2 X 10 5 cells per well) in 
DMEM supplemented with 2 mM L-glutamine and 10% HIFBS at 37°C in 5% CO2. 
The initial bacterial load was on average 5.4 X 105 cfu per well (multiplicity of 
infection [MOI] of 3) for both association and invasion assays. Live WT N. lactamica, 
N. meningitidis as well as live N. meningitidis cap- and pilE- were used. For the 
association assay, after 4 hours incubation, cells were washed 3 times with Hanks’ 
Balanced Salt Solution (HBSS) (Sigma, UK) and incubated with 1 ml of 1% 
(weight/volume) saponin (Sigma, UK) for 10 minutes at 37°C. For the invasion assay, 
after 4 hours incubation, cells were washed three times with HBSS, and overlaid with 
fresh medium containing 150 µg/ml gentamicin. After further 1 hour incubation, cells 
were washed once with HBSS and incubated with 1 ml of 1% (weight/volume) saponin 
for 10 minutes at 37°C.  For both the association and invasion assays, incubation with 
saponin was followed by scraping the bottom of each well and vigorously pipetting to 
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dissociate bacteria from epithelial cells and from aggregation. Appropriate dilutions 
(with HBSS) were plated out to obtain viable counts. 
 
Total bacterial growth in DMEM alone was also investigated in parallel to the 
association and invasion experiments. Enumeration of total bacteria after 4 hours was 
carried out after appropriate dilutions (with HBSS) and plating. 
 
2.4 Treatment of 16HBE14 human epithelial cells 
2.4.1 Co-culture of Neisseria with 16HBE14 cells  
16HBE14 cells were seeded into 6-well plates and incubated in DMEM supplemented 
with 2 mM L-glutamine and 10% HIFBS at 37°C with 5% CO2 for at least 48 hours. 
Confluent epithelial cells (approximately 9.5 X 105 cells per well) were washed 3 times 
with PBS and its medium changed before infection with the various Neisseria (which 
were also washed prior to infection) at an average of 1.3 X 107 cfu per well. There were 
mock-infected cells (eight replicates each) and cells treated with the following 
conditions: inactivated WT N. lactamica, live WT N. lactamica, inactivated WT N. 
meningitidis, live WT N. meningitidis, live N. meningitidis cap- and live N. 
meningitidis pilE- (four replicates each). At various time-points from 0 to 7 hours, the 
epithelial host cells were washed with HBSS and harvested with Trizol (Sigma, UK). 
Initial bacterial inocula were determined by plating out on sGC agar for enumeration of 
viable organisms. 
 
2.4.2 Treatment with neisserial secreted proteins 
16HBE14 cells were seeded into 6-well plates and incubated in DMEM supplemented 
with 2 mM L-glutamine and 10% HIFBS at 37°C with 5% CO2 for up to 48 hours. 
Confluent epithelial cells (approximately 9.5 X 105 cells per well) were washed 3 times 
with PBS and its medium changed before treatment with the secreted protein 
preparations from WT N. lactamica and N. meningitidis. Two µg of neisserial secreted 
proteins were added per well. There were also mock-infected cells and cells infected 
with WT N. lactamica (average of 7.2 X 106 cfu per well). Each condition had four 
replicates each. At various time-points from 0 to 7 hours, the epithelial host cells were 
washed with HBSS and harvested with lysis buffer (Qiagen, USA). The amount of WT 
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N. lactamica added was determined by plating out on BHI agar for enumeration of 
viable organisms. 
 
2.5 RNA extraction and quantification 
Total cellular RNA from human epithelial cells was extracted using the Qiagen RNeasy 
Mini Kit using on column DNase 1 treatment as per the manufacturer’s instructions 
(Qiagen, USA). Quantification of RNA samples was performed by checking the 
absorbance at 260 nm using a NanoDrop 1000 instrument (NanoDrop Technologies, 
Wilmington, DE). The purity of the RNA was determined by A260/A280 and 
A260/A230. For pure RNA the A260/A280 should be 2.0. 
 
2.6 Microarray procedures and analysis 
2.6.1 RNA amplification, chip hybridisation and processing 
Whole genome microarray hybridisations were done as described previously (Hartman 
et al., 2008) on RNA samples from mock-infected host cells or those co-cultured with 
Neisseria. Briefly, total RNA (500 ng) was amplified in a single-round of in vitro 
transcription amplification that allowed incorporation of biotin-labelled nucleotides 
using the Illumina TotalPrep RNA Amplification Kit (Ambion, USA) according to the 
manufacturer’s instructions. Output cRNA was quantified using the NanoDrop ND-
1000 UV-Vis Spectrophotometer. cRNA (750ng) of each sample was hybridised to an 
Illumina HumanRef-8 V2 BeadChip (containing probes to 20,591 RefSeq gene 
sequences) at 58°C for 18 hours following the manufacturer’s instructions (Illumina, 
USA). This was followed by washing, blocking, and streptavidin-Cy3 staining steps, 
followed by scanning with a high resolution Illumina Bead Array Reader confocal 
scanner, all carried out following manufacturer’s instructions. For every array at all 
time-points, a rigorous quality check was carried out to ensure good performance 
before each array data was extracted. 
 
2.6.2 Data extraction, processing and normalisation 
The microarray data was extracted and background normalisation was performed using 
the Illumina Bead Studio v3.1 software. Clustering of samples (using the correlation 
clustering metric) was done to check for any outlier samples. The data was then 
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uploaded into Genespring GX7.3 (Agilent Technologies, USA) software for 
downstream analysis. The standard normalisation procedures as recommended by the 
Genespring software for one colour array data were followed. In brief, data 
transformation was corrected for low signals, with values recorded at less than 0.01 
increased to the minimum (0.01). Per-chip normalisation accounted for chip variability 
by dividing all of the measurements on each chip by a 50th percentile value. Per-gene 
normalisation accounted for variability between probe sets for different genes by 
dividing all of the measurements for each gene by the 50th percentile value. Genes that 
have a less than 99% confidence of detection in all the arrays were excluded from the 
final analysis, leaving 13,226 genes available for differential expression analysis. 
 
2.6.3 Statistical analysis  
Group comparisons were made between mock-infected cells and cells challenged with 
the various Neisseria over a 7 hour time course. Differentially expressed genes were 
selected from the normalised data using a procedure known as Significance Analysis of 
Microarrays (SAM) (Tusher et al., 2001), as installed in Genespring GX 7.3. For all 
comparisons, a false discovery rate of 5% was used. In addition, to remove low signal 
genes that could give false positive results due to a lack of sensitivity, significant genes, 
which did not have a raw intensity value of more than 50 in at least half of the samples 
in the smaller group of comparison, were discounted. For comparisons between mock-
infected cells and cells challenged with (live or inactivated) WT bacteria, significant 
genes, with a less than 2-fold change difference were removed to increase stringency. 
 
2.6.4 Heat maps 
Heat maps of selected genes and conditions were generated in the following manner: 
Per chip-normalised mean values of each condition for each gene were obtained from 
Genespring GX7.3. A separate per-gene normalisation was done by dividing all of the 
measurements for each gene by the mean. The resulting values are subjected to 
logarithmic (log) base 2. Genes were clustered in Gene Cluster 3.0 (Stanford 
University, USA) with uncentred correlation as the similarity metric and average 
linkage as the clustering method. The output file was then visualised using TreeView 
(EisenSoftware, USA). Positive values mean that the gene is up-regulated relatively to 
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the rest of the samples and is indicated as red while negative values mean that the gene 
is down-regulated relatively to the rest of the samples and is indicated as green. 
 
2.6.5 Functional clustering  
Functional clustering of differentially expressed genes was assessed using the Applied 
Biosystems online program “Panther” gene expression analysis systems 
(http://www.pantherdb.org/). The genes were compared with those in the Illumina array 
reference list to statistically determine over representation of functional categories. A 
Bonferroni corrected p value of less than 0.05 was considered significant. 
 
2.7 Quantitative real-time polymerase chain reaction (Q-RT-PCR) 
2.7.1 Taqman Low Density Array (TLDA) 
48-well and 96-well TLDA cards were designed for a subset of genes that were 
differentially expressed in the array experiments including the endogenous controls 18S 
(Applied Biosystems, USA). Gene and ABI assay identities are listed in Table 2.2. 
Total RNA (0.5µg) was converted to 0.5 µg of cDNA using a High-Capacity cDNA 
archive kit (Applied Biosystems, USA). The mixture was diluted with water to obtain a 
cDNA concentration of 2 ng/µl. cDNA (50 µl) from this mixture was added to 50 µl of 
TaqMan universal PCR master mix (Applied Biosystems, USA) and loaded into each 
port. The reactions were run on an ABI 7900 system (Applied Biosystems, USA). Data 
was analysed using the SDS2.2 software where baseline and threshold settings were 
automatically adjusted. Relative gene expression levels were obtained after 
normalisation to 18S rRNA. 
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Table 2.2: Gene ID and Taqman Primers ID 
 
Genbank ID Symbol Assay ID 
NM_003488 AKAP1 Hs00177481_m1 
NM_006492 ALX3 Hs00197798_m1 
NM_139314 ANGPTL4 Hs01101127_m1 
NM_005166 APLP1 Hs00193069_m1 
NM_000041 APOE Hs00171168_m1 
NM_014784 ARHGEF11 Hs00207600_m1 
NM_183376 ARRDC4 Hs00411771_m1 
NM_032885 ATG4D Hs00262792_m1 
NM_006399 BATF Hs00232390_m1 
NM_005178 BCL3 Hs00180403_m1 
NM_003670 BHLHB2 Hs00186419_m1 
NM_001734 C1S Hs01043795_m1 
NM_032587 CARD6 Hs01123611_m1 
NM_002982 CCL2 Hs00234140_m1 
NM_004591 CCL20 Hs00171125_m1 
NM_002983 CCL3 Hs00234142_m1 
NM_001001435 CCL4L1 Hs00237011_m1 
NM_001759 CCND2 Hs00277041_m1 
NM_004354 CCNG2 Hs00171119_m1 
NM_004064 CDKN1B Hs00153277_m1 
NM_001710 CFB Hs00156060_m1 
NM_024111 CHAC1 Hs00225520_m1 
NM_032854 CORO6 Hs00403252_m1 
NM_020989 CRYGC Hs00253214_m1 
NM_000758 CSF2 Hs00171266_m1 
NM_001033506 CSTF3 Hs00154618_m1 
NM_022034 CUZD1 Hs01008815_m1 
NM_001511 CXCL1 Hs00236937_m1 
NM_002089 CXCL2 Hs00236966_m1 
NM_015018 DOPEY1 Hs00392998_m1 
NM_153200 EDF1 Hs00610152_m1 
NM_005228 EGFR Hs00193306_m1 
NM_012153 EHF Hs00171917_m1 
NM_001420 ELAVL3 Hs00154959_m1 
NM_001975 ENO2 Hs00157360_m1 
NM_025209 EPC1 Hs00228677_m1 
NM_015630 EPC2 Hs00248967_m1 
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Genbank ID Symbol Assay ID 
NM_018948 ERRFI1 Hs00219060_m1 
NM_005238 ETS1 Hs00901425_m1 
NM_032836 FLJ14768 Hs00262488_m1 
NM_144605 FLJ25410 Hs00332566_m1 
NM_005438 FOSL1 Hs00759776_s1 
NM_001453 FOXC1 Hs00559473_s1 
NM_032682 FOXP1 Hs00415004_m1 
NM_032664 FUT10 Hs00327091_m1 
NM_006705 GADD45G Hs00198672_m1 
NM_014373 GPR160 Hs00205115_m1 
NM_001945 HBEGF Hs00181813_m1 
NM_014707 HDAC9 Hs00206843_m1 
NM_021170 HES4 Hs00368353_g1 
NM_013332 HIG2 Hs00203383_m1 
NM_000189 HK2 Hs00606086_m1 
NM_006898 HOXD3 Hs00232506_m1 
NM_018411 HR Hs00218222_m1 
NM_002155 HSPA6 Hs00275682_s1 
NM_000575 IL1A Hs00174092_m1 
NM_000576 IL1B Hs00174097_m1 
NM_181339 IL24 Hs01114274_m1 
NM_001008699 IL4R Hs00166237_m1 
NM_000600 IL6 Hs00174131_m1 
NM_175767 IL6ST Hs00174360_m1 
NM_000584 IL8 Hs00174103_m1 
NM_198267 ING3 Hs00219444_m1 
NM_145805 ISL2 Hs00377575_m1 
NM_000214 JAG1 Hs01070036_m1 
NM_002228 JUN Hs99999141_s1 
NM_016270 KLF2 Hs00360439_g1 
NM_001300 KLF6 Hs00810569_m1 
NM_015478 L3MBTL Hs00210032_m1 
NM_005564 LCN2 Hs00194353_m1 
NM_002310 LIFR Hs01123581_m1 
NM_024509 LRFN3 Hs00225874_m1 
NM_023942 LRRC61 Hs00225134_m1 
NM_012323 MAFF Hs00544822_m1 
NM_014994 MAPKBP1 Hs00406365_m1 
NM_004225 MFHAS1 Hs00180264_m1 
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Genbank ID Symbol Assay ID 
NM_015246 MGRN1 Hs00385235_m1 
NM_014632 MICAL2 Hs01121806_m1 
NM_002456 MUC1 Hs00159357_m1 
NM_006454 MXD4 Hs00170799_m1 
NM_015025 MYT1L Hs00392908_m1 
NM_014903 NAV3 Hs00372108_m1 
NM_006163 NFE2 Hs00232351_m1 
NM_002502 NFKB2 Hs00174517_m1 
NM_022123 NPAS3 Hs00223201_m1 
NM_004959 NR5A1 Hs00610436_m1 
NM_016816 OAS1 Hs00242943_m1 
NM_021220 OVOL2 Hs00221902_m1 
NM_030979 PABPC3 Hs00607675_sH 
NM_002610 PDK1 Hs00176853_m1 
NM_005764 PDZK1IP1 Hs00906696_m1 
NM_004566 PFKFB3 Hs00190079_m1 
NM_004567 PFKFB4 Hs00190096_m1 
NM_002638 PI3 Hs00160066_m1 
NM_012398 PIP5K1C Hs00610699_m1 
NM_022572 PNKD Hs00737775_m1 
NM_006238 PPARD Hs00602622_m1 
NM_005729 PPIF Hs00194847_m1 
NM_014731 ProSAPiP1 Hs01595282_g1 
NM_004914 RAB36 Hs00191766_m1 
NM_030665 RAI1 Hs01554690_m1 
NM_032626 RBBP6 Hs00544663_m1 
NM_002894 RBBP8 Hs00161222_m1 
NM_002908 REL Hs00231279_m1 
NM_144964 RG9MTD3 Hs00540873_m1 
NM_002928 RGS16 Hs00892674_m1 
NM_021976 RXRB Hs00232774_m1 
NM_005621 S100A12 Hs00194525_m1 
NM_002964 S100A8 Hs00374263_m1 
NM_199161 SAA1 Hs00761940_s1 
NM_030754 SAA2 Hs00754237_s1 
NM_020436 SALL4 Hs00360675_m1 
NM_012236 SCMH1 Hs00232606_m1 
NM_004630 SF1 Hs00190309_m1 
NM_012309 SHANK2 Hs00373170_m1 
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Genbank ID Symbol Assay ID 
NM_015260 SIN3B Hs00391562_m1 
NM_006931 SLC2A3 Hs00359840_m1 
NM_005070 SLC4A3 Hs00192595_m1 
NM_005902 SMAD3 Hs00232219_m1 
NM_003111 SP3 Hs01595811_m1 
NM_012446 SSBP2 Hs00202825_m1 
NM_003155 STC1 Hs00174970_m1 
NM_003714 STC2 Hs00175027_m1 
NM_004819 SYMPK Hs00191361_m1 
NM_016151 TAOK2 Hs00191170_m1 
NM_080647 TBX1 Hs00271949_m1 
NM_030756 TCF7L2 Hs00181036_m1 
NM_000461 THRB Hs00230861_m1 
NM_005078 TLE3 Hs00183222_m1 
NM_017728 TMEM104 Hs00214626_m1 
NM_000594 TNF Hs00174128_m1 
NM_033396 TNKS1BP1 Hs00286965_m1 
NM_181802 UBE2C Hs00853610_g1 
NM_005108 XYLB Hs00178239_m1 
NM_015117 ZC3H3 Hs00299449_m1 
NM_003438 ZNF137 Hs00231548_m1 
NM_014518 ZNF229 Hs00395484_m1 
NM_004234 ZNF235 Hs00188490_m1 
NM_003415 ZNF268 Hs00398196_m1 
NM_015481 ZNF385 Hs00296462_m1 
NM_025189 ZNF430 Hs00257892_m1 
NM_153263 ZNF549 Hs00401032_m1 
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2.7.2 Fluidigm 
The response of human epithelial cell genes to secreted neisserial proteins were 
determined by Q-RT-PCR using the Fluidigm chip technology (Fluidigm, USA). 
Selected Taqman gene primers (from those stated in Table 2.2) were used for the 
reactions as per manufacturer’s instructions. Briefly, 0.5 µg total RNA was converted 
to 0.5µg of cDNA using the High-Capacity cDNA archive kit. From this, 0.25 µg of 
cDNA was preamplified using the Taqman PreAmp master mix (Applied Biosystems, 
USA). The cDNA was diluted 1:20 with 1X Tris-EDTA buffer to produce the final 
product. 2.25 µl of diluted cDNA, 2.5 µl of Taqman universal PCR master mix and 
0.25 µl of DA sample loading reagent (Fluidigm, USA) were mixed into one sample 
inlet in the chip. 2.5 µl of 20X Taqman gene primers and 2.5 µl of DA assay loading 
reagent were mixed into the assay detector inlet of the chip. Samples, Taqman gene 
primers and reaction reagents were mixed in a specialised integrated fluidic circuit 
controller, after which the chip was loaded into the Biomark data collection machine 
(Fluidigm, USA). Data was analysed using the Biomark Real-Time PCR analysis 
software (Fluidigm, USA). Relative gene expression levels were obtained after 
normalisation to 18S rRNA.  
 
2.8 Measurement of proteins from cell culture supernatants 
After treatment of cells with either whole bacteria or bacterial secreted proteins 
(described in Section 2.4.1 and 2.4.2), supernatants were harvested, centrifuged for 10 
minutes at 3220g and passed through 0.2 µm filters to remove the bacteria. Selected 
proteins in these cell culture supernatants were assayed by standard Enzyme Linked 
Immunosorbent Assays (ELISAs) or multiplex protein assays. 
 
2.8.1 Enzyme Linked Immunosorbent Assay (ELISA) 
PI3 measurements were performed as per instructions in the ELISA kit (R&D systems, 
USA). Individual samples were tested in duplicate and the concentration of cytokines 
was determined using the standard provided by the manufacturer. Briefly, a 96 well 
plate (R&D systems, USA) was coated with 100 µl per well of capture antibody diluted 
in PBS. The plate was sealed and incubated overnight at room temperature (RT). The 
wells were then washed 3 times with 400 µl per well wash buffer. The plate was further 
blocked with 300 µl per well of reagent diluent and incubated at RT for 1 hour. 
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Washing was done as above. The standard and samples were prepared in reagent 
diluent. 100 µl of each standard, sample, and control were added into appropriate wells. 
Again, the plate was sealed and incubated for 2 hours at RT. The plate was washed as 
described above. 100 µl of detection antibody was added to each well and incubated for 
2 hours at RT. The plate was then washed and 100 µl of streptavidin-horseradish-
peroxidase (HRP) was added into each well and the plate was incubated for 20 minutes 
at RT in the dark. The plate was then washed again after this and 100µl of substrate 
solution was added into each well and incubated for another 20 minutes. 50 µl of stop 
solution was then added and absorbance was read at 450nm within 30 minutes of 
stopping the reaction. Absorbance at 540nm was subtracted from absorbance at 450nm 
to obtain more accurate readings. All reagents used were provided in the kit. 
 
2.8.2 Multiplex protein assay 
The concentrations of IL1A, IL8, CCL3 and TNF-α in the cell culture supernatants 
were determined using Bio-Plex Cytokine Assay (Bio-Rad, USA) according to the 
manufacturer’s instructions. This was carried out using the facilities available in the 
Defence Science Organisation (Singapore) and Duke-National University of Singapore 
Graduate Medical School. In brief, a 96-well filter plate was pre-wet with 100 µl of 
Bio-Plex assay buffer. The buffer was then removed by vacuum filtration using 
MultiScreen Vaccum Manifolds (Millipore, USA) and the bottom of the filter plate was 
blotted to dry with a clean paper towel. Fifty µl of pre-mixed multiplex beads (Anti-
cytokine conjugated) was added per well and the buffer was removed by vacuum 
filtration. The beads were then washed twice with 100 µl of Bio-Plex wash buffer. Fifty 
µl of sample was added into each well. The filter plate was sealed with plate sealing 
tape and wrapped with aluminum foil to protect the beads from light. Incubation at RT 
was applied to the plate with shaking (using a microplate shaker) at 1,100 revolutions 
per minute (rpm) (2 g) for the first 30 seconds and 650 rpm (0.7 g) for 1 hour. The 
buffer was then removed and the beads were washed 3 times with 100 µl of wash 
buffer before 25 µl of Bio-Plex detection antibody was added to each well. The plate 
was sealed, covered with aluminum foil and incubated at the same condition as 
described above for 30 minutes. The buffer was then removed and beads were washed 
for 3 times with 100 µl wash buffer. Fifty µl of streptavidin-phycoerythrin (PE) was 
added per well. The plate was then sealed and shaken at 1,100rpm for 30 seconds, then 
650 rpm for 10 minutes in the dark. The buffer was then removed and beads were 
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washed 3 times with 100 µl wash buffer. The beads were then resuspended in 125 µl of 
Bio-Plex assay buffer and the plate shaken at 1,100rpm for 30 seconds immediately 
before reading the plate on the Bio-Plex System (Bio-Rad, USA). Data analysis was 
done using the Bio-Plex Manager software (Bio-Rad, USA) to plot standard curves and 
extract protein measurements. 
 
2.9 Neisserial secreted proteins and whole bacterial cell lysates 
2.9.1 Harvest and processing 
N. meningitidis was grown in RPMI media (Sigma, UK) while N. lactamica was grown 
in media made up of RPMI and MCD in a 1:1 proportion. The composition of MCD is 
shown in Table 2.3 and was kindly provided by Dr Andrew Gorringe (Health 
Protection Agency [HPA], Porton Down). Crude neisserial secreted proteins were 
harvested as described in Robinson et al. (2004) with some modifications. Briefly, the 
bacteria were grown at 37°C with shaking at 200 rpm. Bacterial supernatants were 
harvested at log phase as determined by measuring the optical density (OD). They were 
centrifuged at 3220 g for 1 hour and passed through 0.2 µm filters to remove bacteria. 
The resulting supernatant was ultracentrifuged in a Sorvall RC5C super speed 
centrifuge (Thermo Fisher Scientific, USA) at 40,000 g for 1 hour at 4 °C to remove 
bacterial components such as OMPs. The sample was then concentrated 20 times with a 
10 kilo Dalton (kDa) molecular weight cut off using Vivaspin ultrafiltration spin 
columns (Sartorius Stedim, Germany). Endotoxin removal was carried out using the 
Detoxi-Gel Endotoxin Removing Gel consisting of immobilised polymyxin B (Pierce, 
Thermo Fisher Scientific, USA). The preparation was further concentrated 20 times and 
filter sterilised. 
 
As a comparison, whole cell lysates from WT N. meningitidis, WT N. lactamica, N. 
meningitidis cap- nspA- and N. lactamica nspA- were harvested, resuspended in PBS to 
an OD of 1 and heat-killed for 1 hour at 56°C. 
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Table 2.3: Composition of MCD medium 
 
Component Amount (g/L) Source 
L-Glutamic Acid 3.70 Sigma 
NaCl 5.80 BDH 
K2SO4 1.00 Sigma 
MgCl2.6H20 0.40 Sigma 
NH4Cl 0.20 Sigma 
Glycine 0.25 Sigma 
K2HPO4 4.00 Sigma 
L-Cystine.2HCl 0.10 Sigma 
CaCl2.2H2O 0.04 Sigma 
NaHCO3 0.04 Sigma 
L-Aspartic acid 0.50 Sigma 
Sodium acetate 2.00 Sigma 
Choline Chloride 0.01 Sigma 
D-Biotin 0.01 Sigma 
Myo-inositol 0.04 Sigma 
D-Glucose 10.00 Sigma 
 
2.9.2 Analysis  
2.9.2.1 Limulus amebocyte lysate (LAL) assay 
The endotoxin content of neisserial secreted protein preparations was measured using 
the LAL assay (chromogenic kinetic assay) at a microbiology facility in Singapore 
General Hospital. This is a quantitative method with a sensitivity of 0.1 endotoxin unit 
(EU) per ml.  
 
2.9.2.2 Protein quantification 
Total protein from secreted preparations and whole cell lysates was quantified using the 
Quick Start Bradford protein assay (Bio-Rad, USA) using bovine γ-globulin as the 
standard according to the manufacturer’s protocol. Briefly, 150 µl of sample was mixed 
with 150 µl of 1X dye reagent per well and incubated for at least 5 minutes at RT. 
Absorbance was measured at 595nm and a standard curve was obtained by plotting the 
wavelength reading at 595nm against protein concentration. 
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2.9.2.3 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-
PAGE) 
SDS-PAGE was performed on a 4 to 12% gel (Invitrogen, USA) with 0.25 µg of 
neisserial secreted proteins and whole cell lysates being loaded per lane. The samples 
were mixed in sample buffer (Fermentas, USA) and heated at 95°C for 5 minutes with 
vortexing. They were then loaded into each well alongside 10 µl of the Precision Plus 
Protein Kaleidoscope standard (Bio-Rad, USA). Electrophoresis was carried out using 
consistent voltage of 150 V for approximately 1 hour. 
 
2.9.2.4 Silver staining 
After electrophoresis, protein bands on the gel were visualised by silver staining using 
the SilverQuest silver staining kit (Invitrogen, USA) according to the manufacturer’s 
instructions. 
 
2.9.2.5 Western blotting 
After electrophoresis, the gel was then transferred onto a PVDF membrane (Bio-Rad, 
USA) by using transfer buffer (Pierce, Thermo Fisher Scientific, USA). Filter papers, 
PVDF membrane and sponges for transferring sandwich were presoaked in transfer 
buffer for at least 15 minutes. The separating gel was placed between the pre-soaked 
PVDF membrane and filter papers. One piece of sponge was placed outside the filter 
papers on each side. The transfer was carried out at 100 V for 1.5 hours in the cold 
room using the electrophoretic transfer unit (Bio-Rad, USA). 
 
After transfer, the membrane was blocked in PBS-Tween (PBST) (Invitrogen, USA). 
Anti-NspA monoclonal antibody (Cadieux et al., 1999) was diluted (1:25) in PBST and 
was incubated with the membrane overnight at 4°C on an orbital shaker. The next day, 
the membrane was washed 3 times for 10 minutes each with 10 ml of PBST.  Anti-
mouse HRP-conjugated secondary antibody diluted in PBST was added onto the 
membrane and incubated for 1 hour at RT on an orbital shaker. After that, the 
membrane was washed 3 times for 10 minutes each using PBST. Visualisation of the 
bands was then carried out using ECL Plus Western Blotting Detection Reagents (GE 
Healthcare, UK) according to manufacturer’s instruction. The signals were exposed on 
X-ray film (Kodak, USA) and scanned into computer for analysis. 
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2.10 Statistical analysis 
For the association and invasion assays, as well as the Q-RT-PCR validation by TLDA, 
mean values were used. Significance of differences were determined using the 
Student’s T-test (assuming unequal variance), whereby p values of less than 0.05 were 
considered to be statistically significant. 
 
Selected genes that were followed up in detail at the transcript (TLDA and Fluidigm) 
and protein level were analysed by the SPSS11 (IBM, USA) software. Box plots 
representing the interquartile range, the median and the highest and lowest values 
among the replicates were drawn. The Mann-Whitney test was used to compare 
between samples to determine if the expression of a gene was significantly different 
(with a p value of less than 0.05). 
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Chapter 3 : Neisserial association and invas ion of epithelial cells. 
Neisserial association and invasion of epithelial cells 
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3.1 Introduction 
Colonisation of neisserial species in the nasopharynx involves the adherence, and 
sometimes invasion of bacteria into epithelial cells (Pujol et al., 1997). There have been 
many studies investigating the interaction (adherence and invasion) of pathogenic N. 
meningitidis with host epithelial cells. The postulated series of events is believed to 
start with N. meningitidis attachment to host cells via interaction of bacterial surface-
associated filaments called type IV pili and the epithelial cell CD46 receptor (Kallstrom 
et al., 1997; Merz and So, 2000). This process is called localised adhesion and occurs 
within the first 6 hours after infection. Using human polarised intestinal epithelial cells 
(T84 cells) as a surrogate colonisation model (Pujol et al., 1997), meningococcal 
piliation was shown to be required for adhesion and invasion. At 4 hours post infection 
of T84 cells, localised clumps of meningococci can be seen on the epithelial cell 
surface. At 6 to 18 hours, the pili disappear and individual diplococci become 
intimately associated with the host plasma membrane, where they exhibit a diffuse 
pattern of adherence on T84 epithelial cells. This is consistent with previous evidence, 
where pili facilitated bacterial adherence to other human epithelial cells such as Chang 
cells (human conjunctival epithelial cells), Hep-2 cells (human larynx carcinoma cells) 
and also endothelial cells like HUVECs. Besides piliation, other bacterial attributes, 
such as Opc and the class 5 (Opa) proteins, have been identified as playing a role in the 
ability of N. meningitidis to interact with host cells, where they bind with CEACAM 1 
(Opa) and HSPGs (Opa and Opc) (Virji, 2009). 
 
Following intimate attachment with the host plasma membrane, meningococci can 
invade into epithelial cells as shown by Pujol et al. (1997), where the bacteria could be 
visualised inside T84 epithelial cells by confocal examination and electron microscopy. 
These findings were consistent with that of Stephens et al. (1983) where N. 
meningitidis was found to attach and enter into columnar epithelial cells of a human 
nasopharyngeal organ culture system.  
 
In contrast, little information is known about how N. lactamica can adhere and invade 
epithelial cells. Unlike N. meningitidis which possesses both class 1 and 2 pili, N. 
lactamica only possess class 2 pili (Fowler et al., 2006; Hardy et al., 2000; Snyder et 
al., 2005). Although it is not known, N. lactamica is also thought to use its pilus for the 
initial association with host epithelial cells as part of the colonisation process. A gene 
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encoding Opc was not present in the whole genome sequence of N. lactamica strain 
Y92-1009 (Snyder et al., 2005). This suggests that Opc is not involved in the 
interaction of N. lactamica with epithelial cells. However, further work is required to 
determine whether the lack of an Opc homologue in N. lactamica is a species trait or is 
only confined to a subset of strains.   
 
Neisserial adherence and invasion of respiratory epithelial cells is a vital step in the 
initiation of colonisation. It would be predicted that the extent to which N. lactamica 
and N. meningitidis adhere and invade respiratory epithelial cells will influence the host 
response. The aim of this Chapter is to describe the interactions of WT N. lactamica 
strain Y92-1009 and N. meningitidis strain MC58 (WT and the cap- and pilE- mutants) 
with the 16HBE14 human bronchial epithelial cell line. The latter is a SV40 large T-
antigen transformed epithelial cell line derived from human bronchial epithelium, and 
is representative of the respiratory tract. This cell line retains differentiated epithelial 
morphology and functions such as the presence of tight junctions (Cozens et al., 1994). 
 
Results from association and invasion assays at 4 hours will be presented. The time-
point of 4 hours was chosen for the association and invasion assays as this is the period 
of localised adherence to human epithelial cells (Pujol et al., 1997). Although the 
16HBE14 cell line is not exactly the same as the T84 cell line (they are derived from 
different locations in the human body), the 16HBE14 cell line used in my association 
and invasion assay possesses some similar characteristics to the T84 cell line used by 
Pujol et al. (1997), such as the presence of tight junctions (Cozens et al., 1994) . 
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3.2 Results 
3.2.1 Comparison of the amount of Neisseria in cell culture medium with time 
In order to determine if the amount of N. meningitidis and N. lactamica in the cell 
culture medium after 4 hours could affect how the bacteria associate/invade 16HBE14 
epithelial cells, I determined their amounts in tissue culture medium (DMEM) (Figure 
3.1) after 4 hours. Bacterial numbers were comparable.  
 
Growth of Neisseria in DMEM
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Figure 3.1: Growth of Neisseria in cell culture medium (DMEM)  
Growth of all Neisseria was similar, with the numbers comparable (approximately 106 cfu per well) after 
4 hours. Values represent means from three independent experiments with error bars indicating standard 
error of the mean (SEM). 
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3.2.2 Neisserial association and invasion of epithelial cells 
Association and invasion assays were carried out to compare how N. meningitidis and 
N. lactamica strains interact with host epithelial cells 4 hours post infection. We first 
determined how the two Neisseria associated with the 16HBE14 human bronchial 
epithelial cell line at 4 hours (Figure 3.2, a). The trend observed was that more N. 
lactamica associated with the 16HBE14 epithelial cells compared to N. meningitidis. 
Amongst the N. meningitidis strains, similar amounts of the cap- mutant and WT 
associated with epithelial cells, and these were in higher numbers than the pilE- mutant. 
Statistically wise, however, the association of the two Neisseria with the epithelial cells 
was not significantly different. 
 
Next, I determined the extent to which the two Neisseria invaded 16HBE14 cells at 4 
hours (Figure 3.2, b). Similar amounts of WT N. meningitidis and N. lactamica invaded 
host cells (no significant difference). The comparative order of invasion of N. 
meningitidis strains was: cap- mutant > WT > pilE- mutant. More N. meningitidis cap- 
mutant invaded compared to WT N. meningitidis and N. meningitidis pilE- (p value = 
0.05). 
 
 
Chapter 3 
62 
Bacterial association to epithelial cells 
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Bacterial invasion of epithelial cells 
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(b) 
Figure 3.2: Interactions of the different Neisseria with 16HBE14 epithelial cells at 4 hours 
Values represent means from three independent experiments with error bars indicating SEM. Pairwise 
comparisons were made with Student’s T-test. 
(a) Bacterial association to epithelial cells. The amount of bacteria associated to the epithelial cells per 
well are shown. The association of the different Neisseria to the epithelial cells was not significantly 
different. 
(b) Bacterial invasion of epithelial cells. The amount of bacteria present within the epithelial cells per 
well are shown. More N. meningitidis cap- mutant invaded compared to WT N. meningitidis (p=0.05) 
and N. meningitidis pilE- (p=0.05). 
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3.3 Discussion 
3.3.1 Similar amounts of different Neisseria were recovered from the cell 
culture medium at 4 hours 
The aim of the work in this Chapter was to describe the interactions of WT N. 
lactamica strain Y92-1009 and N. meningitidis strain MC58 (WT and the cap- and 
pilE- mutants) with the 16HBE14 human bronchial epithelial cell line.  
 
Before any comparisons could be made, the growth of the different bacteria in the cell 
culture medium was determined. The total number of bacteria recovered from the cell 
culture medium at 4 hours was similar (Figure 3.1). This initial experiment showed that 
any differences in the cell association and invasion results determined later were due to 
differences between the bacteria used and not due to the different amount of bacteria 
present.  
 
3.3.2 Association and invasion of different Neisseria at 4 hours 
My results show that the association and the invasion of N. lactamica and N. 
meningitidis with bronchial epithelial cells were not significantly different at 4 hours 
post infection. This suggests that any differential host responses seen would be due to 
bacterial differences rather than their numbers per se (at least for the time-point of 4 
hours post infection). To my knowledge, this is the first time that N. lactamica was 
shown to invade epithelial cells derived from the respiratory tract. Therefore, this could 
possibly be a process associated with colonisation rather than disease. 
 
There are very few studies which compare the association of N. lactamica and N. 
meningitidis with epithelial cells. Grifantini et al. (2002) investigated the association of 
N. meningitidis MC58 and N. lactamica strain NL19 with 16HBE14 epithelial cells.  At 
3 hours post infection, they also found no significant difference in the association of N. 
meningitidis and N. lactamica to the epithelial cells. Additionally, N. lactamica NCTC 
10617 associated with explants of human nasal turbinate mucosa similarly to N. 
meningitidis K454 at 4 hours post infection (Townsend et al., 2002). My results 
therefore fit with these studies showing no significant differences in the association of 
N. lactamica and N. meningitidis with host cells derived from the respiratory tract. The 
data contrasts with the study of Fowler et al. (2006) which compared the association of 
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N. meningitidis and of N. lactamica to a meningioma cell line, representative of the 
cells of the meninges. They found that N. meningitidis significantly associated with the 
meningioma cells in 10-fold greater numbers than N. lactamica. This suggests that N. 
meningitidis, unlike N. lactamica, has a tropism for meningeal cells. The capsule of N. 
meningitidis helps to prevent complement mediated bacteriolysis in the bloodstream 
(Schneider et al., 2007), and from there, the bacteria is thought to be able to initiate 
contact with the blood brain barrier via the laminin receptor and possibly lead on to the 
infection of the meninges (Orihuela et al., 2009). This is in contrast to N. lactamica, 
which is not known to cross the blood brain barrier and is unlikely to have evolved 
mechanisms facilitating adhesion or invasion of meningeal cells. In fact, the respiratory 
tract is the one and only natural niche of N. lactamica and it is believed to be cleared 
rapidly if it ever enters the blood stream. 
 
In this study, compared to WT N. meningitidis, the cap- and pilE- mutants invaded 
16HBE14 epithelial cells to greater and lesser extents, respectively. These trends are 
consistent with previous studies. For example, it is known that the expression of the 
capsular polysaccharide inhibits the invasion of the nasopharyngeal barrier by masking 
the meningococcal adhesins and invasins (Hammerschmidt et al., 1996). A very small 
amount of N. meningitidis pilE- mutant invaded into the bronchial epithelial cells 
compared to the rest of the neisserial strains used. This is again consistent with 
previous studies with other types of epithelial cells (Pujol et al., 1997; Virji et al., 
1993b), where the N. meningitidis pili were shown to be important in the interaction 
with the host. 
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3.3.3 Conclusions 
In this Chapter I have presented data showing the association of N. lactamica and N. 
meningitidis WT and mutant strains with 16HBE14 bronchial epithelial cells. There 
were no significant differences in the association and the invasion of N. lactamica and 
N. meningitidis with the bronchial epithelial cells. The effect of the components in N. 
meningitidis like pili and capsule on the interaction was also investigated, with the pilus 
showing a strong contribution while the capsule has a negative effect on the invasion of 
the host cell. 
 
The next Chapter will describe the host transcriptional responses to N. lactamica and N. 
meningitidis WT and mutant strains, and their relationship with the neisserial-16HBE14 
association and invasion data. 
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Chapter 4 : Determination o f hos t transcrip tional response in response to N. meningitid is  and N. lactamica by genome wide m icroar ray analys is. 
Determination of host transcriptional response in response to  
N. meningitidis and N. lactamica by genome wide microarray 
analysis 
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4.1 Introduction 
Bacterial association with, and invasion of host epithelial cells has been described in 
Chapter 3. This Chapter will describe the host response following interaction of 
epithelial cells with Neisseria. Host response microarray studies to N. meningitidis have 
been undertaken before (Bonnah et al., 2004; Plant et al., 2004; Schubert-Unkmeir et 
al., 2007; Wells et al., 2001), but none of these involved the transcriptome at the whole 
genome level. Instead, these studies focused on selected groups of genes involved in 
specific functions. For example, a specialised cDNA microarray platform, the 
‘IronChip’ was used to investigate the expression of genes involved in iron transport, 
storage and regulation (Bonnah et al., 2004).  Host genes involved in inflammation and 
bacterial adhesion were investigated in response to N. meningitidis (Plant et al., 2004).  
 
Investigating the host response to neisserial colonisation ideally should use cells (e.g. 
epithelial) derived from the respiratory tract. There are however, few host response 
studies using such cells. Host responses to infection by N. meningitidis by non-
respiratory cell types such as HUVECs (Linhartova et al., 2006), brain endothelial cells 
(Schubert-Unkmeir et al., 2007) and meningothelial cells (Wells et al., 2001) are more 
extensively described. These latter studies profiled the host responses to the bacteria 
not during colonisation but during invasive disease. 
 
There are few studies which describe the host responses to N. lactamica. For example, 
it has been demonstrated that immunisation with live N. lactamica protect mice against 
meningococcal challenge and can elicit serum bactericidal antibodies (Li et al., 2006). 
However, not much is known about the host epithelial cell responses to N. lactamica 
and no transcriptome study has been described. 
 
To my knowledge, there has only been one study that has compared the host response 
to both N. meningitidis and to N. lactamica (Fowler et al., 2006). The focus was on 
proinflammatory responses of human meningothelial cells and expression of a few 
selected cytokines like IL8 and IL6. Describing the common and differential responses 
of host respiratory epithelial cell responses to N. meningitidis and N. lactamica will 
give insight into how these bacteria can survive and co-exist with the host at the initial 
stage of colonisation. Furthermore, comparison of live and dead bacteria and particular 
mutants has the potential to identify bacterial components associated with specific host 
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responses. In this study I have determined the transcriptome of bronchial epithelial cells 
in response to N .meningitidis and/or N. lactamica as follows: 
 
(1) Live and dead WT N .meningitidis and/or N. lactamica. This allows the contribution 
of active processes i.e. those requiring growth to be determined. 
 
(2) Capsule and pili mutants of N. meningitidis. The meningococcus, but not N. 
lactamica, possesses a capsule. It plays a crucial role in invasive meningococcal disease 
by helping the meningococcus avoid complement mediated lysis (Schneider et al., 
2007) and phagocytic killing. The pilus is involved in the initial contact of N. 
meningitidis with the host cell, where it interacts with CD46 receptor (Kallstrom et al., 
1997) and triggers a cytosolic Ca2+  flux (Kallstrom et al., 1998), lysosome exocytosis 
and increases the chance of survival of the bacteria within the host cell (Ayala et al., 
2001). Although it is not known, N. lactamica is also thought to use its pilus for the 
initial association with host epithelial cells as part of the colonisation process. In 
Chapter 3 the loss of the capsule is shown to enhance the invasion of N. meningitidis, 
while the loss of the pilus reduces this interaction. Comparison of gene expression to 
WT N. meningitidis and its cap- and pilE- mutants not only allows the host response to 
capsule and pili to be determined, but also host responses independent of contact with 
the bacteria, which could indicate a potential involvement of bacterial secreted proteins. 
 
The whole genome transcriptome of bronchial epithelial cells in response to Neisseria 
using the Illumina microarray platform comprising a large set of more than 20,000 
human probes is presented in this Chapter. N. meningitidis and N. lactamica were 
added to 16HBE14 bronchial epithelial cells (representative of the respiratory tract) and 
host transcriptional responses investigated from 2 to 7 hours. These time-points were 
chosen as data presented from Chapter 3 indicated that N. meningitidis and N. 
lactamica substantially interact with the host (via adhesion and invasion) at 4 hours 
post infection. Therefore, time-points taken before, including and after 4 hours would 
provide gene expression data at informative times.  
 
 
 
 
Chapter 4 
69 
4.2 Results  
4.2.1 Analysis of initial load of Neisseria 
 
Figure 4.1 shows the initial amount of live Neisseria added to 16HBE14 cells. The 
mean amount of bacteria added per well (containing 9.5 X 105 host cells) is 1.26 X 107 
with a standard deviation of 8 X 106. Therefore, similar amounts of Neisseria were 
added to the host cells in each experiment. 
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Figure 4.1: Initial amount of Neisseria added to 16HBE14 cells showing that similar amounts of 
bacteria were added to the host cells in each experiment  
Values represent means from four replicates, with error bars indicating SEM. 
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4.2.2 Clustering of microarray data 
There were 224 samples analysed by the microarray platform. These included mock-
infected samples (eight replicates each) and samples treated with the following 
conditions: inactivated WT N. lactamica, live WT N. lactamica, inactivated WT N. 
meningitidis, live WT N. meningitidis, live N. meningitidis cap- and live N. 
meningitidis pilE- (four replicates each). Clustering of the samples indicated an outlier 
group consisting of samples in the 2 hour condition. They included two replicates each 
of the following conditions: mock-infected, inactivated WT N. lactamica and live WT 
N. lactamica (Figure 4.2). The RNA concentrations of these six outliers were analysed 
and found to be lower than the rest of the samples within the same condition. These 
outlier samples were excluded in the subsequent downstream microarray analysis using 
the Genespring GX7.3 software. Host responses to live and inactivated N. lactamica at 
2 hours were also excluded as two replicates per condition remained, which made them 
inappropriate for further statistical analysis. 
 
 
 
 
Figure 4.2: Clustering of samples analysed by microarray 
The numbers on the horizontal axis indicate how similar the samples are to each other. The smaller the 
number, the more similar they are. Six outlier samples are shown (arrow, with a close up of the outlier 
branch). They are mock-infected samples (T2-1 M and T2-2 M), samples infected by inactivated WT N. 
lactamica (T2-1 YK and T2-2 YK) and those infected by live WT N. lactamica (T2-1 YL and T2-2 YL). 
All of them were harvested 2 hours post infection. 
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4.2.3 Defining differentially expressed genes from the microarray 
Data from the microarray was analysed with various stringent filters to minimise false 
positives. The microarray indicated that from the 20,591 genes in the array, 13,226 
genes have at least a 99% confidence of detection in at least one sample. SAM analysis 
(a statistical tool) was carried out to identify which of these 13,226 genes might be 
significantly differentially expressed between cells infected with the various Neisseria 
and mock-infected cells from 0 to 7 hours, with a false discovery rate of 5%. 
Specifically, the following conditions were compared with respect to mock-infected 
cells: Live and inactivated WT N. lactamica, live and inactivated WT N. meningitidis, 
as well as N. meningitidis cap- and pilE- mutants.  
 
The next step was to remove lowly expressed genes by removing those which did not 
have a raw intensity of more than 50 in at least half of the samples in the smaller group 
of comparison. To increase stringency, when comparing mock-infected cells with cells 
challenged with (live and inactivated) WT Neisseria, a 2-fold filter was used. The 
groups of differentially expressed genes generated as described above were considered 
in more detail in the following sections. 
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4.2.4 Host epithelial responses to live wild type (WT) N. meningitidis  
4.2.4.1 Number of genes responding to live WT N. meningitidis 
Table 4.1 shows the number of genes significantly differentially expressed when 
comparing mock-infected cells with cells treated with live WT N. meningitidis from 0 
to 7 hours. The total number of genes responding to the bacteria in all the time-points 
was 2156, with 1271 appearing as unique genes.  
 
Table 4.1: Number of genes responding to live WT N. meningitidis 
There was a total of 2156 genes responding to N. meningitidis from 0 to 7 hours, with 1271 appearing as 
unique genes (as shown in brackets). 
 
Time/h Number of genes responding  to N. meningitidis  
0 296 
2 145 
3 160 
4 358 
5 398 
6 445 
7 354 
Total 2156 (1271) 
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4.2.4.2 Expression profile of all genes responding to live WT N. meningitidis 
Figure 4.3 shows a heat map of the 1271 genes responding to live WT N. meningitidis 
from 0 to 7 hours with respect to mock-infected controls. Two groups of genes could be 
seen: those whose expression is lower (green) and higher (red) in cells infected with 
bacteria compared to mock-infected controls, respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time/h 0 2 3 4 5 6 7 0 2 3 4 5 6 7 
 
Figure 4.3: Heat map of the 1271 genes responding to live WT N. meningitidis compared to mock-
infected controls from 0 to 7 hours   
Each column is the mean signal of four (N. meningitidis) to eight replicates (mock-infected). Genes were 
mainly clustered into two groups: those whose expression was lower (green) and those whose expression 
was higher (red) upon addition of N. meningitidis compared to the mock-infected controls. Gene list is 
listed in Appendix A, Table A.1. 
 
Mock N. meningitidis 
Lower expression 
Higher expression 
Chapter 4 
74 
4.2.4.3 Functional clustering of genes responding to live WT N. meningitidis 
Genes significantly up and down-regulated upon infection with live WT N. 
meningitidis, compared to mock-infected controls, were investigated at each time-point 
for functional clustering using the Panther gene expression analysis program (Table 
4.2). At 3 hours, there was a significant over-representation of immunity and defence 
process genes. At 4 hours, both carbohydrate metabolism and glycolysis processes were 
significantly over-represented. 
 
Table 4.2: Biological processes significantly over-represented during time course infection studies 
with N. meningitidis 
 
 Time/h 
Biological Process 0 2 3 4 5 6 7 
Immunity and defence     4.4 X 10-2         
Carbohydrate metabolism       1.9 X 10-2       
Glycolysis       3.3 X 10-2       
  
Boxes shaded yellow are the time-points where there was a significant over-representation of the 
biological process (with the stated p values). Grey shaded boxes indicate time-points where there were no 
significant processes identified. 
 
Genes in these significant biological processes are listed in Table 4.3. Eighteen out of 
the 21 genes (86%) in immunity and defence have a lower expression upon infection 
with live WT N. meningitidis compared to mock-infected controls, indicating a down-
regulation of the immune system. In contrast, 20 out of 22 genes (91%) in the 
carbohydrate metabolism process and all the genes in the glycolysis process were up-
regulated. 
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Table 4.3: Genes in significant biological 
processes differentially expressed upon 
infection with N. meningitidis at 3 and 4 
hours 
Genes are clustered into three processes: (a) 
immunity and defence, (b) carbohydrate 
metabolism and (c) glycolysis and their fold 
changes with respect to mock-infected controls 
are shown. Human genes are indicated by their 
Genbank ID with an NM prefix. 
 
(a) Immunity and defence (3 hours) 
 
Genbank ID Symbol Fold change 
NM_139314 ANGPTL4 2.5 
NM_001734 C1S -2.2 
NM_002982 CCL2 -2.7 
NM_001001435 CCL4L1 -2.2 
NM_001710 CFB -2.2 
NM_000758 CSF2 2.0 
NM_002155 HSPA6 -2.3 
NM_001008699 IL4R 2.5 
NM_005564 LCN2 -3.0 
NM_002310 LIFR -3.9 
NM_004225 MFHAS1 -2.2 
NM_002456 MUC1 -2.0 
NM_016816 OAS1 -2.1 
NM_022572 PNKD -2.0 
NM_005729 PPIF -2.0 
NM_000963 PTGS2 -17.5 
NM_002908 REL -2.1 
NM_005621 S100A12 -2.2 
NM_002964 S100A8 -2.7 
NM_199161 SAA1 -2.1 
NM_030754 SAA2 -2.1 
 
 
 
 
 
(b) Carbohydrate metabolism (4 hours) 
 
Genbank ID Symbol Fold change 
NM_016161 A4GNT -2.1 
NM_002044 GALK2 2.3 
NM_205847 GMPPA 2.1 
NM_016527 HAO2 -4.1 
NM_138809 LOC134147 2.0 
NM_002641 PIGA 4.9 
NM_024607 PPP1R3B 8.2 
NM_005398 PPP1R3C 4.4 
NM_001001330 REEP3 2.1 
NM_003002 SDHD 2.0 
NM_006516 SLC2A1 2.5 
NM_145176 SLC2A12 2.1 
NM_153449 SLC2A14 2.7 
NM_006931 SLC2A3 2.7 
NM_003104 SORD 5.4 
NM_001001521 UGP2 2.7 
NM_000188 HK1 3.0 
NM_000189 HK2 3.8 
NM_003631 PARG 2.3 
NM_004566 PFKFB3 3.2 
NM_004567 PFKFB4 5.1 
NM_002629 PGAM1 2.2 
 
(c) Glycolysis (4 hours) 
 
Genbank ID Symbol Fold change 
NM_000188 HK1 3.0 
NM_000189 HK2 3.8 
NM_003631 PARG 2.3 
NM_004566 PFKFB3 3.2 
NM_004567 PFKFB4 5.1 
NM_002629 PGAM1 2.2 
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4.2.5 Host epithelial responses to live WT N. lactamica 
4.2.5.1 Number of genes responding to live WT N. lactamica 
Table 4.4 shows the number of genes significantly differentially expressed upon 
infection with live N. lactamica, with respect to mock-infected controls, from 0 to 7 
hours. The total number of genes responding to the bacteria for all the time-points was 
1633, with 1178 genes appearing as unique genes.  
 
Table 4.4: Number of genes responding to live WT N. lactamica 
There was a total of 1633 genes responding to N. lactamica from 0 to 7 hours, with 1178 genes appearing 
as unique genes (as shown in brackets). 
 
Time/h Number of genes responding  to N. lactamica  
0 252 
3 32 
4 491 
5 309 
6 231 
7 318 
Total 1633 (1178) 
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4.2.5.2 Expression profile of all genes responding to live WT N. lactamica 
Figure 4.4 shows a heat map of the 1178 genes responding to live WT N. lactamica in 
from 0 to 7 hours with respect to mock-infected controls. Two groups of genes could be 
seen. Those whose expression was lower (green) and higher (red) in cells infected with 
bacteria compared to mock-infected controls (4 hours onwards), respectively. 
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Figure 4.4: Heat map of the 1178 genes responding to live WT N. lactamica compared to mock-
infected controls from 0 to 7 hours   
Each column is the mean signal of four (N. lactamica) to eight replicates (mock-infected). Genes were 
mainly clustered into two groups: those whose expression was lower (green) and those whose expression 
was higher (red) upon addition of N. lactamica compared to the mock-infected controls. Gene list is 
listed in Appendix A, Table A.2. 
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4.2.5.3 Functional clustering of genes responding to live WT N. lactamica 
Genes significantly up and down-regulated upon infection with live WT N. lactamica 
compared to mock-infected controls were investigated at each time-point for functional 
clustering using the Panther gene expression analysis program (Table 4.5). At 3 hours, 
there was a significant over-representation of cell proliferation and differentiation 
process. At 5 hours, both cytokine and chemokine mediated signalling pathway and 
immunity and defence processes were significantly over-represented. At 6 and 7 hours, 
cell proliferation and differentiation process as well as glycolysis were significantly 
over-represented.  
 
Table 4.5: Biological processes significantly over-represented during time course infection studies 
with live WT N. lactamica 
 
 Time/h 
Biological Process 0 3 4 5 6 7 
Cell proliferation and 
differentiation   1.9 X 10-2     6.8 X 10-4 8.6 X 10-3 
Cytokine and chemokines 
mediated signalling pathway       1.1 X 10-2     
Immunity and defence       3.7 X 10-2     
Glycolysis         3.5 X 10-2 2.0 X 10-2 
 
Boxes shaded yellow are the time-points where there was a significant over-representation of the 
biological process (with the stated p values). Grey shaded boxes indicate time-points where there were no 
significant processes identified. 
 
Genes responding to live WT N. lactamica, and which cluster into the stated significant 
biological processes, are listed in Table 4.6. Fold change values are shown with respect 
to mock-infected controls. There are four genes which have two transcript variants 
each, which were detected by separate array probes. They are ING3 (transcript variant 
1 and 3), KLF6 (transcript variant 1 and 2), DUSP10 (transcript variant 1 and 2) and 
BPGM (transcript variant 1 and 2). Different transcripts of the same gene were 
regulated similarly. For example, ING3 transcript variants 1 and 3 were both down-
regulated while KLF6 transcripts 1 and 2 were both up-regulated. A majority of the 
genes in the cell proliferation and differentiation process were up-regulated at 3 (57%), 
6 (70%) and 7 (65%) hour time-points. Many genes were also up-regulated in the 
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cytokine and chemokine mediated signalling pathway (100%) and the immunity and 
defence process (88%) at 5 hours. The same can be said of the genes in the glycolysis 
process at 6 and 7 hours (80% and 67% of total genes up-regulated, respectively). The 
data indicates that, compared to N. meningitidis-infected cells there was an activation in 
gene expression (especially of immune genes) of the host in response to N. lactamica. 
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Table 4.6: Genes in significant biological 
processes differentially expressed upon 
infection with N. lactamica 
Genes are grouped based on the time of 
infection and the biological process they cluster 
into. Fold change values are with respect to 
mock-infected controls. 
 
(a) Cell proliferation and differentiation 
process at 3 hours 
 
Genbank ID Symbol Fold change 
NM_000576 IL1B 2.6 
NM_001420 ELAVL3 2.3 
NM_000963 PTGS2 2.2 
NM_002228 JUN 2.1 
NM_014518 ZNF229 -2.2 
NM_004058 CAPS -3.8 
NM_019071 
ING3  
(transcript 
variant 1) -5.0 
 
(b) Cytokine and chemokine mediated 
signalling pathway at 5 hours 
 
Genbank ID Symbol Fold change 
NM_000758 CSF2 4.2 
NM_003749 IRS2 3.4 
NM_000575 IL1A 3.2 
NM_181339 IL24 3.1 
NM_004591 CCL20 2.9 
NM_002089 CXCL2 2.5 
NM_175767 IL6ST 2.4 
NM_000584 IL8 2.3 
NM_002983 CCL3 2.3 
NM_000576 IL1B 2.2 
NM_021006 CCL3L1 2.2 
NM_000594 TNF 2.2 
NM_000600 IL6 2.2 
NM_001511 CXCL1 2.0 
 
(c) Immunity and defence process at 5 hours 
 
Genbank ID Symbol Fold change 
NM_139314 ANGPTL4 6.9 
NM_000758 CSF2 4.2 
NM_000575 IL1A 3.2 
NM_181339 IL24 3.1 
NM_004591 CCL20 2.9 
NM_005084 PLA2G7 2.7 
NM_022162 CARD15 2.7 
NM_005384 NFIL3 2.5 
NM_002089 CXCL2 2.5 
NM_006186 NR4A2 2.5 
NM_175767 IL6ST 2.4 
NM_000584 IL8 2.3 
NM_012089 ABCB10 2.3 
NM_014143 CD274 2.3 
NM_001004349 FLJ45422 2.3 
NM_001300 
KLF6  
(transcript 
variant 2) 2.3 
NM_002983 CCL3 2.3 
NM_144728 
DUSP10  
(transcript 
variant 2) 2.3 
NM_000576 IL1B 2.2 
NM_021006 CCL3L1 2.2 
NM_007207 
DUSP10  
(transcript 
variant 1) 2.2 
NM_005438 FOSL1 2.2 
NM_019900 ABCC1 2.2 
NM_000594 TNF 2.2 
NM_000600 IL6 2.2 
NM_001008490 
KLF6  
(transcript 
variant 1) 2.2 
NM_021983 
HLA-
DRB4 2.1 
NM_006147 IRF6 2.1 
NM_001511 CXCL1 2.0 
NM_201545 LGALS8 2.0 
NM_006247 PPP5C -2.0 
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Genbank ID Symbol Fold change 
NM_178272 PILRA -2.1 
NM_013269 CLEC2D -2.6 
NM_013440 PILRB -4.7 
 
(d) Cell proliferation and differentiation 
process at 6 and 7 hours 
 
Genbank ID Symbol Time/h 
    6 7 
    
Fold 
change 
NM_001731 BTG1 2.7   
NM_002089 CXCL2 2.2   
NM_004064 CDKN1B 2.2   
NM_001420 ELAVL3 -2.0   
NM_003438 ZNF137 -2.0   
NM_001024596 DKFZp686I1569 -2.0   
NM_020402 CHRNA10 -2.3   
NM_004058 CAPS -2.6   
NM_003415 ZNF268 -2.7   
NM_014789 ZNF623 -4.3   
NM_006096 NDRG1 5.4 5.2 
NM_181802 UBE2C 4.0 2.4 
NM_000575 IL1A 3.5 3.7 
NM_004354 CCNG2 3.0 2.4 
NM_000584 IL8 2.8 2.7 
NM_000576 IL1B 2.6 3.1 
NM_018948 ERRFI1 2.5 2.1 
NM_001511 CXCL1 2.4 2.4 
NM_001300 
KLF6  
(transcript 
variant 2) 2.4 2.4 
NM_002228 JUN 2.3 2.1 
NM_003670 BHLHB2 2.3 2.1 
NM_001008490 
KLF6  
(transcript 
variant 1) 2.1 2.5 
NM_005238 ETS1 2.1 2.3 
NM_005228 EGFR 2.1 3.0 
NM_005438 FOSL1 2.0 2.7 
NM_032854 CORO6 2.0 2.9 
NM_006705 GADD45G -3.1 -3.5 
Genbank ID Symbol Time/h 
    6 7 
    
Fold 
change 
NM_001001668 FLJ26175   2.1 
NM_001945 HBEGF   2.1 
NM_006238 PPARD   2.1 
NM_012323 MAFF   2.0 
NM_006454 MXD4   -2.0 
NM_004234 ZNF235   -2.0 
NM_002894 RBBP8   -2.0 
NM_003111 SP3   -2.0 
NM_001010877 ZNF311   -2.0 
NM_203282 ZNF539   -2.1 
NM_198267 
ING3  
(transcript 
variant 3) 
  -2.1 
NM_003421 ZNF37A   -2.2 
NM_183238 ZNF605   -2.3 
NM_024639 ZNF322A   -2.5 
 
(e) Glycolysis process at 6 and 7 hours 
 
Genbank ID Symbol Time/h 
    6 7 
    Fold change 
NM_199186 
BPGM  
(transcript 
variant 2) -3.5   
NM_004567 PFKFB4 4.2 4.8 
NM_000189 HK2 4.0 6.1 
NM_001975 ENO2 3.1 4.6 
NM_004566 PFKFB3 2.0 2.5 
NM_001724 
BPGM  
(transcript 
variant 1)   -2.1 
NM_144972 LDHAL6A   -2.5 
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4.2.6 Host epithelial responses specific to live Neisseria 
4.2.6.1 Determination of genes specifically responding to live Neisseria 
To identify genes responding specifically to live Neisseria, inactivated N. meningitidis 
and N. lactamica were used. Specifically, genes differentially responding to inactivated 
bacteria, with respect to mock-infected controls, were derived at each time-point. They 
were then removed from the responses to live bacteria. This enabled the identification 
of genes specifically responding to live but not inactivated bacteria from 0 to 7 hours.  
 
4.2.6.2 Classification of genes specifically responding to live Neisseria 
Genes specifically responding to live but not inactivated bacteria were separated into 
three groups: those that were specific to N. meningitidis, those that were specific to N. 
lactamica and those that were common to both. Table 4.7 shows the number of genes in 
each group from 0 to 7 hours post infection. I then determined if there were any 
biological processes significantly over represented in each of these groups using the 
Panther gene expression analysis program.  
 
Table 4.7: Number of host genes responding to live Neisseria 
 
Time/hour Specific to N.  meningitidis  Specific to N. lactamica  Both Neisseria bacteria   
0 181 138 14 
3 125 14 8 
4 204 425 66 
5 186 198 106 
6 247 103 90 
7 220 185 132 
 
4.2.6.3 Common host responses to N. lactamica and N. meningitidis 
Host genes that responded to both N. lactamica and N. meningitidis clustered into 
biological processes such as mRNA polyadenylation (4 hours), regulation of phosphate 
metabolism (5-7 hours) and glycolysis (6-7 hours) (Table 4.8). The genes involved in 
these biological processes are listed in Table 4.9. All of them were up-regulated in 
response to Neisseria with respect to mock-infected controls. 
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Table 4.8: Host biological processes commonly associated with a live Neisseria infection 
 
 Time/h 
Biological Process 0 3 4 5 6 7 
mRNA polyadenylation     1.7 X 10-2       
Regulation of phosphate metabolism       1.7 X 10-2 1.3 X 10-2 2.7 X 10-2 
Glycolysis         1.1 X 10-2 4.8 X 10-2 
 
Boxes shaded yellow are the time-points where there was a significant over-representation of the 
biological process (with the stated p values). Grey shaded boxes indicate time-points where there were no 
significant processes identified. 
 
Table 4.9: Genes commonly responding to live N. lactamica and N. meningitidis which cluster into 
significant biological processes 
Classification of the genes according to the biological process is as indicated in the legend. Fold change 
values with respect to mock-infected controls are indicated. 
 
Genbank ID Symbol Time/h 
  4 5 6 7 
  Fold change 
 
 
YL ML YL ML YL ML YL ML 
NM_001033506 CSTF3 2.1 2.7       
NM_030979 PABPC3 4.7 2.1       
NM_032626 RBBP6 2.4 2.2       
NM_003155 STC1   2.9 2.3 2.7 2.8 2.7 2.6 
NM_003714 STC2   3.1 3.1 3.3 3.5 3.7 2.4 
NM_001975 ENO2     3.1 2.7 4.6 3.3 
NM_000189 HK2     4.0 4.7 6.1 6.7 
NM_004566 PFKFB3     2.0 2.6 2.5 2.5 
NM_004567 PFKFB4     4.2 6.2 4.8 6.1 
 
 Legend: 
Biological Processes:   
mRNA polyadenylation   
Regulation of phosphate metabolism   
Glycolysis   
 
 YL: Live WT N. lactamica 
 ML: Live WT N. meningitidis 
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4.2.6.4 Host epithelial responses specific to live WT N. meningitidis 
At 3 hours, there was a significant over-representation of immunity and defence 
process genes specifically responding to live WT N. meningitidis, with a p value of 3.8 
X 10-3. Genes involved in this process are listed in Table 4.10. Seventeen out of 20 
(85%) of these genes were down-regulated, indicating that a down-regulation of genes 
involved in immunity and defence was specifically associated with a live WT N. 
meningitidis infection. 
 
Table 4.10: Genes specifically responding to live WT N. meningitidis at 3 hours which cluster into 
the immunity and defence process 
Fold change values with respect to mock-infected controls are shown at 3 hours. 
 
Genbank ID Symbol Fold change  
NM_139314 ANGPTL4 2.5 
NM_001734 C1S -2.2 
NM_002982 CCL2 -2.7 
NM_001001435 CCL4L1 -2.2 
NM_001710 CFB -2.2 
NM_000758 CSF2 2.0 
NM_002155 HSPA6 -2.3 
NM_001008699 IL4R 2.5 
NM_005564 LCN2 -3.0 
NM_002310 LIFR -3.9 
NM_004225 MFHAS1 -2.2 
NM_002456 MUC1 -2.0 
NM_016816 OAS1 -2.1 
NM_022572 PNKD -2.0 
NM_005729 PPIF -2.0 
NM_002908 REL -2.1 
NM_005621 S100A12 -2.2 
NM_002964 S100A8 -2.7 
NM_199161 SAA1 -2.1 
NM_030754 SAA2 -2.1 
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4.2.6.5 Host epithelial responses specific to live WT N. lactamica 
Table 4.11 shows the host biological processes specifically associated with live WT N. 
lactamica infection. At 5 hours, the cytokine and chemokine mediated signalling 
pathway was activated. Other host responses specific to live N. lactamica include 
mRNA transcription regulation (0 and 7 hours), cell proliferation and differentiation (6-
7 hours) and mRNA transcription (7 hours). Table 4.12 indicates the genes involved in 
these processes. 
 
Table 4.11: Host biological processes specifically associated with live N. lactamica infection 
 
  Time/h 
Biological Process 0 3 4 5 6 7 
mRNA transcription  
regulation 4.3 X 10-2         2.0 X 10-3 
Cytokine and chemokines 
mediated signalling pathway       2.2 X 10-3     
Cell proliferation and 
differentiation         8.5 X 10-3 3.7 X 10-6 
mRNA transcription           4.8 X 10-3 
 
Boxes shaded yellow are the time-points where there was a significant over-representation of the 
biological process (with the stated p values). Grey shaded boxes indicate time-points where there were no 
significant processes identified. 
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Table 4.12: Genes specifically responding to 
live N. lactamica which cluster into 
significant biological processes 
Categories (a) to (d) describe the genes 
associated with the different processes at (a) 0, 
(b) 5, (c) 6 and (d) 7 hours, with their fold 
change values (with respect to mock-infected 
controls) at their respective time-points. 
 
(a) Genes associated with mRNA 
transcription regulation at 0 hours 
 
Genbank ID Symbol 
Fold 
change 
NM_006492 ALX3 -2.1 
NM_145696 BRF1 2.1 
NM_080833 C20orf151 3.2 
NM_153200 EDF1 -2.2 
NM_001453 FOXC1 2.2 
NM_032682 FOXP1 -2.1 
NM_020713 GM632 -2.0 
NM_021170 HES4 -2.0 
NM_006898 HOXD3 -3.1 
NM_018411 HR 2.3 
NM_145805 ISL2 -2.2 
NM_000214 JAG1 -2.5 
NM_006163 NFE2 -2.1 
NM_002502 NFKB2 2.1 
NM_022123 NPAS3 -2.0 
NM_004959 NR5A1 -2.3 
NM_021976 RXRB -2.1 
NM_012236 SCMH1 2.1 
NM_012446 SSBP2 2.2 
NM_000461 THRB -2.9 
NM_015481 ZNF385 2.2 
NM_021269 ZNF708 3.7 
 
(b) Genes associated with cytokine and 
chemokine mediated signalling pathway at 5 
hours 
 
Genbank ID Symbol 
Fold 
change 
NM_004591 CCL20 2.9 
NM_002983 CCL3 2.3 
NM_021006 CCL3L1 2.2 
NM_001511 CXCL1 2.0 
NM_002089 CXCL2 2.5 
NM_000575 IL1A 3.2 
NM_000576 IL1B 2.2 
NM_181339 IL24 3.1 
NM_000600 IL6 2.2 
NM_175767 IL6ST 2.4 
NM_000584 IL8 2.3 
NM_000594 TNF 2.2 
 
(c) Genes associated with cell proliferation 
and differentiation process at 6 hours 
 
Genbank ID Symbol 
Fold 
change 
NM_003670 BHLHB2 2.3 
NM_004354 CCNG2 3.0 
NM_004064 CDKN1B 2.2 
NM_032854 CORO6 2.0 
NM_001511 CXCL1 2.4 
NM_005228 EGFR 2.1 
NM_001420 ELAVL3 -2.0 
NM_005438 FOSL1 2.0 
NM_001008490 
KLF6 
(transcript 
variant 1) 2.1 
NM_001300 
KLF6 
(transcript 
variant 2) 2.4 
NM_181802 UBE2C 4.0 
NM_003438 ZNF137 -2.0 
NM_003415 ZNF268 -2.7 
NM_001024596 ZNF772 -2.0 
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(d) Genes associated with mRNA transcription regulation, cell proliferation and differentiation 
and mRNA transcription processes at 7 hours 
 
Genbank ID Symbol Fold change Biological Processes 
    
 
mRNA 
transcription 
regulation 
Cell proliferation 
and differentiation 
mRNA 
transcription 
NM_005438 FOSL1 2.7 x x x 
NM_003670 BHLHB2 2.1 x x x 
NM_001300 
KLF6 
(transcript 
variant 2) 2.4 x x x 
NM_001008490 
KLF6 
(transcript 
variant 1) 2.5 x x x 
NM_002894 RBBP8 -2.0 x x x 
NM_004234 ZNF235 -2.0 x x x 
NM_203282 ZNF539 -2.1 x x x 
NM_001010877 ZNF311 -2.0 x x x 
NM_003421 ZNF37A -2.2 x x x 
NM_001001668 FLJ26175 2.1 x x x 
NM_006454 MXD4 -2.0 x x x 
NM_012323 MAFF 2.0 x x x 
NM_006238 PPARD 2.1 x x x 
NM_002228 JUN 2.1 x x x 
NM_005238 ETS1 2.3 x x x 
NM_015481 ZNF385 2.6 x   x 
NM_006898 HOXD3 -2.3 x   x 
NM_002141 HOXA4 2.2 x   x 
NM_021220 OVOL2 -2.4 x   x 
NM_015025 MYT1L -2.4 x   x 
NM_015630 EPC2 -2.3 x   x 
NM_006399 BATF -7.7 x   x 
NM_025209 EPC1 -2.1 x   x 
NM_005178 BCL3 2.0 x   x 
NM_005902 SMAD3 2.1 x   x 
NM_005078 TLE3 2.2 x   x 
NM_016270 KLF2 2.3 x   x 
NM_015478 L3MBTL 2.7 x   x 
NM_080647 TBX1 3.5 x   x 
NM_020436 SALL4 3.8 x   x 
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Genbank ID Symbol Fold change Biological Processes 
    
 
mRNA 
transcription 
regulation 
Cell proliferation 
and differentiation 
mRNA 
transcription 
NM_003111 SP3 -2.0   x x 
NM_000575 IL1A 3.7   x   
NM_000576 IL1B 3.1   x   
NM_000584 IL8 2.7   x   
NM_001511 CXCL1 2.4   x   
NM_004354 CCNG2 2.4   x   
NM_181802 UBE2C 2.4   x   
NM_032854 CORO6 2.9   x   
NM_005228 EGFR 3.0   x   
NM_006705 GADD45G -3.5   x   
NM_198267 ING3 -2.1   x   
NM_018948 ERRFI1 2.1   x   
NM_001945 HBEGF 2.1   x   
NM_032587 CARD6 -2.2     x 
NM_030665 RAI1 2.2     x 
NM_032205 PHF20L1 -4.3     x 
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4.2.6.6 Effect of capsule and pili on host epithelial responses 
Using N. meningitidis cap- and pilE- mutants, it was shown in Chapter 3 that the loss of 
capsule and pili enhances and reduces the invasion of N. meningitidis, respectively. At 
3 hours, there were 125 genes specifically responding to live WT N. meningitidis, of 
which 20 genes clustered into the immunity and defence process. This was the only 
time-point where genes specifically responding to live WT N. meningitidis clustered in 
a biological process. To further investigate these genes, N. meningitidis cap- and N. 
meningitidis pilE- mutants were used to determine the effects of the capsule and the 
pili, respectively on the expression of these 125 genes. Figure 4.5 shows a heat map of 
these genes, and how their expression differs between the WT and mutant N. 
meningitidis. 
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Figure 4.5: A heat map showing the 125 genes specifically responding to live WT N. meningitidis 
with reference to mock-infected controls at 3 hours post infection  
It also shows how the expression of these genes is affected by the absence of the capsule and pili using 
the N. meningitidis cap- and pilE- mutants, respectively. NM: N. meningitidis. Red indicates a relatively 
higher and green a relatively lower expression level. Gene list is listed in Appendix A, Table A.3. 
 
 
Mock WT NM NM cap- NM pilE- 
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Figure 4.6 shows that out of the 125 genes responding specifically to live WT N. 
meningitidis, 59 genes were differentially expressed with respect to mock-infected 
controls in response to both N. meningitidis cap- and pilE- mutants, suggesting that 
these genes may be expressed in response to non-capsule and pili factors. Thirty eight 
genes were not differentially expressed in response to either of the N. meningitidis 
mutants, suggesting that the expression of these genes was in response to both capsule 
and pili. Twenty four genes were differentially expressed in response to the capsule 
mutant but not the pili mutant, suggesting that the expression of these genes was in 
response to the pili not the capsule. Four genes were differentially expressed in 
response to the pili mutant but not the capsule mutant, suggesting that the expression of 
these genes was in response to the capsule not the pili. 
 
 
 
 
Figure 4.6: Extent of the contribution of pili and capsule on host response to live N. meningitidis  
Out of the 125 genes responding specifically to live WT N. meningitidis, the expression of 59 genes was 
not entirely in response to the capsule and pili, while the expression of 38 genes was in response to these 
two components. The expression of 24 genes was in response to the pili but not the capsule while the 
expression of only four genes was in response to the capsule but not the pili. 
 
Genes specifically responding to live N. meningitidis at 3h 
Pili Capsule 
 
38 
24 4 
59 
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4.2.6.6.1 Identification of host genes specifically responding to live N. 
meningitidis which may be expressed in response to non-capsule and 
pili factors 
Fifty nine genes were differentially expressed with respect to mock-infected controls in 
response to WT N. meningitidis and N. meningitidis cap- and pilE- mutants, suggesting 
that these genes may be expressed in response to non-capsule and pili factors. Instead, 
the expression of these genes could be due to active bacterial processes involving other 
components such as secreted proteins. Table 4.13 shows the 59 genes with their fold 
change values. 11 out of 59 genes were up-regulated (19%) while 48 out of 59 genes 
were down-regulated (81%). 
 
Table 4.13: Genes specifically responding to live WT N. meningitidis which may be expressed in 
response to non-capsule and pili factors 
Fold change values in response to WT and mutant N. meningitidis (cap- and pilE-) are shown at 3 hours. 
 
Genbank ID Symbol WT N. meningitidis N. meningitidis cap- N. meningitidis pilE- 
NM_003488 AKAP1 -2.0 -1.4 -1.5 
NM_005166 APLP1 -2.2 -1.7 -1.8 
NM_000041 APOE -2.0 -1.5 -1.4 
NM_014784 ARHGEF11 -2.0 -1.5 -1.4 
NM_183376 ARRDC4 -3.1 -2.8 -1.6 
NM_032885 ATG4D -2.4 -2.5 -1.6 
NM_001734 C1S -2.2 -1.8 -1.4 
NM_001759 CCND2 -2.1 -2.3 -2.2 
NM_024111 CHAC1 -4.6 -6.2 -1.6 
NM_020989 CRYGC 2.5 2.1 1.6 
NM_022034 CUZD1 -3.5 -3.8 -1.6 
NM_024005 DDX3X -2.5 -1.4 -1.6 
NM_015018 DOPEY1 -2.3 -1.5 -1.5 
NM_012153 EHF -2.7 -1.8 -1.6 
NM_022086 ELMO2 -2.1 -2.1 -1.6 
NM_025209 EPC1 -2.6 -2.1 -1.4 
NM_032836 FLJ14768 -2.1 -1.8 -1.7 
NM_144605 FLJ25410 2.2 1.6 1.4 
NM_032664 FUT10 -2.1 -5.2 -2.5 
NM_014373 GPR160 2.1 1.9 2.5 
NM_014707 HDAC9 -2.5 -2.6 -1.5 
NM_013332 HIG2 3.0 2.8 1.6 
NM_001008699 IL4R 2.5 2.6 2.9 
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Genbank ID Symbol WT N. meningitidis N. meningitidis cap- N. meningitidis pilE- 
NM_005564 LCN2 -3.0 -5.2 -2.6 
NM_001013702 LOC440258 2.0 1.9 1.4 
NM_024509 LRFN3 -2.4 -26.1 -2.5 
NM_023942 LRRC61 -2.3 -2.7 -1.6 
NM_014994 MAPKBP1 -5.7 -3.0 -1.6 
NM_004225 MFHAS1 -2.2 -2.0 -1.5 
NM_015246 MGRN1 -2.0 -2.4 -1.7 
NM_014632 MICAL2 -2.4 -4.9 -1.8 
NM_014903 NAV3 -3.8 -15.2 -4.0 
NM_002610 PDK1 2.1 3.3 2.1 
NM_005764 PDZK1IP1 -4.4 -76.9 -14.2 
NM_004567 PFKFB4 2.8 2.0 1.8 
NM_002638 PI3 -3.4 -4.6 -2.4 
NM_012398 PIP5K1C -2.0 -1.8 -2.5 
NM_025201 PLEKHQ1 -3.1 -3.4 -1.5 
NM_005729 PPIF -2.0 -2.0 -1.7 
NM_014731 ProSAPiP1 -2.5 -1.6 -1.7 
NM_001031698 PRPF40B -2.2 -1.6 -2.3 
NM_004914 RAB36 -2.5 -1.8 -1.5 
NM_144964 RG9MTD3 -2.0 -4.5 -1.8 
NM_002928 RGS16 2.5 4.3 3.2 
NM_004630 SF1 -2.2 -1.9 -1.7 
NM_012309 SHANK2 2.1 2.2 2.2 
NM_015260 SIN3B -2.2 -1.7 -1.7 
NM_006931 SLC2A3 2.1 2.4 1.7 
NM_005070 SLC4A3 -2.4 -2.0 -1.6 
NM_004819 SYMPK -2.0 -1.4 -1.4 
NM_016151 TAOK2 -2.1 -1.8 -1.7 
NM_030756 TCF7L2 -2.3 -2.3 -2.7 
NM_017728 TMEM104 -2.1 -3.1 -1.7 
NM_033396 TNKS1BP1 -2.2 -1.8 -1.4 
NM_005108 XYLB -2.4 -2.3 -2.2 
NM_015117 ZC3H3 -2.1 -1.7 -1.7 
NM_014518 ZNF229 -2.4 -1.3 -1.5 
NM_025189 ZNF430 -2.5 -3.1 -1.8 
NM_153263 ZNF549 -2.8 -2.3 -1.5 
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4.2.7 Stringent selection of genes for validation with Q-RT-PCR 
The analysis of the microarray results ensured that the genes underwent a stringent 
process of selection for subsequent validation and follow up using Q-RT-PCR. For 
example, the number of genes significantly differentially expressed between cells 
infected with live WT N. lactamica and mock-infected cells at 0 hours, after statistical 
analysis, is 2281. Use of a filter that removed genes expressed at low levels, decreased 
the number of genes to 1964. An additional 2-fold expression difference filter was used 
when comparing mock-infected cells with cells challenged with (live and inactivated) 
WT Neisseria. This caused a dramatic drop in the number of genes to 252 (Table 4.4), 
indicating that a huge majority (87%) of the genes were only slightly differentially 
expressed with a fold change of less than 2. 
 
After using the stringent filters to obtain lists of differentially expressed genes, 
functional clustering was done to determine if there were any biological processes 
significantly over represented in these group of genes. An example was the 138 genes 
responding specifically to live N. lactamica (but not N. meningitidis) (Table 4.7) at 0 
hour, where only 22 out of 138 genes cluster into the mRNA transcription regulation 
process (Table 4.12, a).  
 
To further confirm the microarray results, Q-RT-PCR would be carried out to validate 
the differential expression (with respect to mock-infected controls) of genes specifically 
responding to live but not inactivated Neisseria and which also cluster into significant 
biological processes. This included genes specifically responding to live WT N. 
meningitidis, genes specifically responding to live WT N. lactamica and genes 
responding to both live bacteria. 
 
Among the genes responding specifically to live N. meningitidis, 20 out of 125 genes 
clustered into a significant biological process at 3 hours (Table 4.10). Besides 
functional clustering, I further investigated the effect of the capsule and pili on the 
expression of the 125 genes by comparing cells infected with N. meningitidis cap- and 
pilE- mutants with mock-infected cells at 3 hours. The comparison of host responses to 
live N. meningitidis WT, cap- and pilE- mutants at 3 hours identified 59 host genes 
which not only responded specifically to live WT N. meningitidis, but also to N. 
meningitidis cap- and pilE- mutants. This could mean that the expression of these genes 
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was not in response to the capsule and pili but could be due to non capsule and pili 
factors. Q-RT-PCR would also be used to determine if these 59 genes could be 
validated. 
 
TLDA cards were used for the Q-RT-PCR. After eliminating genes which were 
unavailable for selection in the TLDA cards as well as those which are poorly 
characterized (as determined by an extensive literature search), I constructed TLDA 
cards for a total of 142 genes. Ninety five genes were filtered from the functional 
clustering analysis while 54 genes were from the analysis comparing WT N. 
meningitidis and its mutants. There were seven common genes between the two types 
of analysis. Results from the Q-RT-PCR are described in the next two Chapters 
(Chapters 5 and 6). 
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4.3 Discussion 
4.3.1 Bacterial differences mediate differential host responses 
This Chapter has described the transcriptional response of 16HBE14 cells to N. 
lactamica and N. meningitidis, two to seven hours after their addition, using an Illumina 
microarray platform. Similar amounts of the two bacteria (approximately 107 cfu per 
well) were added to ensure a consistent MOI. In addition, from my results in Chapter 3, 
it was found that there was no significant difference in the amount of N. meningitidis 
and N. lactamica associated with and which had invaded host cells at 4 hours post 
infection, suggesting that any differential host responses seen would be due to bacterial 
differences rather than their numbers per se (at least for the time-point of 4 hours). 
 
4.3.2 Activation of the host is associated with a live WT N. lactamica infection 
This, to my knowledge, is the first whole cell transcriptome microarray study of host 
transcriptional responses of human respiratory tract cells to N. lactamica (a commensal) 
and N. meningitidis (a potential pathogen). Studies so far on responses to N. lactamica 
have mainly involved murine challenge models where it was demonstrated that 
systemic immunisation with N. lactamica generates cross-protective immunity against 
meningococcal infection and detectable serum bactericidal antibodies against N. 
meningitidis serogroups A, B and C (Li et al., 2006). Little information, however, is 
known about the host epithelial responses to N. lactamica at the colonisation stage. My 
results show that host genes responding to live WT N. lactamica cluster into processes 
such as cell proliferation and differentiation, cytokine and chemokine mediated 
signalling pathways, glycolysis and immunity and defence processes. The data suggest 
that the epithelial host cells are able to recognise and respond to this commensal. 
 
4.3.3 Host responses to WT live N. meningitidis 
Although there is more gene expression data derived from microarray studies of host 
cells in response to N. meningitidis, they are mainly focused on the response of non-
respiratory tract cells. For example, the study by Schubert-Unkmeir et al. (2007), on 
human brain endothelial cell responses to N. meningitidis MC58, indicated that most of 
the differentially regulated genes were involved in transcription, RNA 
processing/turnover/ transport, translation, and posttranslational modification/protein 
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folding, which suggest very high turnover of nucleic acids in the endothelial cells upon 
bacterial infection. The genes involved in cell metabolism, particularly in energy 
production, were found to be one of the groups of genes with increased transcription in 
infected cells. Similarly, with live WT N. meningitidis and bronchial epithelial cells, I 
observed up-regulation of genes involved in energy production processes such as 
carbohydrate metabolism and glycolysis (Table 4.3, b and c). Therefore, some of the 
responses to live N. meningitidis are similar in different cell types.  
 
However, host responses to N. meningitidis in bronchial epithelial cells were observed 
that were different to those in other cell types. For example, gene expression profiling 
of HUVECs to meningococci (MC58) indicated alterations of expression of human 
genes known to regulate apoptosis, cell proliferation, inflammatory response, adhesion 
and genes for signalling pathway proteins such as TGF-beta/Smad,Wnt/beta-catenin 
and Notch/Jagged (Linhartova et al., 2006). Another study was with human 
meningothelial cells following meningococcal (MC58) challenge for 4 hours (Wells et 
al., 2001). Both of the HUVEC and meningothelial studies suggested that interaction 
with N. meningitidis increased the ability of the host cells to withstand apoptotic signals 
induced by infection and activate a cytoprotective signalling. They also indicate that 
some proinflammatory genes like CCL2 were up-regulated (4 and 6 hours post 
infection in the HUVECs and 4 hours post infection in the meningothelial cells).  This 
is in contrast to this study, where I found that CCL2 was down-regulated in the 
16HBE14 cell line 3 hours post infection (Table 4.3, a). Thus different cell lines 
respond in different ways to infection with N. meningitidis. 
 
Describing the whole genome wide response to N. meningitidis in this study provides 
more information than specialised microarrays which were used to investigate host 
responses involving only a small subset of candidate genes. For example, iron-related 
genes and human cytokine and adhesion related genes were investigated by Bonnah et 
al. (2004) and Plant et al. (2004), respectively. In the two latter studies, the strains of N. 
meningitidis and the types of epithelial cell lines used differed from those in my study. 
Specifically, Bonnah et al. (2004) used a N. meningitidis strain 8013.3 on A431, a 
human epidermoid carcinoma line, while Plant et al. (2004) used N. meningitidis 
serogroup C strain FAM20 on ME-180, an epithelial-like human cell line from cervical 
carcinoma. With the use of different meningococci strains and cell lines compared to 
those in this study, it is hard to make meaningful comparisons between responses 
Chapter 4 
98 
discussed in these and my study. While my analysis indicate that an early (3 hours post 
infection) down-regulation of the immune response was associated with a live WT N. 
meningitidis infection, Bonnah et al. (2004) focused on showing an alteration in mRNA 
expression of host genes involved in iron homeostasis while Plant et al. (2004) 
described the differential expression of several host membrane proteins in response to 
N. meningitidis. 
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4.3.4 Determination of host responses specific to live Neisseria 
4.3.4.1 Use of inactivated Neisseria  
Host responses specific to live Neisseria were identified by comparisons of host cells in 
response to live and dead bacteria with respect to mock-infected controls. 
Formaldehyde inactivation of the bacteria was chosen over other methods such as heat 
inactivation as the former keeps the bacteria whole. Heat inactivation lyses 
meningococci and results in the release of bacterial components such as endotoxins and 
cell debris which may greatly affect the host response. (Massari et al., 2006; Sprong et 
al., 2001).  
 
4.3.4.2 Host responses common to live N. meningitidis and N. lactamica suggest 
that the bacteria are using the host as a source of energy 
Grifantini et al. (2002) used the same 16HBE14 human bronchial epithelial cells as in 
my analysis, where they compared the bacterial expression profile using bacterial 
arrays. They showed that, for both N. lactamica and N. meningitidis, host cell contact 
reduced metabolism in the bacteria. The authors suggested that an explanation for their 
findings was that once bacteria are associated with host cells they are able to utilise part 
of the ATP synthesised by the host. This could explain why, similarly after cell 
association at 4 hours in this study, common host responses to live N. lactamica and N. 
meningitidis include regulation of phosphate metabolism and glycolysis - processes 
involved in energy production in the host. 
 
4.3.4.3 Host responses specific to either live N. lactamica or N. meningitidis 
Activation of genes involved in cytokine and chemokine mediated signalling pathways, 
mRNA transcription and regulation as well as cell proliferation and differentiation was 
specifically associated with a live N. lactamica infection in 16HBE14 cells. In contrast, 
down-regulation of a majority of genes (85%) involved in immunity and defence was 
specifically associated with a live N. meningitidis infection. To our knowledge, there 
has not yet been a whole genome wide comparison of host epithelial responses to N. 
meningitidis and N. lactamica, particularly specific to live bacteria. Differential host 
epithelial responses to N. meningitidis and N. lactamica may point to specific processes 
during colonisation and may also help to explain why N. meningitidis has the potential 
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to cause invasive disease while N. lactamica remains a commensal. The data from the 
initial microarray analysis suggests that N. meningitidis is associated with a down-
regulation of the host defence response, which not only allows it to colonise the host, 
but may be one of the many reasons why it has the potential to cause invasive disease 
in an environment where the host innate immune response is compromised. In contrast, 
N. lactamica can be detected by the host and induces an inflammatory state. Clearly, 
this commensal is not hiding from the host immune response and this initial response to 
N. lactamica may alert the host to its presence and thus prevent colonisation outside of 
its normal niche. In addition, these differential host responses to N. meningitidis and N. 
lactamica are specific to live bacteria, suggesting that besides surface components, 
active bacterial processes are also involved. 
 
4.3.4.4 Similar host responses to WT and mutant N. meningitidis suggest the 
involvement of non capsule and pili factors  
N. meningitidis cap- and pilE- mutants were used to determine which responses 
specific to live WT N. meningitidis were dependent on the presence of the capsule and 
pili. The capsule is present in N. meningitidis but not in N. lactamica (Fowler et al., 
2006) and is thought to be an important virulence factor. The capsule of disease 
associated N. meningitidis is known to be essential for bacterial growth in the 
bloodstream and important for intracellular survival in human cells, where the capsule 
may increase the resistance of the bacteria to cationic antimicrobial peptides (Spinosa et 
al., 2007). The pilus is an important component involved in the localised adhesion of 
the bacteria to the host cells (Pujol et al., 1997). From the data in Chapter 3, N. 
meningitidis pilE- mutant invades the host cells less compared to N. meningitidis cap- 
mutant. In this study, 59 out of the 125 genes responding specifically to live WT N. 
meningitidis at 3 hours were similarly responding (with respect to mock-infected 
controls) to N. meningitidis cap- and pilE- mutants, indicating that the bacteria may be 
able to induce a response from the host in a contact independent way. Such responses 
may be due to non capsule and pili factors such as secreted proteins (which require live 
bacteria). 
 
A well known example of a neisserial secreted protein which has an effect on the host 
cell is IgA1 protease. It is secreted by N. meningitidis and cleaves human mucosal IgA1 
in order to prolong bacterial extracellular survival at mucosal locations. It also cleaves 
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host lysosomal LAMP1 (lysosome-associated membrane protein 1) which is thought to 
be important for the intracellular survival of the bacteria (Lin et al., 1997). More 
recently, Robinson et al. (2004) treated meningothelial cells with crude preparations of 
meningococcal secreted proteins, and demonstrated up-regulation of a number of 
proinflammatory genes, as well as both anti-apoptotic and pro-apoptotic genes, 
indicating that secreted proteins may contribute significantly to the process of 
meningococcus-host cell interaction. 
 
4.3.5 Validation by Q-RT-PCR is an essential step to confirm microarray 
results 
Analysis of the microarray results ensured that the genes underwent a stringent process 
of selection for validation and follow up using Q-RT-PCR, as described in Section 
4.2.7. Validation by Q-RT-PCR requires that that there is similar up or down-regulation 
of the genes with respect to mock-infected controls (as in the array) and that the 
difference is statistically significant with a p value of less than 0.05. Due to the high 
throughput method of the microarray based on target probe hybridisation, it is expected 
that not all the genes from the microarray can be validated by Q-RT-PCR (Chuaqui et 
al., 2002). False positives can arise from non-specific or cross hybridisation in the 
array, and this is likely to be the case for genes differentially expressed at 0 hours 
where they contribute to background noise in the array. Some transcripts are expressed 
at low levels and may not be accurately detected by the microarray, giving rise to false 
positives as well. In addition, the probes used to detect gene transcripts in Q-RT-PCR 
and array are not exactly the same and may target different regions of the transcript. All 
these are possible reasons why not all genes from the microarray can be validated with 
Q-RT-PCR. This also highlights the importance of using Q-RT-PCR as a validation 
platform to confirm the microarray findings. Results from Q-RT-PCR validation 
studies are presented in the subsequent Chapters. 
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4.3.6 Conclusions  
In summary, whole genome wide transcriptional host responses to N. lactamica and N. 
meningitidis were described and compared, with emphasis on responses mediated by 
live bacteria. Clustering of the genes into biological processes helped to associate the 
genes into various functions common to or specifically associated with either live WT 
N. lactamica or N. meningitidis. The utilisation of N. meningitidis cap- and pilE- 
mutants identified host responses to bacteria in a contact independent way, which could 
be potentially mediated by non capsule and pili factors such as secreted bacterial 
proteins. Subsequent Chapters will describe the validation and follow up of these genes. 
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Chapter 5 : Common hos t epithelial responses  to live N. meningitidis  and N. lactamica. 
Common host epithelial responses to live N. meningitidis  
and N. lactamica 
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5.1 Introduction 
5.1.1 Common host responses to N. meningitidis and N. lactamica may 
indicate mechanisms of successful colonisation 
Host epithelial responses common to live N. meningitidis and N. lactamica were 
described in Chapter 4 and indicated a significant over representation of energy 
production processes such as regulation of phosphate metabolism and glycolysis. At 
the colonisation stage, both N. meningitidis and N. lactamica act as commensals. Host 
responses common to these two bacteria may indicate how the epithelial cells and the 
bacteria adapt to each other during this colonisation process. In the highly competitive 
intestinal ecosystem, gut microflora such as B. thetaiotaomicron regulates production 
of fucosylated glycans in intestinal enterocytes and is able to use these as a source of 
energy (Hooper et al., 1999). Our results suggest that Neisseria may utilise a similar 
strategy during colonisation on epithelial cells. 
 
There has been a lack of studies describing host responses that are common to both N. 
meningitidis and N. lactamica during colonisation. Inflammatory responses of human 
meningeal cells following challenge with N. meningitidis and N. lactamica focused on 
selected cytokines and chemokines. It was found that the levels of IL8 and MCP-1 
secretion induced by both neisserial species were similar, indicating that both bacteria 
can induce an inflammatory response in human meningeal cells (Fowler et al., 2006). 
Using the 16HBE14 human epithelial cell line, Grifantini et al. (2002) described the 
expression profile of both N. meningitidis and N. lactamica upon interaction with the 
host cells. Only 167 out of 465 regulated genes were common to both bacteria. 
Specifically, both N. meningitidis and N. lactamica were associated with a reduction 
in expression of many growth-dependent genes. Common host epithelial responses to 
live N. meningitidis and N. lactamica (validated by Q-RT-PCR in this Chapter) may 
explain this phenomenon and provide a better understanding of the host-bacterial 
interactions common to N. meningitidis and N. lactamica at the colonisation stage. 
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5.1.2 Use of high throughput Q-RT-PCR in microarray validation 
Due to the high throughput method of the microarray based on target probe 
hybridisation, non-specific or cross-hybridisation cannot be completely eliminated 
(Chuaqui et al., 2002). Q-RT-PCR is a commonly used validation tool for confirming 
gene expression results obtained from microarray analysis. Detection of specific 
transcripts in a sensitive manner can be carried out using specific probes and primers 
with fluorescent molecules attached. The more template transcripts there are, the more 
PCR product there will be, resulting in an increase in fluorescent signal. This process 
can be combined with microfluidic technology, which can mix different samples with 
different gene primer assays simultaneously. This results in high throughput platforms 
which can analyse the expression of many genes all at once. In this study, the TLDA 
and Fluidigm chips were used for the Q-RT-PCR validation.  
 
The aim of this Chapter is to use Q-RT-PCR to confirm the microarray findings of 
differentially expressed genes responding to live Neisseria (N. meningitidis and N. 
lactamica) and which cluster into significant biological processes. 
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5.2 Results 
5.2.1 Validation of microarray results using Q-RT-PCR 
Q-RT-PCR was used to determine if there was similar up or down-regulation of the 
genes with respect to mock-infected controls (as in the microarray) indicating 
consistent differential expression, and whether the difference in expression was also 
statistically significant. When these two criteria were fulfilled, the array result was 
considered as validated. 
 
As described in the microarray results in Chapter 4, genes specifically responding to 
live Neisseria (both N. meningitidis and N. lactamica) cluster into biological 
processes such as mRNA polyadenylation (4 hours), regulation of phosphate 
metabolism (5-7 hours) and glycolysis (6-7 hours). All the genes clustering into 
mRNA polyadenylation process at 4 hours were not validated (Table 5.1). Fold 
change values of these genes were not consistent or the differences in expression 
between the cells treated with Neisseria and mock-infected cells were small. On the 
other hand, genes clustering in the regulation of phosphate metabolism and glycolysis 
from 5-7 hours were validated. For the two genes in the regulation of phosphate 
metabolism, STC1 and STC2, the expression of STC1 was validated from 5 to 7 hours 
while the expression of STC2 was validated at 6 hours. The expression of genes 
involved in the glycolysis process was validated at 6 and 7 hours. All the validated 
genes in these processes were up-regulated. 
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Table 5.1: Microarray and Q-RT-PCR results showing fold changes in gene expression in response to N. lactamica and N. meningitidis (with respect to mock-infected 
controls) 
These genes were commonly responding to live N. lactamica and N. meningitidis and clustered into significant biological processes. Asterisks (*) mark genes which showed 
consistent expression and were statistically validated. 
 
Genbank ID Symbol Time 
  4h 5h 6h 7h 
  N. lactamica N. meningitidis  N. lactamica N. meningitidis  N. lactamica N. meningitidis N. lactamica N. meningitidis  
  Array Q-RT-PCR Array Q-RT-PCR Array Q-RT-PCR Array Q-RT-PCR Array Q-RT-PCR Array Q-RT-PCR Array Q-RT-PCR Array Q-RT-PCR 
NM_001033506 CSTF3 2.1 -1.2 2.7 -1.4             
NM_030979 PABPC3 4.7 -2.5 2.1 -6.5             
NM_032626 RBBP6 2.4 1.0 2.2 1.0             
NM_003155 STC1     2.9* 2.1* 2.3* 2.1* 2.7* 2.4* 2.8* 2.9* 2.7* 2.7* 2.6* 3.2* 
NM_003714 STC2     3.1 2.9 3.1 3.1 3.3* 3.4* 3.5* 3.8* 3.7 4.6 2.4 3.1 
NM_001975 ENO2         3.1* 2.9* 2.7* 4.3* 4.6* 3.7* 3.3* 3.9* 
NM_000189 HK2         4.0* 6.2* 4.7* 9.1* 6.1* 7.2* 6.7* 7.7* 
NM_004566 PFKFB3         2.0* 6.2* 2.6* 8.6* 2.5* 6.5* 2.5* 5.7* 
NM_004567 PFKFB4         4.2* 4.3* 6.2* 7.4* 4.8* 5.0* 6.1* 6.8* 
 
Legend: 
Biological Processes:  
mRNA polyadenylation   
Regulation of phosphate metabolism   
Glycolysis   
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5.2.2 Expression profile of validated host genes commonly responding to live 
Neisseria 
The expression of the six validated genes commonly responding to live N. meningitidis 
and N. lactamica is shown in Figure 5.1. Significant up-regulation of the six genes 
compared to the mock-infected controls occurred from 4 to 7 hours post infection with 
live N. meningitidis and N. lactamica. The expression levels of these genes increased 
with time. In contrast, these genes were not activated upon addition of inactivated N. 
meningitidis and N. lactamica, indicating that the up-regulation was in response to an 
active bacterial process. 
 
Chapter 5 
109 
(a) 
 
(b) 
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(c) 
 
(d) 
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(e) 
 
 
(f) 
 
Figure 5.1: Host genes responding to live N. meningitidis and N. lactamica 
Expression at the transcript level is shown for STC1 (a), STC2 (b), ENO2 (c), HK2 (d), PFKFB3 (e) and 
PFKFB4 (f). Asterisks (*) indicate statistical significance with p value less than 0.05 with respect to 
mock-infected controls.  M: mock-infected, YK: inactivated N. lactamica, YL: live N. lactamica, MK: 
inactivated N. meningitidis, ML: live N. meningitidis, RQ: relative quantification.  
Outliers (0) defined as between 1.5 to 3X the interquartile range from the 25th or 75th percentile. 
Extreme (E) defined as more than 3X the interquartile range from the 25th or 75th percentile. 
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5.3 Discussion  
5.3.1 Utilisation of host energy production processes by colonising Neisseria 
Genes commonly responding to live Neisseria (N. meningitidis and N. lactamica) in the 
microarray and involved in the regulation of phosphate metabolism and glycolysis were 
validated by Q-RT-PCR.  
 
STC1 and STC2 (from the regulation of phosphate metabolism pathway) encode 
members of a family of secreted homodimeric glycoproteins which are involved in 
phosphate transport, cell metabolism, and cellular calcium/phosphate homeostasis. 
ENO2, HK2, PFKFB3 and PFKFB4 are genes involved in carbohydrate metabolism 
including glycolysis. For example, hexokinases (HK2) phosphorylate glucose to 
produce glucose-6-phosphate, the first step in most glucose metabolism pathways. 
Phosphofructokinases (PFKFB3 and PFKFB4) are key enzymes in glycolysis which 
catalyse the phosphorylation of fructose 6-phosphate to fructose 1,6-bisphosphate. 
 
The clustering of genes responding to Neisseria into regulation of phosphate 
metabolism and carbohydrate metabolism such as glycolysis suggests a situation where 
the human host cell represents a milieu rich in nutrients for bacterial growth, and that 
perhaps, the bacteria is using the host as a source of energy. Grifantini et al. (2002) 
observed that cell contact of N. meningitidis and N. lactamica with 16HBE14 human 
epithelial cells resulted in the down-regulation of several bacterial genes involved in 
metabolism. To explain this, the authors suggested that the bacteria were able to utilise 
part of the ATP synthesised by the host. Similarly, when Dietrich et al. (2003) analysed 
the transcriptome of N. meningitidis after contact with epithelial cells (Hela cells), a 
high proportion of the differentially regulated genes were involved in metabolism. In 
addition, genes involved in cell metabolism, particularly in energy production, were 
found to have increased transcription in human brain endothelial cells in response to N. 
meningitidis (Schubert-Unkmeir et al., 2007). 
 
Interestingly, the PFK gene is absent in the genome of N. meningitidis (MC58) and N. 
lactamica (ST640) which explains the lack of a functional glycolytic pathway in the 
bacteria (Baart et al., 2010). It is thought that under anaerobic conditions, where 
oxidative phosphorylation cannot occur, PFK is essential as the glycolytic process is 
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important for the production of energy. For Neisseria however, which colonises the 
aerobic nasopharyngeal musoca, sufficient energy can be liberated from the substrate 
by oxidative phosphorylation, and the glycolytic process (in which PFK is an enzyme 
in) is not essential. Although Neisseria do not carry out glycolysis by itself, host 
glycolytic enzymes (ENO2, HK2, PFKFB3 and PFKFB4) were up-regulated in 
response to the bacteria in my study. It is tempting to speculate that the bacteria may be 
responsible for this up-regulation so as to increase the amount of energy produced by 
the host, which in turn may be able to be used by the bacteria. 
 
My results seem to be in agreement with other studies describing a similar strategy by 
commensal bacteria to survive in the human host. B. thetaiotaomicron, a component of 
the intestinal microflora of humans uses epithelial fucosylated glycans as a source of 
energy in the highly competitive intestinal ecosystem. In this way, the host appears to 
be a participant in providing for the nutritional needs of the bacteria. In addition, the 
bacteria are able to actively determine the degree to which their nutritional needs are 
met by using a molecular sensor to signal sustained production of an adequate supply of 
host-derived fucose (Hooper et al., 1999).  
 
5.3.2 Conclusions 
Genes commonly responding to both live N. meningitidis and N. lactamica and 
involved in the regulation of phosphate metabolism and glycolysis pathways were 
validated by Q-RT-PCR. This suggests that Neisseria colonising respiratory epithelial 
cells use the host as a source of energy. 
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Chapter 6 : Different ial hos t epithelial responses  to N. meningitidis  and N. lactamica. 
Differential host epithelial responses to N. meningitidis  
and N. lactamica 
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6.1 Introduction 
6.1.1 Validation of genes differentially responding to N. meningitidis and N. 
lactamica 
The previous Chapter described common host bronchial epithelial cell responses to N. 
meningitidis and N. lactamica. In this Chapter I describe differential responses of 
bronchial epithelial cells to N. meningitidis and N. lactamica. In particular it describes 
the validation of the array results both at the transcriptional level (using Q-RT-PCR) 
and for some genes at the protein level (using ELISAs). Validation means that there 
was similar up or down-regulation of the genes with respect to mock-infected controls 
(as in the array) and that the difference was statistically significant with a p value of 
less than 0.05.  
 
6.1.2 Identification of bacterial components involved in differential gene 
expression 
To identify possible bacterial mediators involved in differential expression, inactivated 
Neisseria, N. meningitidis mutants lacking capsule or pili and culture supernatants from 
both N. lactamica and N. meningitidis were used. The rationale for the latter was to 
determine whether neisserial secreted proteins were responsible for host differential 
gene expression.  In a previous study, Robinson et al. (2004) used crude supernatants 
(only from N. meningitidis, not from N. lactamica) as a source of secreted proteins and 
found they resulted in up-regulation of several proinflammatory and apoptosis related 
genes in human meningeal-derived cells. Crude supernatants contain several 
components (other than secreted mediators) such as LOS, OMPs and OMVs which 
could contribute to the host response. For example, a stimulation of a minimum of 1 
ng/ml of LOS from H44/76 strain of N. meningitidis resulted in the secretion of 
proinflammatory cytokines such as IL1 and TNF-α by human peripheral blood 
mononuclear cells (Sprong et al., 2001). In this study we sought to remove LOS and 
OMVs by the use of polymyxin B columns and ultracentrifugation, respectively. The 
extent of contamination of secreted protein preparations by LOS was determined by 
LAL assay and that of OMVs by the presence or absence of NspA. NspA is an OMP 
common in both N. meningitidis and N. lactamica, and is present as a major component 
in their OMVs (Mukhopadhyay et al., 2005).  
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The aims in this Chapter are to validate the differential expression of genes in response 
to N. meningitidis and N. lactamica, and to identify possible bacterial mediators 
involved in this differential expression. 
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6.2 Results 
6.2.1 Host responses specific to N. meningitidis 
6.2.1.1 Validation of microarray results using Q-RT-PCR 
6.2.1.1.1 Genes clustering into immunity and defence process 
Chapter 4 describes the identification of bronchial epithelial cell genes that were 
responding specifically to live WT N. meningitidis (Section 4.2.6.4). They were 
associated with the immunity and defence process at 3 hours post infection, with 85% 
being down-regulated. Table 6.1 shows that 75% (15/20) of these genes were validated 
by Q-RT-PCR, out of which 93% (14/15) were down-regulated. 
 
Table 6.1: Validation of genes clustering into immunity and defence process 
Microarray and Q-RT-PCR results showing fold changes of genes specifically responding to live N. 
meningitidis at 3 hours and which cluster into immunity and defence process. Asterisks (*) mark genes 
which showed consistent expression and were statistically validated by Q-RT-PCR (significantly 
differentially expressed in response to live N. meningitidis with respect to mock-infected controls with a 
p value of less than 0.05).  
 
Genbank ID Symbol N. meningitidis vs Mock 
  
Array Q-RT-PCR 
NM_139314 ANGPTL4 2.5* 1.8* 
NM_001734 C1S -2.2* -2.5* 
NM_002982 CCL2 -2.7* -3.2* 
NM_001001435 CCL4L1 -2.2* -2.8* 
NM_001710 CFB -2.2* -2.3* 
NM_000758 CSF2 2.0 1.0 
NM_002155 HSPA6 -2.3* -1.7* 
NM_001008699 IL4R 2.5 -1.3 
NM_005564 LCN2 -3.0* -3.5* 
NM_002310 LIFR -3.9 -1.8 
NM_004225 MFHAS1 -2.2 -1.6 
NM_002456 MUC1 -2.0 -1.3 
NM_016816 OAS1 -2.1* -1.4* 
NM_022572 PNKD -2.0* -1.7* 
NM_005729 PPIF -2.0* -1.9* 
NM_002908 REL -2.1* -2.0* 
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Genbank ID Symbol N. meningitidis vs Mock 
  
Array Q-RT-PCR 
NM_005621 S100A12 -2.2* -2.1* 
NM_002964 S100A8 -2.7* -3.6* 
NM_199161 SAA1 -2.1* -2.2* 
NM_030754 SAA2 -2.1* -2.0* 
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6.2.1.1.2 Genes responding similarly to WT and mutant N. meningitidis  
The expression of 59 out of the 125 genes responding specifically to live WT N. 
meningitidis at 3 hours is similar upon infection with N. meningitidis cap- and pilE- 
mutants, and so is not in response to the capsule or pili. Fifty four out of the 59 genes 
were followed up with Q-RT-PCR. The remaining five genes were either unavailable 
for selection (in the TLDA cards) or are poorly characterised (as determined by an 
extensive literature search). Table 6.2 shows that 11% (6/54) of these genes were 
validated by Q-RT-PCR (shaded yellow). Although this is a low percentage, it is not 
entirely surprising as the genes need to fulfil several criteria in all three bacteria before 
their expression can be considered validated. Firstly, they must show consistent 
expression between array and Q-RT-PCR. They must also respond similarly (in the 
same direction) to both WT and mutant N. meningitidis (cap- and pilE-). Lastly, their 
expression must be statistically significant in all three bacteria with respect to the 
mock-infected controls. In fact, 46% of the genes (25 out of 54) fulfil the first two 
criteria (shaded blue in Table 6.2). Although the expression of these 25 genes was not 
statistically significant in all three bacteria, eight genes were significant in one 
bacterium while eight genes were significant in two bacteria. 
 
This example illustrates the effectiveness of using the 2-fold filter and functional 
clustering in the microarray analysis to reduce false positives. The selection of the 59 
genes did not take into account these two factors and so could also be a possible reason 
why the percentage of genes statistically validated by Q-RT-PCR in this case is 
relatively low. 
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Table 6.2: Validation of genes responding to WT and mutant N. meningitidis 
Microarray and Q-RT-PCR results showing fold changes of the 54 genes specifically responding to WT N. meningitidis at 3 hours. Genes shaded yellow show consistent expression 
and are statistically validated (significantly differentially expressed in response to N. meningitidis with respect to mock-infected controls with a p value of less than 0.05) in WT and 
mutant N. meningitidis (cap- and pilE-). Genes shaded in blue marks genes which show consistent expression but do not pass statistical significance in all three conditions. 
 
Genbank ID Symbol WT N. meningitidis vs Mock N. meningitidis cap- vs Mock N. meningitidis pilE- vs Mock 
  
Array Q-RT-PCR Array Q-RT-PCR Array Q-RT-PCR 
  
Fold change Fold change P value Fold change Fold change P value Fold change Fold change P value 
NM_003488 AKAP1 -2.0 -1.3 0.3 -1.4 -1.1 0.6 -1.5 -1.7 0.07 
NM_005166 APLP1 -2.2 -1.3 0.09 -1.7 1.2 0.08 -1.8 -1.4 0.06 
NM_000041 APOE -2.0 -1.8 0.01 -1.5 -1.1 0.3 -1.4 -1.5 0.04 
NM_014784 ARHGEF11 -2.0 -1.4 0.08 -1.5 -1.2 0.4 -1.4 -1.6 0.03 
NM_183376 ARRDC4 -3.1 -2.8 0.0001 -2.8 -2.4 0.0003 -1.6 -1.9 0.001 
NM_032885 ATG4D -2.4 -1.4 0.06 -2.5 -1.2 0.3 -1.6 -1.5 0.04 
NM_001734 C1S -2.2 -2.5 0.002 -1.8 -1.9 0.002 -1.4 -2.0 0.003 
NM_001759 CCND2 -2.1 -1.6 0.3 -2.3 -1.2 0.6 -2.2 -2.0 0.2 
NM_024111 CHAC1 -4.6 -2.9 0.00003 -6.2 -1.6 0.002 -1.6 -1.4 0.1 
NM_020989 CRYGC 2.5 1.4 0.3 2.1 -1.1 0.5 1.6 1.0 1 
NM_022034 CUZD1 -3.5 -2.2 0.02 -3.8 -1.4 0.2 -1.6 -1.7 0.05 
NM_015018 DOPEY1 -2.3 -1.4 0.08 -1.5 -1.3 0.2 -1.5 -1.6 0.02 
NM_012153 EHF -2.7 -4.8 0.04 -1.8 -2.7 0.08 -1.6 -2.8 0.08 
NM_025209 EPC1 -2.6 -1.8 0.04 -2.1 -1.4 0.1 -1.4 -1.7 0.05 
NM_032836 FLJ14768 -2.1 -1.6 0.001 -1.8 -1.3 0.01 -1.7 -1.2 0.3 
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Genbank ID Symbol WT N. meningitidis vs Mock N. meningitidis cap- vs Mock N. meningitidis pilE- vs Mock 
  
Array Q-RT-PCR Array Q-RT-PCR Array Q-RT-PCR 
  
Fold change Fold change P value Fold change Fold change P value Fold change Fold change P value 
NM_144605 FLJ25410 2.2 -1.2 0.6 1.6 2.1 0.1 1.4 1.3 0.4 
NM_032664 FUT10 -2.1 -1.3 0.1 -5.2 1.0 0.9 -2.5 -1.6 0.03 
NM_014373 GPR160 2.1 -1.2 0.3 1.9 1.1 0.4 2.5 -1.4 0.06 
NM_014707 HDAC9 -2.5 -2.3 0.06 -2.6 -1.8 0.1 -1.5 -2.4 0.06 
NM_013332 HIG2 3.0 2.5 0.03 2.8 2.8 0.002 1.6 -1.1 0.5 
NM_001008699 IL4R 2.5 -1.3 0.04 2.6 -1.1 0.4 2.9 -1.6 0.005 
NM_005564 LCN2 -3.0 -3.5 0.01 -5.2 -6.9 0.004 -2.6 -5.4 0.005 
NM_024509 LRFN3 -2.4 -1.3 0.06 -26.1 -1.2 0.1 -2.5 -1.4 0.02 
NM_023942 LRRC61 -2.3 -1.1 0.9 -2.7 -1.3 0.7 -1.6 -1.5 0.5 
NM_014994 MAPKBP1 -5.7 -1.6 0.002 -3.0 1.2 0.2 -1.6 -1.4 0.05 
NM_004225 MFHAS1 -2.2 -1.6 0.1 -2.0 -1.5 0.2 -1.5 -2.1 0.05 
NM_015246 MGRN1 -2.0 -1.3 0.2 -2.4 1.0 0.8 -1.7 -1.6 0.04 
NM_014632 MICAL2 -2.4 1.2 0.7 -4.9 -50.2 0.1 -1.8 -1.6 0.6 
NM_014903 NAV3 -3.8 -3.9 0.1 -15.2 -6.2 0.09 -4.0 -5.4 0.1 
NM_002610 PDK1 2.1 1.2 0.03 3.3 1.9 0.003 2.1 1.0 0.9 
NM_005764 PDZK1IP1 -4.4 -4.4 0.003 -76.9 -6.5 0.002 -14.2 -4.7 0.002 
NM_004567 PFKFB4 2.8 1.7 0.001 2.0 1.2 0.1 1.8 -1.1 0.4 
NM_002638 PI3 -3.4 -3.1 0.004 -4.6 -4.2 0.001 -2.4 -3.4 0.002 
NM_012398 PIP5K1C -2.0 -1.3 0.2 -1.8 -1.1 0.8 -2.5 -1.5 0.05 
NM_005729 PPIF -2.0 -1.9 0.05 -2.0 -1.8 0.06 -1.7 -1.7 0.06 
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Genbank ID Symbol WT N. meningitidis vs Mock N. meningitidis cap- vs Mock N. meningitidis pilE- vs Mock 
  
Array Q-RT-PCR Array Q-RT-PCR Array Q-RT-PCR 
  
Fold change Fold change P value Fold change Fold change P value Fold change Fold change P value 
NM_014731 ProSAPiP1 -2.5 -1.3 0.2 -1.6 -1.3 0.04 -1.7 -1.3 0.01 
NM_004914 RAB36 -2.5 -1.3 0.2 -1.8 1.0 0.9 -1.5 -1.4 0.08 
NM_144964 RG9MTD3 -2.0 -1.4 0.06 -4.5 1.1 0.5 -1.8 -1.4 0.03 
NM_002928 RGS16 2.5 1.8 0.002 4.3 4.2 6 X 10-6 3.2 2.1 0.003 
NM_004630 SF1 -2.2 -1.5 0.2 -1.9 -1.4 0.4 -1.7 -1.8 0.1 
NM_012309 SHANK2 2.1 -1.2 0.3 2.2 1.1 0.3 2.2 -1.4 0.1 
NM_015260 SIN3B -2.2 -1.3 0.2 -1.7 -1.2 0.3 -1.7 -1.8 0.04 
NM_006931 SLC2A3 2.1 1.9 0.01 2.4 2.8 2 X 10-9 1.7 1.2 0.1 
NM_005070 SLC4A3 -2.4 -1.3 0.07 -2.0 1.1 0.4 -1.6 -1.4 0.04 
NM_004819 SYMPK -2.0 -1.3 0.1 -1.4 1.0 0.8 -1.4 -1.6 0.02 
NM_016151 TAOK2 -2.1 -1.4 0.04 -1.8 -1.1 0.4 -1.7 -1.5 0.04 
NM_030756 TCF7L2 -2.3 -1.3 0.3 -2.3 1.0 0.8 -2.7 -1.8 0.06 
NM_017728 TMEM104 -2.1 -1.3 0.05 -3.1 1.0 0.9 -1.7 -1.4 0.04 
NM_033396 TNKS1BP1 -2.2 -1.3 0.1 -1.8 1.3 0.06 -1.4 -1.1 0.6 
NM_005108 XYLB -2.4 -1.4 0.1 -2.3 1.0 0.8 -2.2 -1.9 0.03 
NM_015117 ZC3H3 -2.1 -1.3 0.08 -1.7 1.0 0.8 -1.7 -1.4 0.08 
NM_014518 ZNF229 -2.4 -1.5 0.02 -1.3 -1.2 0.2 -1.5 -2.1 0.002 
NM_025189 ZNF430 -2.5 -1.6 0.02 -3.1 -1.3 0.09 -1.8 -1.8 0.01 
NM_153263 ZNF549 -2.8 -1.2 0.7 -2.3 2.6 0.3 -1.5 -1.4 0.5 
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6.2.1.2 Follow up of genes responding specifically to N. meningitidis 
The expression of 67 out of the 142 genes followed up in the Q-RT-PCR were 
significantly different in response to N. meningitidis and N. lactamica and they were 
also significantly differentially expressed with respect to the mock-infected controls. 
By plotting the expression profiles of these 67 genes (in mock-infected cells, cells 
infected with N. meningitidis and cells infected with N. lactamica) from 0 to 7 hours 
post infection, and focusing mainly on immune defence genes (as indicated by the 
microarray), 11 genes were identified to be specifically responding to N. meningitidis. 
They are IL1A, IL8, PI3, C1S, CCL3, CXCL2, LCN2, LIFR, PDZK1IP1, S100A8 and 
NAV3. TNF-α was also added into this group as the expression of this gene (as 
indicated by the protein level) was not only significantly different in response to N. 
meningitidis and N. lactamica but was also significantly differentially expressed with 
respect to the mock-infected controls.    
 
The expression of these 12 genes was lower upon infection with N. meningitidis 
compared to with N. lactamica. Specifically, there was a lack of activation of these 
genes as their expression was either reduced or was similar, with respect to mock-
infected controls, compared to when infected with N. lactamica. To investigate further 
how the expression of these genes was dependent on live bacteria, as well as 
components such as the capsule and the pili, inactivated (WT) and mutant N. 
meningitidis cap- and pilE- were used. Analysis indicated that the 12 genes can be 
divided into three groups based on how the genes respond to the various strains of N. 
meningitidis. These three groups will be presented in the following sections. 
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6.2.1.2.1 Expression of host genes up-regulated in response to N. lactamica 
compared to live, inactivated and mutant N. meningitidis 
The expression of IL1A and TNF-α was higher in response to N. lactamica compared 
to live, inactivated (both WT) and mutant N. meningitidis (cap- and pilE-). Figures 6.1 
and 6.2 show the expression level of IL1A and TNF-α respectively, from 0 to 7 hours 
post infection at (a) the transcript level (by Q-RT-PCR) and (b) the protein level (by 
measuring culture supernatants by ELISAs). For IL1A, the lack of activation (with 
respect to mock-infected controls) upon infection with N. meningitidis compared to 
with N. lactamica can be seen at the 5 hour time-point (at the transcript level) and the 7 
hour time-point (at the protein level). In the case of TNF-α, the lack of activation (with 
respect to mock-infected controls) can be seen at the 4 and 7 hour time-points (at the 
transcript level) and the 7 hour time-point (at the protein level). 
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(a) 
 
(b) 
 
Figure 6.1: Expression of IL1A with time at the (a) transcript and (b) protein level 
Data is shown with box plots with median and interquartile range. 
Asterisks (*) indicate statistical significance with p value less than 0.05 with respect to mock-infected 
controls. M: mock-infected, YL: live N. lactamica, MK: inactivated WT N. meningitidis, ML: live WT 
N. meningitidis, MC: N. meningitidis cap-, MP: N. meningitidis pilE-. RQ: relative quantification 
Outliers (0) defined as between 1.5 to 3X the interquartile range from the 25th or 75th percentile.
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(a) 
 
(b) 
 
Figure 6.2: Expression of TNF-α with time at the (a) transcript and (b) protein level 
Asterisks (*) indicate statistical significance with p value less than 0.05 with respect to mock-infected 
controls. M: mock-infected, YL: live N. lactamica, MK: inactivated WT N. meningitidis, ML: live WT 
N. meningitidis, MC: N. meningitidis cap-, MP: N. meningitidis pilE-. RQ: relative quantification 
Outliers (0) defined as between 1.5 to 3X the interquartile range from the 25th or 75th percentile. 
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6.2.1.2.2 The down-regulation of IL8 upon addition of N. meningitidis is 
associated with live bacteria and the presence of the capsule and the 
pilus 
Figure 6.3 shows the response of IL8 to N. meningitidis or N. lactamica with time from 
0 to 7 hours at the (a) transcript and (b) protein level. IL8 is down-regulated upon 
infection (with respect to mock-infected controls) with live but not inactivated WT N. 
meningitidis at 3 hours (at the transcript level) and at 5 and 7 hours (at the protein 
level).  This decrease in expression however, was not found when N. meningitidis 
capsule and pilus mutants were used, suggesting that the capsule and the pilus may 
have a role in this effect. 
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(a) 
 
 
(b) 
 
Figure 6.3: Expression of IL8 with time at the (a) transcript and (b) protein level 
Asterisks (*) indicate statistical significance with p value less than 0.05 with respect to mock-infected 
controls. M: mock-infected, YL: live N. lactamica, MK: inactivated WT N. meningitidis, ML: live WT 
N. meningitidis, MC: N. meningitidis cap-, MP: N. meningitidis pilE-. RQ: relative quantification 
Outliers (0) defined as between 1.5 to 3X the interquartile range from the 25th or 75th percentile. 
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6.2.1.2.3 Down-regulation of host genes upon infection with live WT and mutant 
N. meningitidis 
The last group of genes responding specifically to N. meningitidis were those which 
were down-regulated upon infection with not only live WT N. meningitidis, but also 
with the N. meningitidis cap- and the pilE- mutants (with respect to mock-infected 
controls). The genes are: PI3, C1S, CCL3, CXCL2, LCN2, LIFR, PDZK1IP1, S100A8 
and NAV3. The results indicate that the reduction in gene expression occurs 
irrespective of the extent to which N. meningitidis invades the host, since N. 
meningitidis cap- invades to a much greater extent than the pilE- mutants (as shown in 
Chapter 3 Section 3.2.2).  Therefore, the results indicate that the down-regulation may 
not be in response to the capsule or the pili, but could be due to active bacterial 
mechanisms involving secreted proteins. To test this hypothesis, WT N. meningitidis 
supernatant was harvested and processed. The resultant secreted protein preparations 
were added to the host epithelial cells and any effects on expression of these host genes 
were determined.  
 
6.2.1.2.3.1 Harvesting and processing of WT N. meningitidis supernatant 
6.2.1.2.3.1.1 Growth of N. meningitidis in RPMI 
Growth curves of N. meningitidis were carried out so as to determine when log phase 
occurs. Figure 6.4 shows the growth curve of N. meningitidis in serum free, defined 
medium (RPMI). The log phase occurs 2 to 4 hours after inoculation and reaches 
stationary phase after 4 hours. Therefore, for the preparation of samples containing 
secreted proteins, bacterial supernatants were harvested between 3 to 4 hours during log 
phase growth. The rationale is that the supernatants would contain minimal amounts of 
material derived from dead cells and allowing maximum harvest of secreted proteins. 
Chapter 6 
130 
Growth of N. meningitidis  in RPMI
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Figure 6.4: Growth of N. meningitidis in RPMI 
Growth of bacteria was measured by OD at several time-points up to 23 hours. Log phase growth of the 
bacteria occurs between 2 to 4 hours. Values represent means from 3 replicates with error bars indicating 
standard deviation. 
 
6.2.1.2.3.1.2 Removal of endotoxin from N. meningitidis supernatant 
After filtration and ultracentifugation (to remove bacterial debris and OMVs), the 
supernatant was concentrated. To minimise the contamination of LOS (either shed into 
the supernatants or contained within OMVs) in the bacterial supernatant, immobilised 
polymyxin B was used for endotoxin removal. Table 6.3 shows the endotoxin readings 
after the removal of endotoxin from N. meningitidis supernatant by the polymyxin B 
column. Two columns were used for the sample. The supernatant was passed through 
the first column for 5 times, with the column being regenerated for endotoxin removal 
between samples. After passing the sample through the column for the 5th time, there 
was leaching of endotoxin back into the sample. The use of a new column resulted in 
the removal of the remaining endotoxin to less than 0.1 EU/ml. 
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Table 6.3: Removal of endotoxin from N. meningitidis supernatant 
 
Number of times through 
column 
Endotoxin content 
(EU/ml) 
Remarks 
0 >50 
1 >50 
2 >50 
3 >50 
4 0.6 
5 1.03 
Column 1 
1 <0.1 Column 2 
 
6.2.1.2.3.1.3 Minimal detection of OMPs in N. meningitidis secreted protein 
preparation 
The supernatant from N. meningitidis was further concentrated 20X and filter sterilised 
as described in Chapter 2 (Section 2.9), to give a secreted protein preparation with a 
final protein concentration of 16.1 µg/ml and 0.61EU/ml of endotoxin. To determine if 
this sample was contaminated with OMPs/OMVs, SDS-PAGE protein gels were run 
and Western blotting carried out. The blots were probed with a monoclonal antibody 
against NspA (18.4 kDa), which is an OMP present as a major component in OMVs of 
N. meningitidis. Figure 6.5 shows (a) the total protein present as well as the (b) Western 
blot. Two controls were run together with the secreted protein preparation: WT N. 
meningitidis whole cell lysate, which is a positive control containing NspA and mutant 
N. meningitidis cap- nspA-, which is a negative control for NspA. The results indicate 
that there is minimal presence of NspA in the secreted protein preparation. 
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(a)               (b)          
 
Figure 6.5: WT N. meningitidis secreted protein preparation has minimal presence of OMPs 
(a) Total protein present in N. meningitidis (NM) cell lysates and secreted protein preparation as indicated by silver staining. 0.25 µg of protein was loaded per lane. (b) An identical 
gel from (a) was blotted and probed with anti-NspA antibody. Minimal detection of NspA (18.4 kDa) in the secreted protein preparation from WT N. meningitidis as compared to in 
WT N. meningitidis cell lysates is shown. N. meningitidis cap- nspA- do not possess NspA as expected. 
NspA 
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6.2.1.2.3.2 Effects of WT N. meningitidis secreted protein preparations on the 
expression of host genes down-regulated upon infection with live WT 
and mutant N. meningitidis  
To determine if the nine host genes that were down-regulated upon infection with live 
WT and mutant N. meningitidis could be due to N. meningitidis secreted proteins, 
secreted protein preparations from N. meningitidis (containing 2 µg of secreted proteins 
per well) was added to 16HBE14 cells and the expression of the nine genes followed at 
selected time-points from 0 to 7 hours. The nine genes are: PI3, C1S, CCL3, CXCL2, 
LCN2, LIFR, PDZK1IP1, S100A8 and NAV3.  
 
6.2.1.2.3.2.1  PI3 and C1S were down-regulated by neisserial secreted proteins 
The data suggests that N. meningitidis secreted proteins may have a role in the down-
regulation of PI3 and C1S genes. This is shown in Figures 6.6 and 6.7 respectively. The 
down-regulation of both PI3 and C1S (with respect to mock-infected controls) was 
specifically associated with live WT and mutant N. meningitidis (cap- and pilE-). For 
PI3, this occurred at time-points of 3, 4 and 7 hours at the transcript level and at 3, 6 
and 7 hours at the protein level. For C1S, this occurred at 3 hours at the transcript level. 
Treatment of host epithelial cells with secreted protein preparations from WT N. 
meningitidis indicate that secreted proteins may be involved in the down-regulation of 
PI3 at 3 and 5 hours at the transcript level and at 3 hours at the protein level. Secreted 
proteins may also be involved in the down-regulation of C1S at 5 hours at the transcript 
level. 
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Figure 6.6: PI3 was down-regulated in response to live WT and mutant N. meningitidis and is likely 
to involve neisserial secreted proteins 
Down-regulation of PI3 (with respect to mock-infected controls) was specifically associated with live 
WT and mutant N. meningitidis (cap- and pilE-). This occurred at (a) time-points of 3, 4 and 7 hours at 
the transcript level and at (b) 3, 6 and 7 hours at the protein level. Treatment of host epithelial cells with 
secreted protein preparations from WT N. meningitidis indicate that secreted proteins may be involved in 
the down-regulation at (c) 3 and 5 hours at the transcript level and at (d) 3 hours at the protein level.  
Asterisks (*) indicate statistical significance with p value less than 0.05 with respect to mock-infected 
controls. M: mock-infected, YL: live N. lactamica, MK: inactivated WT N. meningitidis, ML: live WT 
N. meningitidis, MC: N. meningitidis cap-, MP: N. meningitidis pilE-, MLS: WT N. meningitidis secreted 
protein preparations. RQ: relative quantification. Outliers (0) defined as between 1.5 to 3X the 
interquartile range from the 25th or 75th percentile. 
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(a) 
 
(b) 
 
Figure 6.7: C1S was down-regulated in response to live WT and mutant N. meningitidis and is 
likely to involve neisserial secreted proteins 
Down-regulation of C1S (with respect to mock-infected controls) was specifically associated with live 
WT and mutant N. meningitidis (cap- and pilE-). This occurred at (a) a time-point of 3 hours at the 
transcript level .Treatment of host epithelial cells with secreted protein preparations from WT N. 
meningitidis indicate that secreted proteins may be involved in the down-regulation at (b) 5 hours at the 
transcript level. Asterisks (*) indicate statistical significance with p value less than 0.05 with respect to 
mock-infected controls. M: mock-infected, YL: live N. lactamica, MK: inactivated WT N. meningitidis, 
ML: live WT N. meningitidis, MC: N. meningitidis cap-, MP: N. meningitidis pilE-, MLS: WT N. 
meningitidis secreted protein preparations. RQ: relative quantification. 
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6.2.1.2.3.2.2 Host genes down-regulated upon infection with live WT and mutant 
N. meningitidis but were unaffected by neisserial secreted proteins 
In contrast, the expression of the remaining seven genes (CCL3, CXCL2, LCN2, LIFR, 
PDZK1IP1, S100A8 and NAV3), which were down-regulated (with respect to mock-
infected controls) upon infection with live WT and mutant N. meningitidis (cap- and 
pilE-), were not affected by addition of the secreted protein preparation. This is shown 
in Figures 6.8 to 6.14. Figure 6.8 shows the expression of CCL3 at both the transcript 
and protein level, while Figures 6.9 to 6.14 show the expression of CXCL2, LCN2, 
LIFR, PDZK1IP1, S100A8 and NAV3 at the transcript level.  
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Figure 6.8: CCL3 was down-regulated in response to live WT and mutant N. meningitidis but was 
unaffected by neisserial secreted proteins 
Down-regulation of CCL3 (with respect to mock-infected controls) was specifically associated with live 
WT and mutant N. meningitidis (cap- and pilE-). This occurred at (a) a time-point of 3 hours at the 
transcript level and (b) at 7 hours at the protein level. Treatment of host epithelial cells with secreted 
protein preparations from WT N. meningitidis did not have an effect on the expression of CCL3 at either 
the (c) transcript or (d) protein level. Asterisks (*) indicate statistical significance with p value less than 
0.05 with respect to mock-infected controls. M: mock-infected, YL: live N. lactamica, MK: inactivated 
WT N. meningitidis, ML: live WT N. meningitidis, MC: N. meningitidis cap-, MP: N. meningitidis pilE-, 
MLS: WT N. meningitidis secreted protein preparations. RQ: relative quantification. 
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 (a) 
 
(b) 
 
Figure 6.9: CXCL2 was down-regulated in response to live WT and mutant N. meningitidis but was 
unaffected by neisserial secreted proteins 
Down-regulation of CXCL2 (with respect to mock-infected controls) was specifically associated with 
live WT and mutant N. meningitidis (cap- and pilE-). This occurred at (a) a time-point of 6 hours at the 
transcript level. Treatment of host epithelial cells with secreted protein preparations from WT N. 
meningitidis did not have an effect on the expression of CXCL2 at the (b) transcript level. Asterisks (*) 
indicate statistical significance with p value less than 0.05 with respect to mock-infected controls. M: 
mock-infected, YL: live N. lactamica, MK: inactivated WT N. meningitidis, ML: live WT N. 
meningitidis, MC: N. meningitidis cap-, MP: N. meningitidis pilE-, MLS: WT N. meningitidis secreted 
protein preparations. RQ: relative quantification. Outliers (0) defined as between 1.5 to 3X the 
interquartile range from the 25th or 75th percentile. 
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Figure 6.10: LCN2 was down-regulated in response to live WT and mutant N. meningitidis but was 
unaffected by neisserial secreted proteins. 
Down-regulation of LCN2 (with respect to mock-infected controls) was specifically associated with live 
WT and mutant N. meningitidis (cap- and pilE-). This occurred at (a) time-points of 3, 4 and 5 hours at 
the transcript level. Treatment of host epithelial cells with secreted protein preparations from WT N. 
meningitidis did not have an effect on the expression of LCN2 at the (b) transcript level. Asterisks (*) 
indicate statistical significance with p value less than 0.05 with respect to mock-infected controls. M: 
mock-infected, YL: live N. lactamica, MK: inactivated WT N. meningitidis, ML: live WT N. 
meningitidis, MC: N. meningitidis cap-, MP: N. meningitidis pilE-, MLS: WT N. meningitidis secreted 
protein preparations. RQ: relative quantification.  
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Figure 6.11: LIFR was down-regulated in response to live WT and mutant N. meningitidis but was 
unaffected by neisserial secreted proteins 
Down-regulation of LIFR (with respect to mock-infected controls) was specifically associated with live 
WT and mutant N. meningitidis (cap- and pilE-). This occurred at (a) a time-point of 5 hours at the 
transcript level. Treatment of host epithelial cells with secreted protein preparations from WT N. 
meningitidis did not have an effect on the expression of LIFR at the (b) transcript level. Asterisks (*) 
indicate statistical significance with p value less than 0.05 with respect to mock-infected controls. M: 
mock-infected, YL: live N. lactamica, MK: inactivated WT N. meningitidis, ML: live WT N. 
meningitidis, MC: N. meningitidis cap-, MP: N. meningitidis pilE-, MLS: WT N. meningitidis secreted 
protein preparations. RQ: relative quantification. Outliers (0) defined as between 1.5 to 3X the 
interquartile range from the 25th or 75th percentile. 
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Figure 6.12: PDZK1IP1 was down-regulated in response to live WT and mutant N. meningitidis 
but was unaffected by neisserial secreted proteins 
Down-regulation of PDZK1IP1 (with respect to mock-infected controls) was specifically associated with 
live WT and mutant N. meningitidis (cap- and pilE-). This occurred at (a) time-points of 3 and 4 hours at 
the transcript level. Treatment of host epithelial cells with secreted protein preparations from WT N. 
meningitidis did not have an effect on the expression of PDZK1IP1 at the (b) transcript level. Asterisks 
(*) indicate statistical significance with p value less than 0.05 with respect to mock-infected controls. M: 
mock-infected, YL: live N. lactamica, MK: inactivated WT N. meningitidis, ML: live WT N. 
meningitidis, MC: N. meningitidis cap-, MP: N. meningitidis pilE-, MLS: WT N. meningitidis secreted 
protein preparations. RQ: relative quantification. Outliers (0) defined as between 1.5 to 3X the 
interquartile range from the 25th or 75th percentile. 
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Figure 6.13: S100A8 was down-regulated in response to live WT and mutant N. meningitidis but 
was unaffected by neisserial secreted proteins 
Down-regulation of S100A8 (with respect to mock-infected controls) was specifically associated with 
live WT and mutant N. meningitidis (cap- and pilE-). This occurred at (a) time-points of 3 and 4 hours at 
the transcript level. Treatment of host epithelial cells with secreted protein preparations from WT N. 
meningitidis did not have an effect on the expression of S100A8 at the (b) transcript level. Asterisks (*) 
indicate statistical significance with p value less than 0.05 with respect to mock-infected controls. M: 
mock-infected, YL: live N. lactamica, MK: inactivated WT N. meningitidis, ML: live WT N. 
meningitidis, MC: N. meningitidis cap-, MP: N. meningitidis pilE-, MLS: WT N. meningitidis secreted 
protein preparations. RQ: relative quantification.  
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Figure 6.14: NAV3 was down-regulated in response to live WT and mutant N. meningitidis but was 
unaffected by neisserial secreted proteins 
Down-regulation of NAV3 (with respect to mock-infected controls) was specifically associated with live 
WT and mutant N. meningitidis (cap- and pilE-). This occurred at (a) a time-point of 3 hours at the 
transcript level. Treatment of host epithelial cells with secreted protein preparations from WT N. 
meningitidis did not have an effect on the expression of NAV3 at the (b) transcript level. Asterisks (*) 
indicate statistical significance with p value less than 0.05 with respect to mock-infected controls. M: 
mock-infected, YL: live N. lactamica, MK: inactivated WT N. meningitidis, ML: live WT N. 
meningitidis, MC: N. meningitidis cap-, MP: N. meningitidis pilE-, MLS: WT N. meningitidis secreted 
protein preparations. RQ: relative quantification. Outliers (0) defined as between 1.5 to 3X the 
interquartile range from the 25th or 75th percentile. Extreme (E) defined as more than 3X the interquartile 
range from the 25th or 75th percentile. 
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6.2.2 Host response specific to N. lactamica 
6.2.2.1 Validation of microarray results using Q-RT-PCR 
The microarray results described in Chapter 4 (Section 4.2.6.5) indicated those genes 
specifically responding to live N. lactamica were associated with several processes. At 
5 hours, cytokine and chemokine mediated signalling pathways were activated. Other 
host responses specific to live N. lactamica include mRNA transcription regulation (7 
hours), cell proliferation and differentiation (6-7 hours) and mRNA transcription (7 
hours). Q-RT-PCR was used to validate expression of genes associated with these 
processes. The results are shown in Table 6.4. 
 
At 0 hours, none of the genes clustering in mRNA transcription regulation were 
validated. Fifty percent of these genes display inconsistent trends of expression 
compared to the array results. Ninety-four percent of the genes (17 out of 18) were 
expressed at low level (with a fold change of less than 2 in the Q-RT-PCR) and may 
not be accurately detected by the microarray. In addition, as mentioned in Chapter 4, 
false positives can arise from non-specific or cross hybridisation in the array, and this is 
likely to be the case for genes apparently differentially expressed at 0 hours where there 
is unlikely to be a biological explanation. Thus, these responses may be taken as 
background noise in the array results. Nine percent (1 out of 11) of the genes clustering 
in the cytokine and chemokine mediated signaling pathway at 5 hours were validated, 
and this gene (IL1A) was up-regulated. At 6 hours, 42% (5 out of 12) of the genes in 
the cell proliferation and differentiation process were validated, of which 80% (4 out of 
5 genes) were up-regulated. At the 7 hour time-point, many of the genes belonged to 
more than one of the three biological processes (mRNA transcription regulation, cell 
proliferation and differentiation and mRNA transcription). Sixty three percent (15 out 
of 24) of the genes in the mRNA transcription regulation process, 61% (14 out of 23) of 
the genes in the cell proliferation and differentiation process, and 67% (18 out of 27) of 
the genes in the mRNA transcription process were validated. Amongst the validated 
genes, 53% (8 out of 15 genes) from the mRNA transcription regulation process, 64% 
(9 out of 14 genes) from the cell proliferation and differentiation process and 50% (9 
out of 18 genes) from the mRNA transcription process were up-regulated. 
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Table 6.4: Validation of genes specifically responding to live N. lactamica and which cluster into 
significant biological processes 
Microarray and Q-RT-PCR results of genes specifically responding to live N. lactamica and which 
cluster into significant biological processes are shown. Categories (a) to (d) describe the genes associated 
with the different processes at (a) 0, (b) 5, (c) 6 and (d) 7 hours, as well as their fold changes in response 
to live N. lactamica (with respect to mock-infected controls) at the respective time-points. Asterisks (*) 
mark genes which showed consistent expression and were statistically validated by Q-RT-PCR 
(significantly differentially expressed in response to live N. lactamica with respect to mock-infected 
controls with a p value of less than 0.05). 
 
(a) Genes associated with mRNA transcription regulation at 0 hours 
 
Genbank ID Symbol Array Q-RT-PCR 
NM_006492 ALX3 -2.1 1.1 
NM_153200 EDF1 -2.2 1.1 
NM_001453 FOXC1 2.2 1.0 
NM_032682 FOXP1 -2.1 -1.6 
NM_021170 HES4 -2.0 -1.2 
NM_006898 HOXD3 -3.1 1.1 
NM_018411 HR 2.3 -1.3 
NM_145805 ISL2 -2.2 -1.1 
NM_000214 JAG1 -2.5 1.0 
NM_006163 NFE2 -2.1 1.2 
NM_002502 NFKB2 2.1 1.1 
NM_022123 NPAS3 -2.0 1.1 
NM_004959 NR5A1 -2.3 -4.3 
NM_021976 RXRB -2.1 -1.1 
NM_012236 SCMH1 2.1 1.1 
NM_012446 SSBP2 2.2 1.0 
NM_000461 THRB -2.9 1.2 
NM_015481 ZNF385 2.2 -1.3 
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(b) Genes associated with cytokine and chemokine mediated signaling pathway at 5 hours 
 
Genbank ID Symbol Array Q-RT-PCR 
NM_004591 CCL20 2.9 2.1 
NM_002983 CCL3 2.3 1.5 
NM_001511 CXCL1 2.0 1.4 
NM_002089 CXCL2 2.5 1.3 
NM_000575 IL1A 3.2* 2.0* 
NM_000576 IL1B 2.2 1.7 
NM_181339 IL24 3.1 1.4 
NM_000600 IL6 2.2 1.5 
NM_175767 IL6ST 2.4 0.7 
NM_000584 IL8 2.3 1.7 
NM_000594 TNF 2.2 2.3 
 
(c) Genes associated with cell proliferation and differentiation process at 6 hours 
 
Genbank ID Symbol Array Q-RT-PCR 
NM_003670 BHLHB2 2.3* 3.1* 
NM_004354 CCNG2 3.0* 1.7* 
NM_004064 CDKN1B 2.2 1.5 
NM_032854 CORO6 2.0 -1.1 
NM_001511 CXCL1 2.4 1.4 
NM_005228 EGFR 2.1* 1.3* 
NM_001420 ELAVL3 -2.0 3.0 
NM_005438 FOSL1 2.0 1.5 
NM_001300 KLF6 2.4* 2.1* 
NM_181802 UBE2C 4.0 -1.0 
NM_003438 ZNF137 -2.0 1.1 
NM_003415 ZNF268 -2.7* -1.7* 
 
Chapter 6 
149 
(d) Genes associated with mRNA transcription regulation, cell proliferation and differentiation 
and mRNA transcription processes at 7 hours 
Undisplayed fold change means that the gene was not expressed in the samples. 
 
Genbank ID Symbol Array Q-RT-PCR Biological Processes 
  
  
mRNA 
transcription 
regulation 
Cell 
proliferation 
and 
differentiation 
mRNA 
transcription 
NM_005438 FOSL1 2.7 1.4 x x x 
NM_003670 BHLHB2 2.1* 2.0* x x x 
NM_001300 KLF6 2.4* 2.3* x x x 
NM_002894 RBBP8 -2.0* -1.6* x x x 
NM_004234 ZNF235 -2.0* -2.1* x x x 
NM_006454 MXD4 -2.0* -1.5* x x x 
NM_012323 MAFF 2.0* 1.7* x x x 
NM_006238 PPARD 2.1 1.6 x x x 
NM_002228 JUN 2.1* 1.9* x x x 
NM_005238 ETS1 2.3* 2.1* x x x 
NM_015481 ZNF385 2.6 1.2 x  x 
NM_006898 HOXD3 -2.3 1.1 x  x 
NM_021220 OVOL2 -2.4* -1.9* x  x 
NM_015025 MYT1L -2.4 - x  x 
NM_015630 EPC2 -2.3* -2.1* x  x 
NM_006399 BATF -7.7* -2.1* x  x 
NM_025209 EPC1 -2.1* -1.8* x  x 
NM_005178 BCL3 2.0 1.3 x  x 
NM_005902 SMAD3 2.1* 1.7* x  x 
NM_005078 TLE3 2.2 1.0 x  x 
NM_016270 KLF2 2.3* 2.0* x  x 
NM_015478 L3MBTL 2.7 -1.1 x  x 
NM_080647 TBX1 3.5 1.3 x  x 
NM_020436 SALL4 3.8* 2.7* x  x 
NM_003111 SP3 -2.0* -1.4*  x x 
NM_000575 IL1A 3.7* 2.4*  x  
NM_000576 IL1B 3.1 2.0  x  
NM_000584 IL8 2.7* 2.1*  x  
NM_001511 CXCL1 2.4 1.2  x  
NM_004354 CCNG2 2.4* 1.8*  x  
NM_181802 UBE2C 2.4 1.1  x  
NM_032854 CORO6 2.9 1.0  x  
NM_005228 EGFR 3.0 1.5  x  
NM_006705 GADD45G -3.5 -1.3  x  
NM_198267 ING3 -2.1* -2.3*  x  
NM_018948 ERRFI1 2.1* 3.1*  x  
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Genbank ID Symbol Array Q-RT-PCR Biological Processes 
  
  
mRNA 
transcription 
regulation 
Cell 
proliferation 
and 
differentiation 
mRNA 
transcription 
NM_001945 HBEGF 2.1 1.4  x  
NM_032587 CARD6 -2.2* -2.4*   x 
NM_030665 RAI1 2.2* 1.6*   x 
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6.2.2.2 Follow up of genes responding specifically to N. lactamica  
The expression of 67 out of the 142 genes followed up by Q-RT-PCR was significantly 
different in response to N. meningitidis and N. lactamica and they were also 
significantly differentially expressed with respect to the mock-infected controls. By 
plotting the expression profiles of these 67 genes (in mock-infected cells, cells infected 
with N. meningitidis and cells infected with N. lactamica) from 0 to 7 hours post 
infection, and focusing mainly on genes validated by Q-RT-PCR, four genes were 
identified to be specifically responding to N. lactamica. They were ERRFI1, JUN, 
KLF6 and SALL4. TNF-α was also added into this group as the expression of this gene 
(as indicated at the protein level) was not only significantly different in response to N. 
meningitidis and N. lactamica but was also significantly differentially expressed with 
respect to the mock-infected controls.    
 
The expression of the five genes upon infection with N. lactamica was higher compared 
to after infection with N. meningitidis. Specifically, live but not inactivated N. 
lactamica was associated with an increased expression of these genes, suggesting that 
this could be due to active bacterial mechanisms involving secreted proteins. To test 
this hypothesis, N. lactamica supernatant was harvested and processed, and then added 
to the host epithelial cells to determine if there were any effects on these host genes.  
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6.2.2.2.1 Harvesting and processing of N. lactamica supernatant 
6.2.2.2.1.1 Optimisation of growth of N. lactamica in defined media 
Growth curves of N. lactamica were determined to identify the log phase of growth i.e. 
the most appropriate time to harvest the bacterial supernatants for the preparation of 
samples containing secreted proteins. As for the N. meningitidis supernatant 
preparation, N. lactamica was first grown in RPMI. As can be seen in Figure 6.15, N. 
lactamica grew to a maximum OD of 0.23 after 1 hour, after which the OD started to 
fall (pink line). Subsequently, a recipe for another chemically defined medium 
designated MCD was kindly supplied by Dr Andrew Gorringe (HPA). MCD had been 
specifically developed for the growth of N. lactamica Y92-1009 (the strain used in this 
study) in both microwells and bioreactors, the latter with a view to optimising OMV 
production for vaccine purposes. The medium had been derived from the original 
Catlin medium (Catlin, 1973). When grown in microwells, MCD was found to improve 
upon the growth in semi-defined Frantz medium by increasing the OD of N. lactamica 
by almost two-fold to 0.46 after 16 hours of culture (Dr Andrew Gorringe, personal 
communication). Therefore, I tried to grow N. lactamica in MCD medium in an attempt 
to establish a better growth curve. Figure 6.15 shows that the growth of N. lactamica 
did not improve with the use of MCD medium (blue line). There are many reasons why 
my results differed from that mentioned by Dr Gorringe, one of which is that, I grew N. 
lactamica in 10 ml shaking aerated Falcon tubes. The use of different containers for 
bacterial growth could affect their growth by affecting oxygen availability. 
 
Subsequently, a hybrid of RPMI and MCD was used in a proportion of 1:1. As can be 
see from Table 6.5 (which compares the concentrations of various components between 
RPMI, MCD and a hybrid of RPMI and MCD in a proportion of 1:1), the addition of 
MCD into RPMI increased the concentrations of amino acids (L-aspartic acid, L-
cystine•2HCl, L-glutamic acid and glycine), vitamins (D-biotin, choline chloride and 
myo-inositol) and glucose.  
 
The increase in the amount of nutrients provided to N. lactamica is the most likely 
reason for the hybrid RPMI: MCD medium allowing enhanced growth of N. lactamica, 
with the OD peaking at 0.96 after 6 hours as seen in Figure 6.15 (red line). Therefore, 
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N. lactamica was cultured in a hybrid media of RPMI and MCD in a proportion of 1:1 
and its supernatant was harvested between 3 to 5 hours (log phase). 
 
Growth of N. lactamica in defined media 
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Figure 6.15: Growth of N. lactamica in RPMI, MCD and a hybrid of RPMI and MCD 
Bacterial growth was measured using OD at 600 nm hourly from 0 to 6 hours and up till 24 hours for the 
three different types of chemically defined media. The hybrid of RPMI and MCD in proportion of 1:1 
gave the best growth with the log phase occurring between 3 to 5 hours. Values represent means from 
three replicates with error bars indicating standard deviation. 
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Table 6.5: Comparison of the components present in RPMI, MCD and hybrid RPMI and MCD 
media 
 
Component RPMI (g/L) MCD (g/L) RPMI and MCD (1:1) (g/L) 
Inorganic salts    
Ca(NO3)2•4H2O 0.1 — 0.05 
CaCl2.2H2O — 0.04 0.02 
MgSO4 (anhydrous) 0.04884 — 0.02442 
KCl 0.4 — 0.2 
K2SO4 — 1 0.5 
K2HPO4 — 4 2 
MgCl2.6H20 — 0.4 0.2 
NaHCO3 2 0.04 1.02 
NaCl 6 5.8 5.9 
Na2HPO4 (anhydrous) 0.8 — 0.4 
NH4Cl — 0.2 0.1 
Amino acids    
L-Arginine (free base) 0.2 — 0.1 
L-Asparagine (anhydrous) 0.05 — 0.025 
L-Aspartic Acid 0.02 0.5 0.26 
L-Cystine•2HCl 0.0652 0.1 0.0826 
L-Glutamic Acid 0.02 3.7 1.86 
L-Glutamine 0.3 — 0.15 
Glycine 0.01 0.25 0.13 
L-Histidine (free base) 0.015 — 0.0075 
Hydroxy-L-Proline 0.02 — 0.01 
L-Isoleucine 0.05 — 0.025 
L-Leucine 0.05 — 0.025 
L-Lysine•HCl 0.04 — 0.02 
L-Methionine 0.015 — 0.0075 
L-Phenylalanine 0.015 — 0.0075 
L-Proline 0.02 — 0.01 
L-Serine 0.03 — 0.015 
L-Threonine 0.02 — 0.01 
L-Tryptophan 0.005 — 0.0025 
L-Tyrosine•2Na•2H2O 0.02883 — 0.014415 
L-Valine 0.02 — 0.01 
Vitamins    
D-Biotin 0.0002 0.01 0.0051 
Choline chloride 0.003 0.01 0.0065 
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Component RPMI (g/L) MCD (g/L) RPMI and MCD (1:1) (g/L) 
Folic acid 0.001 — 0.0005 
myo-inositol 0.035 0.04 0.0375 
Niacinamide 0.001 — 0.0005 
p-Amino benzoic acid 0.001 — 0.0005 
D-Pantothenic acid•½Ca 0.00025 — 0.000125 
Pyridoxine•HCl 0.001 — 0.0005 
Riboflavin 0.0002 — 0.0001 
Thiamine•HCl 0.001 — 0.0005 
Vitamin B-12 0.000005 — 0.0000025 
Other    
D-Glucose 2 10 6 
Glutathione (reduced) 0.001 — 0.0005 
Phenol Red•Na 0.0053 — 0.00265 
Sodium acetate — 2 1 
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6.2.2.2.1.2 Removal of endotoxin from N. lactamica supernatant 
N. lactamica supernatants were treated the same as those obtained from N. meningitidis 
as described in Chapter 2 (Section 2.9). Table 6.6 shows the endotoxin readings after 
the removal of endotoxin from N. lactamica supernatant by the polymyxin B column. 
The sample was passed through the column four times resulting in an endotoxin 
concentration of less than 0.1 EU/ml. 
 
Table 6.6: Removal of endotoxin from N. lactamica supernatant 
 
Number of times through column Endotoxin content (EU/ml) 
0 >50 
1 4.4 
2 0.09 
3 <0.1 
4 <0.1 
 
6.2.2.2.1.3 Minimal detection of OMPs in N. lactamica secreted protein 
preparation 
The N. lactamica secreted protein preparation was concentrated and filter sterilised as 
with those from N. meningitidis. The final protein and endotoxin concentrations were 
13.1 µg/ml and 2.3EU/ml, respectively. Western blotting experiments indicated that 
there was minimal contamination with OMPs or OMVs as indicated by the absence of 
NspA (Fig 6.16).   
 
Figure 6.16 shows (a) the total protein present and (b) the Western blot. Two controls 
were run together with the secreted proteins sample: WT N. lactamica whole cell 
lysate, which is a positive control containing NspA and mutant N. lactamica nspA- 
which is a negative control for NspA. The results indicate a minimal presence of OMPs 
such as NspA in the secreted protein preparation. 
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(a)         (b)                 
 
Figure 6.16: WT N. lactamica secreted protein preparation has minimal presence of OMPs 
This Figure shows (a) the total protein present as well as the (b) Western blot. 0.25 µg of protein was loaded per lane. Two controls were run together with the secreted protein 
preparation: WT N. lactamica whole cell lysate, which is a positive control containing NspA and mutant N. lactamica nspA-, which is a negative control for NspA. The results 
indicate that there was minimal presence of OMPs such as NspA in the secreted protein preparation. 
NspA 
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6.2.2.2.2 Determination of the effects of N. lactamica secreted proteins on host 
genes activated by live N. lactamica 
To determine if the five host genes specifically activated in response to live but not 
inactivated N. lactamica could be due to N. lactamica secreted proteins, secreted 
protein preparations from N. lactamica was added to bronchial epithelial cells 
(containing 2 µg of secreted proteins per well) and the expression of the five genes 
followed at selected time-points from 0 to 7 hours. The five genes are: TNF-α, ERRFI1, 
JUN, KLF6 and SALL4.  
 
6.2.2.2.2.1 TNF-α was specifically activated in response to live N. lactamica and 
is likely to involve neisserial secreted proteins 
The results suggest that secreted proteins of N. lactamica may have a role in the 
activation of TNF-α (Figure 6.17). The activation of TNF-α (with respect to mock-
infected controls) was specifically associated with live but not inactivated N. lactamica. 
This occurred at time-points of 4 and 7 hours at the transcript level and at 7 hours at the 
protein level. Treatment of host epithelial cells with secreted protein preparations from 
N. lactamica indicate that secreted proteins may be involved in the activation of TNF-α 
at 3 hours at the transcript and protein levels. 
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(a) 
 
(b) 
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(c) 
 
(d) 
 
Figure 6.17: Activation of TNF-α in response to live N. lactamica is likely to involve neisserial 
secreted proteins 
Activation of TNF-α (with respect to mock-infected controls) was specifically associated with live N. 
lactamica. This occurred at (a) time-points of 4 and 7 hours at the transcript level and at (b) 7 hours at the 
protein level. Treatment of host epithelial cells with secreted protein preparations from N. lactamica 
indicate that secreted proteins may be involved in the activation at 3 hours at both the (c) transcript and 
(d) protein levels. Asterisks (*) indicate statistical significance with p value less than 0.05 with respect to 
mock-infected samples. M: mock-infected, YK: inactivated N. lactamica, YL: live N. lactamica, ML: 
live WT N. meningitidis, YLS: N. lactamica secreted protein preparations. RQ: relative quantification.  
Outliers (0) defined as between 1.5 to 3X the interquartile range from the 25th or 75th percentile. 
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6.2.2.2.2.2 Host genes specifically activated in response to live N. lactamica but 
which are unaffected by neisserial secreted proteins 
In contrast, the expression of the remaining four genes (ERRFI1, JUN, KLF6 and 
SALL4), which was up-regulated (with respect to mock-infected controls) in response 
to live N. lactamica, was not affected by the secreted protein preparations. This is 
shown in Figures 6.18 to 6.21, all of which show the expression of the genes at the 
transcript level.  
 
In addition, it is interesting to note that while both N. lactamica and N. meningitidis 
activate these four genes at earlier time-points, at a later time-point of 7 hours there was 
a much higher level of activation by live N. lactamica compared to N. meningitidis. It 
can also be noted that in both experiments involving treatment of the host cells with 
whole bacteria and processed supernatants, cells treated with live N. lactamica were 
consistently activated.  
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(a) 
 
(b) 
 
Figure 6.18: ERRFI1 was up-regulated in response to live N. lactamica but was unaffected by 
neisserial secreted proteins 
Activation of ERRFI1 (with respect to mock-infected controls) was specifically associated with live N. 
lactamica. This occurred at (a) a time-point of 7 hours at the transcript level. Treatment of host epithelial 
cells with secreted protein preparations from N. lactamica did not have an effect on the expression of 
ERRFI1 at the (b) transcript level. Asterisks (*) indicate statistical significance with p value less than 
0.05 with respect to mock-infected samples. M: mock-infected, YK: inactivated N. lactamica, YL: live 
N. lactamica, ML: live WT N. meningitidis, YLS: N. lactamica secreted protein preparations. RQ: 
relative quantification. Outliers (0) defined as between 1.5 to 3X the interquartile range from the 25th or 
75th percentile. 
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(a) 
 
(b) 
 
Figure 6.19: JUN was up-regulated in response to live N. lactamica but was unaffected by neisserial 
secreted proteins 
Activation of JUN (with respect to mock-infected controls) was specifically associated with live N. 
lactamica. This occurred at (a) a time-point of 7 hours at the transcript level. Treatment of host epithelial 
cells with secreted protein preparations from N. lactamica did not have an effect on the expression of 
JUN at the (b) transcript level. Asterisks (*) indicate statistical significance with p value less than 0.05 
with respect to mock-infected samples. M: mock-infected, YK: inactivated N. lactamica, YL: live N. 
lactamica, ML: live WT N. meningitidis, YLS: N. lactamica secreted protein preparations. RQ: relative 
quantification. Outliers (0) defined as between 1.5 to 3X the interquartile range from the 25th or 75th 
percentile. Extreme (E) defined as more than 3X the interquartile range from the 25th or 75th percentile.  
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(a) 
 
(b) 
 
Figure 6.20: KLF6 was up-regulated in response to live N. lactamica but was unaffected by 
neisserial secreted proteins 
Activation of KLF6 (with respect to mock-infected controls) was specifically associated with live N. 
lactamica. This occurred at (a) time-points of 4 and 7 hours at the transcript level. Treatment of host 
epithelial cells with secreted protein preparations from N. lactamica did not have an effect on the 
expression of KLF6 at the (b) transcript level. Asterisks (*) indicate statistical significance with p value 
less than 0.05 with respect to mock-infected samples. M: mock-infected, YK: inactivated N. lactamica, 
YL: live N. lactamica, ML: live WT N. meningitidis, YLS: N. lactamica secreted protein preparations. 
RQ: relative quantification. Outliers (0) defined as between 1.5 to 3X the interquartile range from the 
25th or 75th percentile. Extreme (E) defined as more than 3X the interquartile range from the 25th or 75th 
percentile.  
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(a) 
 
(b) 
 
Figure 6.21: SALL4 was up-regulated in response to live N. lactamica but was unaffected by 
neisserial secreted proteins 
Activation of SALL4 (with respect to mock-infected controls) was specifically associated with live N. 
lactamica. This occurred at (a) a time-point of 7 hours at the transcript level. Treatment of host epithelial 
cells with secreted protein preparations from N. lactamica did not have an effect on the expression of 
SALL4 at the (b) transcript level. Asterisks (*) indicate statistical significance with p value less than 0.05 
with respect to mock-infected samples. M: mock-infected, YK: inactivated N. lactamica, YL: live N. 
lactamica, ML: live WT N. meningitidis, YLS: N. lactamica secreted protein preparations. RQ: relative 
quantification. Extreme (E) defined as more than 3X the interquartile range from the 25th or 75th 
percentile.  
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6.3 Discussion 
This Chapter describes the validation by Q-RT-PCR and follow up of genes that were 
differentially expressed between N. meningitidis and N. lactamica in the initial array 
experiments (Chapter 4). It also describes experiments designed to suggest possible 
bacterial mediators (pili, capsule, and secreted proteins) responsible for differential 
expression.  
 
6.3.1 Treatment of host epithelial cells with neisserial secreted protein 
preparations 
6.3.1.1 Optimisation of the growth of Neisseria in chemically defined media 
To determine if secreted proteins from N. meningitidis or N. lactamica could be 
responsible for host responses specific to live N. meningitidis or N. lactamica, bacteria 
were grown in chemically defined media and supernatants harvested. The use of 
chemically defined media minimised interference from unknown components (which 
are commonly present in complex media) which may also have effects on the gene 
expression of human epithelial cells. Additionally, this simplified downstream 
processing. Log phase supernatants were used so as to obtain samples where bacterial 
lysis would be minimal. N. meningitidis successfully grew in RPMI unlike N. 
lactamica. In fact, few studies have managed to successfully grow N. lactamica in 
chemically defined liquid media.  
 
The easiest way to grow N. lactamica is on complex nutrient agar plates (using BHI 
and sGC plates). In liquid, the bacterium is most commonly grown in Frantz medium, 
which is strictly not chemically defined due to the presence of yeast extract. Catlin 
(1973) developed a chemically defined medium (agar) that supported the growth of 15 
strains of N. lactamica obtained from pharyngeal culture. This was named NEDA 
(Neisseria-defined agar). Nutritional profile requirements of N. lactamica were 
investigated by using NEDA media lacking selected compounds. Work from the 
laboratory of Dr Andrew Gorringe at the HPA also compared the growth profiles of N. 
lactamica in MC7, MCD and Frantz media in microwells. MC7 medium is a hybrid of 
MC6 medium, a chemically defined medium for N. meningitidis growth (Fu et al., 
1995), and the original Frantz medium. MCD is a modified version of the original 
Catlin medium (NEDA in liquid form) which excluded the use of thiamine and tryptone 
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but included biotin, myo-inositol and choline chloride. Relatively speaking in the above 
studies, N. lactamica grew best in MC7, moderately well in MCD and worst in Frantz 
media. In this study, N. lactamica grew best in a 1:1 mixture of MCD and RPMI.  This 
is in contrast to N. meningitidis, which grew well, unlike N. lactamica, solely in RPMI 
medium. The results are likely to be due to different nutritional profiles between N. 
lactamica and N. meningitidis in a similar manner to that described by Catlin (1973) 
where it is was found that N. lactamica required many more compounds e.g. cystine, 
choline and biotin for growth compared to N. meningitidis. The addition of MCD into 
RPMI increased the concentrations of nutrients such as L-aspartic acid, L-
cystine•2HCl, L-glutamic acid, glycine, D-biotin, choline chloride, myo-inositol and 
glucose and led to enhanced growth of N. lactamica. 
 
6.3.1.2 Minimal contamination of endotoxin in neisserial secreted protein 
preparations used to treat epithelial cells 
The use of polymyxin B columns reduced endotoxin in the secreted protein 
preparations to miniscule levels. There was only 0.07 EU/ml and 0.02 EU/ml in wells 
treated with neisserial secreted proteins derived from N. lactamica and N. meningitidis 
respectively. Sprong et al. (2001) found that a minimum concentration of 1 ng/ml of 
meningococcal LOS was required to induce proinflammatory cytokine responses. One 
nanogram of meningococcal LOS is equivalent to 33 EU (Ovstebo et al., 2008). Thus, 
the concentrations of endotoxin in my experiment would be considered as insufficient 
to activate the host response. Treatment of human bronchial epithelial cells with LPS 
results in the activation of IL8 at the protein level (Becker et al., 2000). In contrast, 
there was a lack of activation of IL8 (at both transcript and protein level) when the 
epithelial cells here were treated with the neisserial secreted protein preparations 
(results not shown).  
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6.3.2 Neisserial cell components that were associated with an altered bronchial 
epithelial host cell response  
6.3.2.1 The lack of activation of host defence genes specifically associated with 
N. meningitidis infection 
As suggested by the microarray results (Chapter 4), many genes associated with live N. 
meningitidis (and involved in the immunity and defence process) were down-regulated. 
This trend was confirmed when 93% of those genes validated by Q-RT-PCR were 
down-regulated relative to mock-infected controls (Section 6.2.1.1.1). The genes 
include the cytokines IL1A and TNF-α, LIFR (which is a cytokine receptor), the 
chemokines CCL3, CXCL2 and IL8, a complement defence molecule (C1S), 
antimicrobial peptides (LCN2, PI3 and S100A8), a cell cycle related molecule 
(PDZK1IP1) and NAV3. For genes like IL1A, TNF-α, IL8, CCL3 and PI3 where both 
transcript and protein expression was shown, it can be seen that down-regulation upon 
infection with N. meningitidis at the transcript level occurs first at earlier time-points (3 
to 5 hours) while the effect on the protein levels occurred later at 7 hours. The results 
suggest that regulation of the gene occurs at the transcript level but there is a delay in 
cognate protein expression.  
 
To identify bacterial mediators involved in down-regulation of these host defence 
genes, inactivated WT N. meningitidis and live N. meningitidis capsule and pilus 
mutants were used. Analysis identified three groups of genes specifically associated 
with N. meningitidis infection. The first group is IL1A and TNF-α which were not 
activated after infection with live or inactivated WT N. meningitidis or mutants lacking 
capsule and pili. This suggests that N. meningitidis capsule and pili are not required for 
the lack of activation of IL1A and TNF-α. 
 
IL8 was also down-regulated after infection of bronchial epithelial cells with live but 
not inactivated N. meningitidis. No such down-regulation was seen with live cap- and 
pilE- mutants, indicating that an active interaction with the host involving the presence 
of these two bacterial surface components.   
 
Finally, PI3, C1S, CCL3, CXCL2, LCN2, LIFR, PDZK1IP1, S100A8 and NAV3 genes 
were also down-regulated after infection with live N. meningitidis. There was no effect 
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of capsule or pili on expression of these nine genes. Data (Chapter 3, Section 3.2.2) 
showed that the N. meningitidis cap- mutant invaded much more compared to the N. 
meningitidis pilE- mutant. Yet, the effect on gene expression of these nine host genes is 
the same (down-regulation) by N. meningitidis WT, cap- and pilE- mutants, which 
means that the effect on the host is not entirely dependent on bacterial-host cell contact. 
This led to the hypothesis that the down-regulation of these nine genes, especially at 
early time-points, could be due to secreted bacterial proteins. In the case of PI3 and 
C1S, down-regulation was observed after exposure to preparations of secreted proteins.   
 
Expression of the remaining seven genes (CCL3, CXCL2, LCN2, LIFR, PDZK1IP1, 
S100A8 and NAV3) was not altered by exposure of bronchial cells to neisserial 
secreted protein preparations. This suggests a role for OMVs since these will be 
secreted by live but not inactivated Neisseria and they were removed from the secreted 
protein preparations. OMVs are thought to be made up of OMPs, periplasmic proteins 
and LOS (Abel et al., 2007). OMVs are thought to be a mechanism by which bacteria 
can secrete many periplasmic and membrane components associated with the virulence 
of the bacterium. For example, the secretion of virulence factors in OMVs has been 
previously described in P. aeruginosa (Ellis and Kuehn, 2010; Kadurugamuwa and 
Beveridge, 1997). Once liberated, the vesicles are capable of fusing with the 
membranes of epithelial cells and liberating their virulence factors into host cells, 
where they can contribute to the pathogenicity of the bacteria. Alternatively, the 
secreted proteins present in the supernatants of log phase N. meningitidis in serum-free 
RPMI could be different to those present after co culture of meningococci with 
bronchial epithelial cells in the presence of serum. 
 
6.3.2.2 The activation of host genes specifically associated with N. lactamica 
infection  
Genes specifically responding to live N. lactamica from 5 to 7 hours post infection 
cluster into processes such as cytokine and chemokine mediated signalling pathways, 
mRNA transcription regulation, cell proliferation and differentiation and mRNA 
transcription. Nine to sixty-seven percent of the genes were validated by Q-RT-PCR. 
 
There were a number of genes that were up-regulated at later time-points between 5 to 
7 hours in the presence of live N. lactamica. These include TNF-α, ERRFI1, JUN, 
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KLF6 and SALL4. In contrast to TNF-α, there was no effect on gene expression of 
ERRFI1, JUN, KLF6 and SALL4 when bronchial epithelial cells were treated with N. 
lactamica secreted protein preparations.  
 
As for N. meningitidis, a role for N. lactamica OMVs or the presence of secreted 
proteins in the presence of host cells, as opposed to chemically defined medium, may 
explain the up-regulation of ERRFI1, JUN, KLF6 and SALL4.  
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6.3.3 Differential expression of host defence genes in response to N. meningitidis 
and N. lactamica 
Data from the microarray and Q-RT-PCR has indicated a differential expression of host 
defence genes in response to N. meningitidis and N. lactamica. Changes in epithelial 
cell defence gene expression after infection with bacteria is not a new concept. With a 
huge surface area that is exposed to microbes in the environment, the epithelial layer 
(including those in the respiratory tract) not only serves as a barrier to prevent invasion 
of the bacteria into the bloodstream, but also possess many other protective functions, 
including the production of host defence molecules. For example, pattern recognition 
receptors on epithelial cells are involved in the detection of pathogenic microbes. 
Injured or infected epithelial cells help initiate the inflammatory response by emitting 
chemotactic signals that attract blood-borne host defence cells. In addition, they can 
also secrete a variety of antimicrobial molecules (Ganz, 2002). All these underline the 
importance of the epithelial cells (in the respiratory tract and elsewhere) as important 
effectors in mucosal innate immunity. 
 
There were two sets of host defence genes that specifically responded to either N. 
meningitidis or N. lactamica in human bronchial epithelial cells. For instance, there was 
a down-regulation of genes such as IL1A, TNF-α, IL8, LIFR, PI3, C1S, CCL3, 
CXCL2, LCN2, PDZK1IP1, S100A8 and NAV3 after infection with N. meningitidis 
relative to N. lactamica. In contrast, there was a greater activation of genes such as 
TNF-α, ERRFI1, JUN, KLF6 and SALL4 after infection with N. lactamica relative to 
N. meningitidis. The results suggest that, in broad terms, N. meningitidis is associated 
with a lack of activation of the host defence response while N. lactamica is associated 
with an activation of the epithelial cell defence response. 
 
As described in the Introduction, there are many studies which have profiled the 
response of human cells to N. meningitidis, using endothelial and meningeal cell lines 
(Christodoulides et al., 2002; Linhartova et al., 2006; Schubert-Unkmeir et al., 2007; 
Sokolova et al., 2004; Wells et al., 2001). In general they have reported that N. 
meningitidis induces the production of proinflammatory mediators such as IL8, 
CXCL2, TNF-α and IL1A.  However, there are few studies comparing host responses 
to both N. meningitidis and N. lactamica. In one such study using human meningioma 
cells (cells representative of membranes lining the brain), cells infected with N. 
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meningitidis secreted higher amounts of proinflammatory markers like IL8 compared to 
cells infected with N. lactamica (Fowler et al., 2006). It is also well documented that 
during invasive meningococcal disease, potentially life-threatening meningitis and 
septicaemia arises from the host releasing and responding to an overwhelming amount 
of proinflammatory cytokines and chemokines (van Deuren et al., 2000), and thus it is 
not surprising that cells from the blood and brain area respond the same way at the in 
vitro level. In contrast to Fowler et al. (2006), I used an epithelial cell line from the 
respiratory tract. It is therefore possible that N. meningitidis cause different immune 
responses in cells originating from different parts of the human body, depending on 
whether the bacteria is already causing invasive disease or colonising the nasopharynx 
as a commensal.  
 
6.3.3.1 N. meningitidis prevent activation of host defence genes 
There was down-regulation or a lack of activation of genes such as IL1A, TNF-α, IL8, 
LIFR, PI3, C1S, CCL3, CXCL2, LCN2, PDZK1IP1, S100A8 and NAV3 upon 
infection with N. meningitidis relative to upon infection with N. lactamica. Most of 
these are host defence genes involved in the immune response to pathogens. 
 
IL1A and TNF-α are proinflammatory cytokines while LIFR is a cytokine receptor. For 
instance, TNF-α is an acute phase protein which initiates a cascade of cytokines and 
increases vascular permeability, thereby recruiting macrophage and neutrophils to a site 
of infection. Chemokines like CCL3, CXCL2 and IL8 also play a role in neutrophils 
recruitment and activation. Cytokines and chemokines typically play a role in the 
immune response against pathogens in an effort to clear the infection, and the lack of 
activation of these genes upon infection with N. meningitidis may be one of the many 
reasons why the bacteria can persist in the host and have the potential to cause invasive 
disease. There are studies which have shown that pathogenic bacteria can interfere with 
host signalling pathways resulting in suppression or a lack of activation of the immune 
system. The enteric bacterium Yersinia pseudotuberculosis counteracts induction of 
proinflammatory genes by inhibiting the activation of mitogen-activated protein kinase 
kinase which in turn inhibits signalling pathways like that involving NF-κB, which in 
turn results in a block of proinflammatory response (Orth et al., 1999). A S. flexneri 
effector, OspG inhibits activation of NF-κB  by binding a subset of ubiquitin-
conjugating enzymes, thereby preventing ubiquitination of phosphorylated I-κB, which 
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is consequently not degraded by the proteasome (Kim et al., 2005). Epigenetic 
regulation of inflammatory responses by pathogens has also been described, whereby 
Listeriolysin O, a membranolytic toxin secreted by Listeria monocytogenes, was shown 
to modulate host gene expression by inducing dephosphorylation of Ser10 on histone 
H3, and deacetylation of histone H4, leading to decreased expression of 
proinflammatory chemokines like CXCL2 (Hamon et al., 2007). 
 
C1s encodes a serine protease, which is a major constituent of the human complement 
subcomponent C1. C1s associates with two other complement components C1r and 
C1q in order to yield the first component of the serum complement system. It is widely 
known that an effective complement system is pivotal for host resistance against N. 
meningitidis. It is, therefore, not too surprising that N. meningitidis has been found to 
use two negative complement regulators from its human host, fH (Schneider et al., 
2006) and C4 binding protein (Schneider et al., 2007) to avoid the host complement 
defence system. For example, N. meningitidis mimics the mechanism by which host 
cells regulate complement activation on their surface by facilitating the high affinity 
interaction between fH and factor H binding protein on the bacteria. This suggests that 
N. meningitidis could rapidly sequester fH and avoid clearance by the complement 
system (Schneider et al., 2009). Suppression of another common complement 
component like the C1s gene (as shown in my results), could be another way to subvert 
host defences during colonisation, and reduce the ability of the host to clear the 
bacteria. 
  
The next group of host defence genes that were specifically down-regulated as a result 
of N. meningitidis infection are the antimicrobial peptides LCN2, PI3 and S100A8. 
LCN2 inhibits microbial growth by limiting iron availability (Reigstad et al., 2007) 
while S100A8 is part of a complex called calprotectin which protects the host 
cytoplasm against invading bacteria (Bando et al., 2007). These antimicrobial peptide 
genes are known to be up-regulated by IL1A (Bando et al., 2007) and it is expected that 
they were down-regulated as the expression of IL1A was also down-regulated as 
described previously. PI3 is a low molecular weight cationic peptide and acts as an 
antimicrobial defensin-like molecule with the ability to eliminate pulmonary pathogens 
(Simpson et al., 1999). Its expression and secretion are induced in human keratinocytes 
(Meyer-Hoffert et al., 2003) and in bronchial epithelial cells (Vos et al., 2005) after 
exposure to P. aeruginosa. Other pathogens like viruses (for example adenoviruses) 
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have been found to be responsible for the suppression of PI3 in primary human 
bronchial epithelial cells (Higashimoto et al., 2005). In addition, another antimicrobial 
peptide LL-37 has also been found to be consistently suppressed by N. gonorrhoeae 
(another pathogenic species of the Neisseria) in a cervical epithelial cell line (Bergman 
et al., 2005). Therefore, down-regulation of antimicrobial peptides may be a general 
mechanism in order to disrupt host defence mechanisms and reduce the ability of the 
host to clear the bacteria.  
 
It is interesting to note that PDZK1IP1, just like the other host defence molecules 
mentioned before, was also down-regulated by N. meningitidis. This seems to be the 
first instance in which PDZK1IP1 has been associated with Neisseria-host interactions. 
Few studies have been done on PDZK1IP1, which is a small 17 kDa non-glycosylated 
membrane protein which binds several PDZ domain-containing proteins including 
PDZK1. It modulates cell replication and bypasses TNF-induced G1 growth arrest in 
tumour cell lines (Guijarro et al., 2007). Down-regulation of this gene upon infection 
with N. meningitidis may therefore cause a growth arrest in the host cell. Infection of 
human epithelial cell lines by N. gonorrhoeae is known to also cause a G1 arrest (Jones 
et al., 2007). Therefore, it is tempting to speculate that PDZK1IP1 could be another 
host molecule used by the bacteria to modulate and interfere with the cell cycle, for 
example, by causing growth arrest in the infected host cell. Perhaps, by inducing this 
arrest, it is beneficial to the bacterium by prolonging bacterial survival in epithelial 
cells.  
 
Lastly, NAV3 belongs to the neuron navigator family and is expressed predominantly 
in the nervous system. The encoded protein contains coiled-coil domains and a 
conserved AAA domain characteristic for ATPases associated with a variety of cellular 
activities. Enhanced neuronal NAV3 expression in Alzheimer disease brains is thought 
to affect neurodegenerative processes (Shioya et al., 2010). However, this gene has 
never been implicated in pathogenic infection and its role in Neisseria-host interaction 
is unknown. 
 
In summary, my results at the transcript and protein level (of selected genes) indicate a 
lack of activation and a down-regulation of host defence molecules in epithelial cells in 
response to N. meningitidis. This not only allows the bacteria to colonise the host, but 
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may be one of the many reasons why it has the potential to cause invasive disease in an 
environment where the host innate immune response is compromised. 
 
6.3.3.2 N. lactamica activates TNF-α and genes encoding transcription factors 
and a cytoplasmic protein at higher levels compared to N. meningitidis 
There is a greater activation of genes such as TNF-α, JUN, KLF6, ERRFI1 and SALL4 
upon infection with N. lactamica relative to upon infection with N. meningitidis, 
particularly at later time-points. The aforementioned genes can be classified into 
immune genes (TNF-α) or those that encode transcription factors (JUN, KLF6 and 
SALL4) and a cytoplasmic protein (ERRFI1). The activation of transcription factors 
such as JUN and the production of cytokines is part of the host response to a bacterial 
infection, suggesting that in my experiment, the host epithelial cells are differentially 
detecting and responding more to the presence of N. lactamica compared to that of N. 
meningitidis. This activation of the host is likely to be due to the recognition of the live 
Neisseria together with its components such as bacterial porins and LOS (recognised by 
TLR2 and 4 respectively) (Massari et al., 2002; Mogensen et al., 2006; Zughaier et al., 
2004). Although the latter studies were done with N. meningitidis, my results suggest 
that N. lactamica, which also possess LOS and porins such as PorB (Snyder and 
Saunders, 2006) is also able to activate the host at the epithelial cell level. 
 
My results indicate that N. lactamica can activate the host and up-regulate 
proinflammatory genes such as TNF-α and this may help to initiate local immune 
responses which could potentially confine the commensal bacteria to the nasopharynx, 
and thus avoid invasive disease. Such an activation of the host requires a highly 
complex and regulated signaling network and this is likely to involve inhibitor 
molecules as well so that there will not be an over inflammation of the respiratory tract, 
as this may disrupt epithelial barriers (Beisswenger et al., 2007) and allow the invasion 
of N. lactamica into the blood stream. Two up-regulated genes were found in this study 
that may play a role to prevent excessive production of proinflammatory cytokines and 
over activation of the epithelial cell barrier. One of them is ERRFI1, which is a 
cytoplasmic protein whose expression is up-regulated with cell growth (Wick et al., 
1995). It shares significant homology with the protein product of rat gene-33, which is 
induced during cell stress and mediates cell signaling (Fiorentino et al., 2000; Makkinje 
et al., 2000). Recently, it has been hinted to act as a negative feedback inhibitor of EGF 
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receptor signaling through a direct, physical interaction with the EGF receptor (Zhang 
et al., 2007). The other gene is KLF6, which belongs to the Kruppel-like protein 
family. Together with KLF2, they have an important regulatory role in controlling and 
inhibiting numerous host cellular processes, including phagocytosis, proinflammatory 
cytokine expression and cell proliferation (O'Grady et al., 2007). My data suggest that a 
commensal like N. lactamica can also activate KLF6 (even more than N. meningitidis 
at later time-points), such that it does not completely evade host defence (since genes 
like JUN and TNF-α are still activated), but to prevent an over activation of the host 
proinflammatory response. 
 
Lastly, SALL4 has a critical role in the maintenance of embryonic stem cell 
pluripotency (Li, 2010). This role of this gene in the response of host cells to neisserial 
or other bacterial infections is unknown. 
 
Therefore, N. lactamica can be detected by the host and induces an inflammatory state. 
This, however, is likely to be regulated to prevent over activation of the 
proinflammatory response of the host so as to allow colonisation of the commensal 
bacteria. Additional evidence that commensals are recognised by the host comes from 
the gut, where it has been shown that some degree of innate immune recognition of 
commensal bacteria is essential for normal development and function of the mucosal 
and peripheral immune system (Macpherson and Harris, 2004). In addition, interaction 
of commensal bacteria with host microbial pattern recognition receptors such as TLRs 
plays a critical role in resistance to intestinal epithelial injury (Rakoff-Nahoum et al., 
2004).  
 
In summary, N. lactamica is not hiding from the host immune response (seen from the 
activation of genes such as TNF-α and JUN) and this initial response to the bacteria 
may alert the host to its presence and thus prevent colonisation outside of this niche. On 
the other hand, a constitutive and overwhelming activation of the proinflammatory 
response can be prevented (perhaps by using regulators such as ERRFI1 and KLF6) in 
order to maintain colonisation. 
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6.3.4  Conclusions 
Host defence genes in human bronchial epithelial cells are differentially responding to 
N. meningitidis (a potential pathogen) and to N. lactamica (a commensal). This occurs 
at the transcript level, and for some genes, at the protein level too. Some of these 
differentially expressed genes are typical proinflammatory mediators while others have 
not yet ever been described to be involved in Neisseria-host interactions. Specifically, 
N. meningitidis is associated with a down-regulation while N. lactamica is associated 
with an up-regulation of host defence genes, pointing to specific mechanisms for 
successful colonisation of the host, which potentially may also explain the occasional 
different clinical outcomes. In addition, the use of inactivated bacteria, N. meningitidis 
capsule and pili mutants, as well as neisserial secreted protein preparations have 
enabled an association of active bacterial processes as well as bacterial products with 
specific gene regulation to be identified. 
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Chapter 7 : Final comments. 
Final comments 
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7.1 Overview 
N. meningitidis is a bacterium that exclusively colonises the human respiratory tract 
mucosal surface. In some individuals, it can migrate from the respiratory tract to cause 
potentially life-threatening meningitis and septicaemia. In contrast, closely related 
bacteria such as N. lactamica, which also colonises the respiratory tract, do not cause 
invasive disease. I hypothesised that early interactions of these two different 
Neisseria species with respiratory epithelial cells are associated with differential host 
cell responses which in turn may be capable of altering the outcome of this host-
bacteria interaction. 
 
This thesis describes the interactions of N. meningitidis and N. lactamica with a human 
bronchial epithelial cell line. Association and invasion studies were first carried out to 
establish and compare how these two Neisseria species interact with the cell line. The 
association and the invasion of N. lactamica and N. meningitidis with bronchial 
epithelial cells were not significantly different at 4 hours post infection. The 
comparative order of the extent of invasion of N. meningitidis strains was: cap- mutant 
> WT > pilE- mutant. The loss of the capsule enhances invasion while the loss of the 
pilus reduces this interaction. 
 
Next, human epithelial gene expression profiles in response to N. meningitidis and N. 
lactamica were described and compared using a genome-wide microarray platform. 
Selected genes were verified both at the transcript and protein level. Host gene 
responses that have altered expression in the presence of both Neisseria species cluster 
into host metabolic and energy production processes, suggesting that both N. 
meningitidis and N. lactamica utilise host resources for energy as a way to possibly 
survive and adapt in the host during colonisation. In contrast, the data also suggest that 
while N. meningitidis down-regulates immune response genes, N. lactamica initiates a 
proinflammatory response.  
 
The contribution of the capsule and the pilus on host responses specific to N. 
meningitidis were also determined using mutant bacteria. Using inactivated bacteria 
and neisserial secreted protein preparations, I also show that active bacterial processes 
involving secreted proteins may be responsible for directing some of the host responses 
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specific to either N. lactamica or N. meningitidis. This suggests novel mechanisms for 
modulation of the host response by Neisseria.  
 
There are many studies which have profiled the response of human cells to N. 
meningitidis, using different cell lines, for example endothelial and meningeal cell lines 
(Christodoulides et al., 2002; Linhartova et al., 2006; Schubert-Unkmeir et al., 2007; 
Sokolova et al., 2004; Wells et al., 2001). In contrast to my results, which indicate a 
lack of activation and a down-regulation of host defence molecules, these other studies 
have reported that N. meningitidis induces the production of proinflammatory 
mediators such as IL8, CXCL2, TNF-α and IL1A. It is well documented that during 
invasive meningococcal disease, potentially life-threatening meningitis and septicaemia 
arises from the host releasing and responding to an overwhelming amount of 
proinflammatory cytokines and chemokines (van Deuren et al., 2000), and therefore, it 
may be expected that cells from the blood and brain area respond the same way at the 
in vitro level. In contrast to these other studies, we used an epithelial cell line from the 
respiratory tract. It is therefore possible that N. meningitidis cause different immune 
responses in cells originating from different parts of the human body, depending on 
whether the bacteria is already causing invasive disease or just colonising the 
nasopharynx as a commensal. In addition, although there are studies with epithelial 
cells showing an activation of cytokines such as IL1A in response to N. meningitidis, 
these cells are derived from cervical carcinoma and may not be an accurate 
representation of those in the respiratory tract (Plant et al., 2004). 
 
7.2 Limitations of the study 
One possible limitation relating to the use of the 16HBE14 cell line could be that 
although the epithelial cells were visualised by microscopy to determine how confluent 
they were (about 70% to 80%) upon infection, individual cells could be in different 
stages of growth and so their gene expression in response to Neisseria may not be 
strictly homogenous. 
 
In addition, the association and invasion of N. meningitidis (WT, cap- and pilE- strains) 
and N. lactamica were determined only at 4 hours post infection of the 16HBE14 
epithelial cells. My results showed that at this time point, WT N. meningitidis and N. 
lactamica associated and invaded in similar amounts while N. meningitidis cap- mutant 
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invaded much more than the pilE- mutant. Investigation of the host gene expression by 
microarray was however done from 0 to 7 hours post infection and further 
determination of the association and invasion of Neisseria with this cell line at time 
points other than 4 hours could better interpret the microarray results at the other time 
points. 
 
To determine host responses specific to live Neisseria, both WT live and dead N. 
meningitidis and N. lactamica were used to treat the epithelial cells in separate wells 
and genes responding to dead Neisseria were removed from those responding to live 
bacteria. Although similar amounts of live and dead bacteria were added at the 
beginning of the experiment (an average of 1.3 X 107 cfu per well), the bacterial dose 
would be different as time progresses since the live bacteria would replicate in the 
medium while the dead ones would not.  
 
Finally, it should be mentioned that single strains of N. meningitidis (MC58) and N. 
lactamica (Y92-1009) were used to determine the host epithelial responses specific to 
each of these bacteria. The population of N. meningitidis is highly diverse, with at least 
13 serogroups which can be divided into several serotypes and subtypes (as described 
in Chapter 1). This could also be said of N. lactamica, where MLST of N. lactamica 
isolates from infants show that they are genetically diverse, with 69 distinct genotypes 
(Bennett et al., 2005). Therefore, the results in this study are associated specifically 
with the strains used, and it is not yet known if other strains of N. meningitidis and N. 
lactamica would elucidate similar host responses. 
 
7.3 Conclusions and future work 
To my knowledge, this is the first time that host epithelial responses to N. meningitidis 
and N. lactamica have been described using a human genome wide microarray 
platform. In addition, it has also been shown for the first time that both N. meningitidis 
and N. lactamica can associate and invade bronchial epithelial cells, suggesting that 
these two commensals share these processes during colonisation. Figure 7.1 shows 
possible postulated mechanisms on the colonisation process of N. meningitidis and N. 
lactamica on human epithelial cells derived from the respiratory tract. Common host 
responses to these two bacteria suggest a shared mechanism for successful colonisation, 
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whereby both N. meningitidis and N. lactamica utilise host resources for energy as a 
way to possibly survive and adapt in the host. 
 
Besides sharing common mechanisms for colonisation, differential host responses to N. 
meningitidis and N. lactamica also indicate that some aspects of their colonisation are 
different and may possibly contribute to different clinical outcomes. It can be 
postulated that N. meningitidis actively down-regulates host defence genes as a strategy 
to maintain colonisation in the host. For example, the lack of activation of genes 
encoding chemokines (such as CCL3, CXCL2, IL8) results in a reduced ability to 
recruit immune cells such as PMNs, and so is less able to clear the bacteria.  
 
N. meningitidis also prevents the airway epithelial cells from expressing complement 
genes such as C1S and antimicrobial peptide genes such as PI3. As described in the 
Introduction, the complement system is a first line innate defence response against N. 
meningitidis. C1s encodes a serine protease, which is a major constituent of the human 
complement subcomponent C1. C1s associates with two other complement components 
C1r and C1q in order to yield the first component of the serum complement system. A 
reduced expression of C1S may corresponding reduce the production of activated C1 
complex, which subsequently may reduce the lysis of the bacteria by the MAC. In 
addition to my results, other studies have shown other strategies by N. meningitidis to 
avoid the host complement defence system. For example, N. meningitidis mimics the 
mechanism by which host cells regulate complement activation on their surface by 
facilitating the high affinity interaction between fH and factor H binding protein on the 
bacteria. This suggests that N. meningitidis could rapidly sequester fH and avoid 
clearance by the complement system (Schneider et al., 2009).  
 
PI3 is known to be bactericidal to pathogens in the respiratory tract such as P. 
aeruginosa and Staphylococcus aureus. Analysis by scanning electron microscopy 
indicate that PI3 interferes with the membrane integrity of bacterial cells, causing 
structural changes such as membrane wrinkling and the formation of ion-permeable 
channels that is likely to increase membrane permeability and finally lead to cell lysis 
(Baranger et al., 2008). In addition, PI3 has been shown to inhibit the growth of P. 
aeruginosa via the inhibition of a bacterial serine protease (Bellemare et al., 2008). The 
down-regulation of this gene by N. meningitidis could prevent these antibacterial 
activities from similarly happening to itself and thus again reduce its clearance by the 
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host. Therefore, there is a lack of activation and a down-regulation of host defence 
molecules in epithelial cells in response to N. meningitidis. This not only reduces the 
ability of the host to clear the bacteria, thus allowing colonisation, but may be one of 
the many reasons why it has the potential to cause invasive disease in an environment 
where the host innate immune response is compromised. 
 
In contrast, the host response to N. lactamica is different and could suggest another 
mechanism of successful colonisation of the host distinct from N. meningitidis. N. 
lactamica can be detected by the host immune response (seen from the activation of 
genes such as TNF-α and JUN) and this initial response to the bacteria may alert the 
host to its presence and thus prevent colonisation outside of this niche. Despite this 
proinflammatory response, N. lactamica continues to colonise the host. This is likely to 
be due to an up-regulation of genes such as KLF6 and ERRFI1 that regulate and 
prevent an over activation of the proinflammatory response so that the commensal is 
not cleared completely by the host. In particular, KLF6 belongs to the Kruppel-like 
protein family and has an important regulatory role in controlling and inhibiting 
numerous host cellular processes, including pro-inflammatory cytokine expression and 
cell proliferation (O'Grady et al., 2007). It was previously thought that only microbial 
pathogens like P. aeruginosa and S. aureus activate the expression of KLF6 in order to 
increase host susceptibility and evade host defences in human epithelial cell lines 
(Moreilhon et al., 2005; O'Grady et al., 2006). My findings that KLF6 is activated by 
N. lactamica to control the inflammatory response could also be a strategy in this case, 
by this commensal to continue colonisation of host epithelial cells, since an 
overwhelming inflammatory response to the bacteria can contribute to the breakdown 
of epithelial barrier function and disrupt its colonisation niche in the host (Beisswenger 
et al., 2007). 
 
In conclusion, contrary to previous thoughts that the host alone adopt various strategies 
to cope with colonising commensals as shown in the gut, such as the 
compartmentalisation of TLRs to avoid stimulation by the normal flora (Artis, 2008), 
my results show that both N. meningitidis and N. lactamica actively interact with the 
host in the respiratory tract and yet they adopt different strategies to maintain 
colonisation.  Differences in colonisation resulting in different host responses may be 
one of several possible reasons why N. meningitidis has the potential to cause invasive 
disease while N. lactamica does not.  
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In addition, I have identified neisserial secreted proteins as being involved in some of 
these differential host responses, suggesting an active modulation of the host by both N. 
meningitidis and N. lactamica to achieve successful colonisation. To identify the N. 
lactamica or N. meningitidis specific secreted proteins responsible for the host 
differential expression, and to determine if the differential modulation is restricted to 
specific strains of N. meningitidis or N. lactamica the following can be done:  
 
Bioinformatic and proteomic studies have already identified proteins that are known or 
predicted to be secreted by N. meningitidis and N. lactamica (van Ulsen and 
Tommassen, 2006). Analysis of the repertoire of bacterial secreted proteins that differ 
between N. meningitidis and N. lactamica will allow identification of potential 
mediators of host response. The contents of the secreted protein preparations from N. 
meningitidis and N. lactamica could be analysed by mass spectrometry to aid in the 
identification of secreted proteins specifically produced by N. meningitidis or N. 
lactamica. Cognate genes could then be cloned and recombinant proteins added to host 
cell lines and human nasopharyngeal mucosa explants (as described earlier) and host 
cell gene responses determined. The prevalence of the genes encoding the secreted 
proteins of interest within N. meningitidis and N. lactamica could be determined by 
screening (by PCR and/or Southern blotting) a diverse collection of representative 
MLST sequence types from around the world. 
 
These future studies on the identification and characterisation of bacterial mediators 
used to influence host defence and inflammatory genes (and thus achieve successful 
colonisation by N. meningitidis and N. lactamica) may lead to the discovery of novel 
bacterial immune regulators that might have therapeutic potential. 
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Figure 7.1: Postulated mechanisms of colonisation by N. meningitidis and N. lactamica 
Host metabolic and energy production processes were associated with both neisserial species, suggesting 
that both N. meningitidis and N. lactamica utilise host resources for energy. In addition, differential host 
responses to N. meningitidis and N. lactamica may indicate different colonisation processes. N. 
meningitidis down-regulates host defence genes such as chemokines (for example CCL3, CXCL2 and 
IL8), complement (C1S) and antimicrobial peptides (for example PI3) so as to possibly reduce the ability 
of the host to clear the bacteria, thus allowing colonisation. This may also explain why N. meningitidis 
has the potential to cause invasive disease in an environment where host defences are compromised. In 
contrast, N. lactamica is detected by the host which initiates a proinflammatory response, with an 
activation of genes such as TNF-α and JUN. This may alert the host to its presence and prevent 
colonisation outside of its niche. However, activation of KLF6 may prevent an overwhelming 
proinflammatory response and so prevent a breakdown of the epithelial barrier, thus allowing N. 
lactamica to continue colonisation at the nasopharynx. Some of these differential responses could be 
directed by active bacterial processes involving neisserial secreted proteins (and so may be contact 
independent).
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Supplementary data to Chapter 4 
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Table A.1: List of the 1271 genes responding 
to live WT N. meningitidis from 0 to 7 hours 
with respect to mock-infected controls 
The order of the genes is as shown in the heat 
map in Figure 4.3. 
 
Genbank ID Symbol 
NM_015272 KIAA1005 
NM_145307 PLEKHK1 
NM_032584 ZNF347 
NM_001018008 TPM1 
NM_000963 PTGS2 
NM_000575 IL1A 
NM_000584 IL8 
NM_206835 TRAF7 
NM_001663 ARF6 
NM_001012989 UBE2NL 
NM_199290 NACAL 
NM_001001791 C10orf55 
NM_173827 FLJ38991 
NM_003338 UBE2D1 
NM_032833 PPP1R15B 
NM_024005 DDX3X 
NM_030972 ZNF611 
NM_014827 ZC3H11A 
NM_177951 PPM1A 
NM_004087 DLG1 
NM_001730 KLF5 
NM_001024457 RGPD2 
NM_153363 ZNF679 
NM_017752 FLJ20298 
NM_153042 AOF1 
NM_198150 ARSK 
NM_152549 MGC39633 
NM_022065 THADA 
NM_004253 PLAA 
NM_152289 ZNF561 
NM_004505 USP6 
NM_024615 PARP8 
NM_199161 SAA1 
Genbank ID Symbol 
NM_030754 SAA2 
NM_004282 BAG2 
NM_018396 METTL2B 
NM_001515 GTF2H2 
NM_016816 OAS1 
NM_017922 PRPF39 
NM_014395 DAPP1 
NM_001005269 C15orf21 
NM_173671 FLJ37396 
NM_006607 PTTG2 
NM_001023567 GOLGA8B 
NM_031208 FAHD1 
NM_199144 UBE2V1 
NM_001024916 CBWD5 
NM_004483 GCSH 
NM_145036 MGC33887 
NM_019002 ETAA16 
NM_001031850 PSG6 
NM_178231 ALS2CR14 
NM_001010915 PTPLAD2 
NM_001029950 DKFZp434K191 
NM_013361 ZNF223 
NM_005665 EVI5 
NM_004264 SURB7 
NM_031438 NUDT12 
NM_004365 CETN3 
NM_153689 FLJ38973 
NM_017847 C1orf27 
NM_030780 SLC25A32 
NM_139164 STARD4 
NM_145802 SEPT6/SEP2 
NM_022550 XRCC4 
NM_006948 STCH 
NM_012343 NNT 
NM_018479 ECHDC1 
NM_014155 BTBD15 
NM_207418 FAM72A 
NM_000786 CYP51A1 
NM_018221 MOBK1B 
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Genbank ID Symbol 
NM_015450 POT1 
NM_016614 TTRAP 
NM_203437 AFTIPHILIN 
NM_030920 ANP32E 
NM_022874 SMN1 
NM_005054 RANBP2L1 
NM_001003 RPLP1 
NM_001012321 RPSA 
NM_000990 RPL27A 
NM_153332 THEX1 
NM_004757 SCYE1 
NM_005000 NDUFA5 
NM_016301 ATPBD1C 
NM_002128 HMGB1 
NM_024725 FLJ23518 
NM_017423 GALNT7 
NM_176869 PPA2 
NM_013341 PTD004 
NM_004236 COPS2 
NM_173060 CAST 
NM_005610 RBBP4 
NM_006817 C12orf8 
NM_001023570 IQCB1 
NM_016312 WBP11 
NM_145203 CSNK1A1L 
NM_001444 FABP5 
NM_003051 SLC16A1 
NM_006333 C1D 
NM_014597 DNTTIP2 
NM_004902 RNPC2 
NM_014283 C1orf9 
NM_016283 TAF9 
NM_005872 BCAS2 
NM_138730 HMGN3 
NM_004622 TSN 
NM_032315 MGC4399 
NM_198549 FAM73A 
NM_024745 SHCBP1 
NM_020409 MRPL47 
Genbank ID Symbol 
NM_080422 PTPN2 
NM_018981 DNAJC10 
NM_005499 UBA2 
NM_001008735 HMG1L1 
NM_006107 CROP 
NM_000877 IL1R1 
NM_020729 ODF2L 
NM_025114 CEP290 
NM_194299 LOC221711 
NM_006267 RANBP2 
NM_025189 ZNF430 
NM_020943 KIAA1604 
NM_003430 ZNF91 
NM_004079 CTSS 
NM_001010927 TIAM2 
NM_138426 GLCCI1 
NM_033087 ALG2 
NM_001032282 KLF10 
NM_014718 CLSTN3 
NM_198991 KCTD1 
NM_001031698 PRPF40B 
NM_032995 ARHGEF4 
NM_002908 REL 
NM_181777 UBE2A 
NM_020914 C17orf27 
NM_014632 MICAL2 
NM_138347 ZNF551 
NM_025209 EPC1 
NM_183376 ARRDC4 
NM_019071 ING3 
NM_002310 LIFR 
NM_023915 GPR87 
NM_012153 EHF 
NM_022365 DNAJC1 
NM_194434 VAPA 
NM_017736 THUMPD1 
NM_003488 AKAP1 
NM_002006 FGF2 
NM_016220 ZNF588 
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Genbank ID Symbol 
NM_001008390 CGGBP1 
NM_014849 SV2A 
NM_018279 TMEM19 
NM_000059 BRCA2 
NM_014518 ZNF229 
NM_000199 SGSH 
NM_032529 KIAA1875 
NM_198935 SS18L1 
NM_015896 ZMYND10 
NM_018009 TAPBPL 
NM_182608 ANKRD33 
NM_020895 GRAMD1A 
NM_194292 SASS6 
NM_012315 KLK9 
NM_017811 UBE2R2 
NM_145185 MAP2K7 
NM_003247 THBS2 
NM_007112 THBS3 
NM_020654 SENP7 
NM_015392 NPDC1 
NM_001306 CLDN3 
NM_002699 POU3F1 
NM_152417 TMEM68 
NM_014292 CBX6 
NM_006045 ATP9A 
NM_177939 PH-4 
NM_130791 WWOX 
NM_003586 DOC2A 
NM_002547 OPHN1 
NM_014406 CESK1 
NM_002249 KCNN3 
NM_052854 CREB3L1 
NM_004066 CETN1 
NM_012385 P8 
NM_152554 C6orf195 
NM_032207 FLJ21742 
NM_144621 ZBTB8 
NM_014381 MLH3 
NM_033129 SCRT2 
Genbank ID Symbol 
NM_145172 WDR63 
NM_004750 CRLF1 
NM_001005851 LOC163131 
NM_001803 CD52 
NM_022444 SLC13A1 
NM_201444 DGKA 
NM_139025 ADAMTS13 
NM_199131 VAX1 
NM_007227 GPR45 
NM_024335 IRX6 
NM_205855 UNQ1940 
NM_021708 LAIR1 
NM_003219 TERT 
NM_020638 FGF23 
NM_002019 FLT1 
NM_206922 CRIP3 
NM_138424 KIF12 
NM_001023566 LOC401398 
NM_033311 KCNK4 
NM_001732 BTN1A1 
NM_182500 FLJ25143 
NM_000869 HTR3A 
NM_000412 HRG 
NM_021209 CARD12 
NM_213653 HFE2 
NM_002584 PAX7 
NM_000627 LTBP1 
NM_001460 FMO2 
NM_002377 MAS1 
NM_194294 INDOL1 
NM_032518 COL25A1 
NM_152745 NXPH1 
NM_153487 MDGA1 
NM_005608 PTPRCAP 
NM_015158 ANKRD15 
NM_021237 SELK 
NM_170610 HIST1H2BA 
NM_022789 IL17E 
NM_172107 KCNQ2 
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Genbank ID Symbol 
NM_016527 HAO2 
NM_017521 FEV 
NM_003950 F2RL3 
NM_030812 ACTL8 
NM_001012717 C14orf165 
NM_015912 C8ORFK32 
NM_033364 C3orf15 
NM_182833 GDPD4 
NM_005421 TAL2 
NM_004991 MDS1 
NM_033057 OR2B2 
NM_001024947 YIPF5 
NM_198232 RNASE1 
NM_001004688 OR2M2 
NM_000054 AVPR2 
NM_020813 ZNF471 
NM_001148 ANK2 
NM_001008224 UACA 
NM_001033082 MYCL1 
NM_153425 TRADD 
NM_182561 FLJ36144 
NM_001364 DLG2 
NM_001007542 FLJ40453 
NM_031309 SCRT1 
NM_021796 PLAC1 
NM_003527 HIST1H2BO 
NM_152323 SPIC 
NM_153367 C10orf56 
NM_207483 FLJ45964 
NM_001442 FABP4 
NM_002235 KCNA6 
NM_004532 MUC4 
NM_020418 PCBP4 
NM_174918 MCEMP1 
NM_012125 CHRM5 
NM_020769 RGAG1 
NM_001004744 OR5R1 
NM_173682 FLJ40288 
NM_016060 MED31 
Genbank ID Symbol 
NM_175882 IMP5 
NM_203348 MGC50722 
NM_033201 C16orf45 
NM_022094 CIDEC 
NM_002338 LSAMP 
NM_175908 LOC284296 
NM_178828 C9orf79 
NM_004171 SLC1A2 
NM_006898 HOXD3 
NM_178568 RTN4RL1 
NM_001013719 LOC441136 
NM_144605 FLJ25410 
NM_004503 HOXC6 
NM_003629 PIK3R3 
NM_058189 C21orf69 
NM_001362 DIO3 
NM_001008699 IL4R 
NM_004724 ZW10 
NM_015725 RDH8 
NM_205768 ZNF238 
NM_021082 SLC15A2 
NM_207509 FLJ46836 
NM_002990 CCL22 
NM_007368 RASA3 
NM_207331 LOC153561 
NM_003931 WASF1 
NM_145350 SCARF1 
NM_033151 ABCC11 
NM_170711 DAZAP1 
NM_023942 LRRC61 
NM_152727 CPNE2 
NM_001012301 ARSI 
NM_033396 TNKS1BP1 
NM_015117 ZC3H3 
NM_022572 PNKD 
NM_032885 ATG4D 
NM_015246 MGRN1 
NM_032836 FLJ14768 
NM_014784 ARHGEF11 
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Genbank ID Symbol 
NM_015260 SIN3B 
NM_004819 SYMPK 
NM_002653 PITX1 
NM_014405 CACNG4 
NM_014994 MAPKBP1 
NM_173547 TRIM65 
NM_022086 ELMO2 
NM_004225 MFHAS1 
NM_020947 KIAA1609 
NM_144964 RG9MTD3 
NM_153035 C1orf83 
NM_001003891 PCQAP 
NM_213604 ADAMTSL5 
NM_138402 LOC93349 
NM_005418 ST5 
NM_017967 FLJ20850 
NM_003355 UCP2 
NM_020690 MASK-BP3 
NM_001012973 PLAC9 
NM_001974 EMR1 
NM_032664 FUT10 
NM_002214 ITGB8 
NM_001010911 C10orf114 
NM_022147 RTP4 
NM_001795 CDH5 
NM_002982 CCL2 
NM_148571 MRPL27 
NM_016562 TLR7 
NM_018334 LRRN3 
NM_022341 PDF 
NM_018411 HR 
NM_152558 IQCE 
NM_001033873 LOC57228 
NM_133450 ANKS3 
NM_001953 ECGF1 
NM_030753 WNT3 
NM_014731 ProSAPiP1 
NM_005729 PPIF 
NM_153214 FLJ37440 
Genbank ID Symbol 
NM_014494 TNRC6A 
NM_000229 LCAT 
NM_005933 MLL 
NM_005764 PDZK1IP1 
NM_002780 PSG4 
NM_002963 S100A7 
NM_005621 S100A12 
NM_001734 C1S 
NM_003280 TNNC1 
NM_000050 ASS 
NM_001710 CFB 
NM_005564 LCN2 
NM_002638 PI3 
NM_002964 S100A8 
NM_000041 APOE 
NM_006580 CLDN16 
NM_033294 CASP1 
NM_002783 PSG7 
NM_031246 PSG2 
NM_080645 COL12A1 
NM_004438 EPHA4 
NM_030968 C1QTNF1 
NM_024639 ZNF322A 
NM_003937 KYNU 
NM_001085 SERPINA3 
NM_003141 TRIM21 
NM_021915 ZNF69 
NM_003810 TNFSF10 
NM_152504 FLJ25067 
NM_183238 ZNF605 
NM_173811 FLJ32675 
NM_003455 ZNF202 
NM_005429 VEGFC 
NM_174898 LOC129530 
NM_018295 FLJ11000 
NM_016151 TAOK2 
NM_203434 IER5L 
NM_017541 CRYGS 
NM_001932 MPP3 
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Genbank ID Symbol 
NM_002185 IL7R 
NM_015018 DOPEY1 
NM_152246 CPT1B 
NM_020754 CDGAP 
NM_001001435 CCL4L1 
NM_024111 CHAC1 
NM_014707 HDAC9 
NM_080282 ABCA10 
NM_002442 MSI1 
NM_177963 SYT12 
NM_004287 GOSR2 
NM_175617 MT1E 
NM_016488 PPHLN1 
NM_203287 PSG11 
NM_013360 ZNF222 
NM_002155 HSPA6 
NM_025201 PLEKHQ1 
NM_018443 ZNF302 
NM_145204 SENP8 
NM_145312 ZNF485 
NM_014716 CENTB1 
NM_032405 TMPRSS3 
NM_182757 IBRDC2 
NM_001751 CARS 
NM_018700 TRIM36 
NM_014789 ZNF623 
NM_032779 FLJ14397 
NM_005070 SLC4A3 
NM_015186 VPS13A 
NM_018382 FLJ11292 
NM_004995 MMP14 
NM_032552 DAB2IP 
NM_003023 SH3BP2 
NM_001014444 CRYM 
NM_020702 KIAA1161 
NM_023931 MGC2474 
NM_005311 GRB10 
NM_174942 GAS2L3 
NM_016464 HSPC196 
Genbank ID Symbol 
NM_138775 ALKBH8 
NM_001013701 LOC440157 
NM_016929 CLIC5 
NM_014331 SLC7A11 
NM_001184 ATR 
NM_024641 MANEA 
NM_006620 HBS1L 
NM_006705 GADD45G 
NM_032230 C12orf26 
NM_004738 VAPB 
NM_024689 CXorf36 
NM_001809 CENPA 
NM_017759 FLJ20309 
NM_022344 C17orf75 
NM_175866 UHMK1 
NM_019067 GNL3L 
NM_003530 HIST1H3D 
NM_032718 MGC11332 
NM_014959 CARD8 
NM_145796 POGZ 
NM_032890 DISP1 
NM_006933 SLC5A3 
NM_170725 PGBD2 
NM_015230 CENTD1 
NM_144581 C14orf149 
NM_002184 IL6ST 
NM_021979 HSPA2 
NM_003918 GYG2 
NM_001946 DUSP6 
NM_001759 CCND2 
NM_004854 CHST10 
NM_181339 IL24 
NM_032487 ARPM1 
NM_177559 CSNK2A1 
NM_005345 HSPA1A 
NM_005346 HSPA1B 
NM_014480 ZNF544 
NM_003518 HIST1H2BG 
NM_001634 AMD1 
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Genbank ID Symbol 
NM_021945 C6orf85 
NM_004175 SNRPD3 
NM_020967 NCOA5 
NM_000862 HSD3B1 
NM_152240 WIG1 
NM_013390 TMEM2 
NM_022106 C20orf177 
NM_000024 ADRB2 
NM_005627 SGK 
NM_024804 ZNF669 
NM_018372 C1orf103 
NM_024767 DLC1 
NM_018082 POLR3B 
NM_001024733 DGCR13 
NM_080669 HCP1 
NM_201997 SF1 
NM_023077 C1orf163 
NM_016507 CRKRS 
NM_001030007 AP1G1 
NM_005226 EDG3 
NM_181725 METTL2A 
NM_012330 MYST4 
NM_198562 C3orf62 
NM_003803 MYOM1 
NM_004630 SF1 
NM_001969 EIF5 
NM_030756 TCF7L2 
NM_138926 SON 
NM_201269 ZNF644 
NM_002166 ID2 
NM_003431 ZNF124 
NM_014226 RAGE 
NM_003177 SYK 
NM_024654 NOL9 
NM_024102 WDR77 
NM_032018 C1orf124 
NM_019605 SERTAD4 
NM_170753 PGBD3 
NM_015169 RRS1 
Genbank ID Symbol 
NM_001015509 PTRH2 
NM_021826 FLJ13149 
NM_006260 DNAJC3 
NM_003804 RIPK1 
NM_033480 FBXO9 
NM_181703 GJA5 
NM_175901 LOC283932 
NM_144973 MGC24039 
NM_053055 THEM4 
NM_006306 SMC1L1 
NM_018646 TRPV6 
NM_015065 EXPH5 
NM_019888 MC3R 
NM_153345 FLJ90586 
NM_012242 DKK1 
NM_001010867 C1orf69 
NM_212460 ARL4 
NM_005738 ARL4 
NM_017866 TMEM70 
NM_018696 ELAC1 
NM_003447 ZNF165 
NM_022746 MOSC1 
NM_203374 LOC147808 
NM_012398 PIP5K1C 
NM_199181 C20orf117 
NM_024585 ARMC7 
NM_001761 CCNF 
NM_015321 CRTC1 
NM_020421 ADCK1 
NM_152236 GAS2L1 
NM_005012 ROR1 
NM_000373 UMPS 
NM_020789 IGSF9 
NM_017728 TMEM104 
NM_170768 ZFP91 
NM_173163 NFATC3 
NM_004268 CRSP6 
NM_032501 ACSS1 
NM_004177 STX3A 
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Genbank ID Symbol 
NM_032818 C9orf100 
NM_015288 PHF15 
NM_139131 NUP98 
NM_015020 PHLPPL 
NM_031485 GRWD1 
NM_022748 TNS3 
NM_058238 WNT7B 
NM_004914 RAB36 
NM_173872 CLCN3 
NM_153691 FLJ90036 
NM_024831 NCOA6IP 
NM_002546 TNFRSF11B 
NM_022034 CUZD1 
NM_017952 FLJ20758 
NM_018259 TTC17 
NM_006472 TXNIP 
NM_001006657 WDR35 
NM_181785 LOC283537 
NM_025077 TOE1 
NM_003010 MAP2K4 
NM_018947 CYCS 
NM_015428 ZNF473 
NM_001017969 KIAA2026 
NM_153263 ZNF549 
NM_002243 KCNJ15 
NM_018389 SLC35C1 
NM_013376 SERTAD1 
NM_001015072 LOC402682 
NM_025262 LY6G5C 
NM_173660 FLJ33718 
NM_199421 SOCS4 
NM_178497 FLJ23657 
NM_022774 C1orf176 
NM_145014 HYLS1 
NM_001033059 AMD1 
NM_145316 C6orf128 
NM_206825 GNL3 
NM_006399 BATF 
NM_017806 LIME1 
Genbank ID Symbol 
NM_017586 C9orf7 
NM_014777 KIAA0133 
NM_001280 CIRBP 
NM_153340 ATXN7L2 
NM_022908 NT5DC2 
NM_015059 TLN2 
NM_032895 MGC14376 
NM_013246 CLCF1 
NM_153359 MGC24975 
NM_013409 FST 
NM_003330 TXNRD1 
NM_003420 ZNF35 
NM_005911 MAT2A 
NM_207326 LOC149134 
NM_003679 KMO 
NM_032199 ARID5B 
NM_001004125 TUSC1 
NM_173807 C1orf101 
NM_020402 CHRNA10 
NM_017993 PIG38 
NM_020325 ABCD4 
NM_018302 FLJ11017 
NM_004460 FAP 
NM_021133 RNASEL 
NM_006145 DNAJB1 
NM_001343 DAB2 
NM_006473 TAF6L 
NM_018984 SSH1 
NM_019014 POLR1B 
NM_013370 OKL38 
NM_001012987 DKFZp686K16132 
NM_006738 AKAP13 
NM_018941 CLN8 
NM_014891 PDAP1 
NM_003244 TGIF 
NM_014903 NAV3 
NM_197941 ADAMTS6 
NM_015156 RCOR1 
NM_025195 TRIB1 
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Genbank ID Symbol 
NM_019885 CYP26B1 
NM_006470 TRIM16 
NM_003514 HIST1H2AM 
NM_018292 QRSL1 
NM_138400 NOM1 
NM_003253 TIAM1 
NM_002089 CXCL2 
NM_000958 PTGER4 
NM_001901 CTGF 
NM_001554 CYR61 
NM_057158 DUSP4 
NM_178517 PIGW 
NM_022767 ISG20L1 
NM_003633 ENC1 
NM_006988 ADAMTS1 
NM_207330 NPAL1 
NM_006732 FOSB 
NM_032782 HAVCR2 
NM_001116 ADCY9 
NM_033446 C9orf28 
NM_152348 WDR81 
NM_007350 PHLDA1 
NM_020762 SRGAP1 
NM_001007538 TMEM46 
NM_018050 MANSC1 
NM_032436 C13orf8 
NM_033107 DKFZP686A10121 
NM_001432 EREG 
NM_033261 IDI2 
NM_145273 CD300LG 
NM_012458 TIMM13 
NM_003545 HIST1H4E 
NM_020453 ATP10D 
NM_017738 C9orf39 
NM_025019 TUBA4 
NM_003356 UCP3 
NM_020987 ANK3 
NM_016161 A4GNT 
NM_032849 FLJ14834 
Genbank ID Symbol 
NM_002923 RGS2 
NM_014600 EHD3 
NM_004507 HUS1 
NM_003268 TLR5 
NM_020038 ABCC3 
NM_025235 TNKS2 
NM_177417 KLC3 
NM_012278 ITGB1BP2 
NM_000224 KRT18 
NM_013269 CLEC2D 
NM_020778 ALPK3 
NM_005374 MPP2 
NM_007068 DMC1 
NM_005108 XYLB 
NM_100264 WAC 
NM_001007559 SS18 
NM_001733 C1R 
NM_005178 BCL3 
NM_022824 FBXL17 
NM_001315 MAPK14 
NM_182664 RASSF5 
NM_003062 SLIT3 
NM_015335 THRAP2 
NM_030979 PABPC3 
NM_021230 MLL3 
NM_173354 SNF1LK 
NM_001018021 MUC1 
NM_002508 NID1 
NM_019900 ABCC1 
NM_007207 DUSP10 
NM_001005372 METTL2A 
NM_014744 TBC1D5 
NM_015393 DKFZP564O0823 
NM_001394 DUSP4 
NM_177442 FTSJ2 
NM_001017923 C14orf28 
NM_006186 NR4A2 
NM_006654 FRS2 
NM_177926 CSRP2BP 
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Genbank ID Symbol 
NM_006449 CDC42EP3 
NM_014991 WDFY3 
NM_000216 KAL1 
NM_003143 SSBP1 
NM_153267 MAMDC2 
NM_002228 JUN 
NM_000758 CSF2 
NM_003670 BHLHB2 
NM_004840 ARHGEF6 
NM_033445 HIST3H2A 
NM_001232 CASQ2 
NM_138555 KIF23 
NM_006298 ZNF192 
NM_001033567 RHOT1 
NM_175767 IL6ST 
NM_201545 LGALS8 
NM_033402 LRRCC1 
NM_198312 TAB3 
NM_001031683 IFIT3 
NM_001007245 IFRD1 
NM_006731 FCMD 
NM_033001 GTF2I 
NM_005983 SKP2 
NM_018080 VPS13C 
NM_005406 ROCK1 
NM_024583 SCRN3 
NM_000021 PSEN1 
NM_152622 DKFZP781I1119 
NM_001001330 REEP3 
NM_015641 TES 
NM_130398 EXO1 
NM_003825 SNAP23 
NM_001018102 GRINL1A 
NM_170681 GFM2 
NM_001030316 C4orf13 
NM_006310 NPEPPS 
NM_177952 PPM1A 
NM_153810 C10orf46 
NM_181889 UBE2D3 
Genbank ID Symbol 
NM_003286 TOP1 
NM_001018159 APPBP1 
NM_001004067 NOMO3 
NM_173075 APBB2 
NM_015472 WWTR1 
NM_012167 FBXO11 
NM_002737 PRKCA 
NM_000484 APP 
NM_001011516 PDLIM5 
NM_178313 SPTBN1 
NM_014719 KIAA0738 
NM_199123 SETD3 
NM_004169 SHMT1 
NM_020960 GPR107 
NM_181831 NF2 
NM_014373 GPR160 
NM_022918 FLJ22104 
NM_018710 TMEM55A 
NM_003002 SDHD 
NM_181354 OXR1 
NM_152731 C6orf65 
NM_001012665 DYNC2LI1 
NM_145005 C9orf72 
NM_002402 MEST 
NM_005502 ABCA1 
NM_138809 LOC134147 
NM_178815 ARL5B 
NM_002641 PIGA 
NM_003588 CUL4B 
NM_183043 RNF6 
NM_002629 PGAM1 
NM_001024948 FNBP1L 
NM_001010875 SLC25A30 
NM_080666 C14orf150 
NM_024009 GJB3 
NM_080805 COL13A1 
NM_006245 PPP2R5D 
NM_177524 MEST 
NM_198945 NBEAL1 
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Genbank ID Symbol 
NM_001009552 PPP2CB 
NM_139007 HFE 
NM_004346 CASP3 
NM_004866 SCAMP1 
NM_019028 ZDHHC13 
NM_001025595 ARFIP1 
NM_139013 MAPK14 
NM_152328 ADSSL1 
NM_153188 TNPO1 
NM_153485 NUP155 
NM_014599 MAGED2 
NM_133494 NEK7 
NM_032335 PHF6 
NM_003111 SP3 
NM_138270 ATRX 
NM_007086 WDHD1 
NM_032581 DRCTNNB1A 
NM_015365 AMMECR1 
NM_138423 CASC4 
NM_005968 HNRPM 
NM_001329 CTBP2 
NM_177937 GOLPH2 
NM_003104 SORD 
NM_139169 TRUB1 
NM_173829 P18SRP 
NM_004318 ASPH 
NM_006457 PDLIM5 
NM_003816 ADAM9 
NM_015884 MBTPS2 
NM_018843 MCFP 
NM_013386 SLC25A24 
NM_002979 SCP2 
NM_144695 C1orf58 
NM_001003680 LEPR 
NM_016315 GULP1 
NM_031919 FSD1NL 
NM_001001521 UGP2 
NM_002044 GALK2 
NM_014812 CEP170 
Genbank ID Symbol 
NM_003631 PARG 
NM_001003679 LEPR 
NM_005230 ELK3 
NM_014997 KIAA0265 
NM_007139 ZNF92 
NM_182960 MGC21644 
NM_198449 EMB 
NM_205836 FBXO38 
NM_078476 BTN2A1 
NM_024613 PLEKHF2 
NM_024949 WWC2 
NM_152527 SLC16A14 
NM_003692 TMEFF1 
NM_032943 SYTL2 
NM_012403 ANP32C 
NM_024529 CDC73 
NM_024612 DHX40 
NM_001017962 P4HA1 
NM_006756 TCEA1 
NM_198974 PTK9 
NM_031942 CDCA7 
NM_020164 ASPH 
NM_001017373 SAMD3 
NM_004368 CNN2 
NM_173551 ANKS6 
NM_001007524 F8A3 
NM_001025107 ADAR 
NM_177965 C8orf37 
NM_138625 BCL2L11 
NM_153044 FLJ35801 
NM_012334 MYO10 
NM_001615 ACTG2 
NM_002335 LRP5 
NM_001699 AXL 
NM_152314 MGC34830 
NM_012309 SHANK2 
NM_020338 RAI17 
NM_130440 PTPRF 
NM_000227 LAMA3 
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Genbank ID Symbol 
NM_017751 FLJ20297 
NM_014612 C9orf10 
NM_005231 CTTN 
NM_016576 GMPR2 
NM_020445 ACTR3B 
NM_018983 NOLA1 
NM_205847 GMPPA 
NM_194247 HNRPA3 
NM_015963 THAP4 
NM_005916 MCM7 
NM_080548 PTPN6 
NM_017860 C1orf56 
NM_004395 DBN1 
NM_001331 CTNND1 
NM_017979 UNC45A 
NM_006201 PCTK1 
NM_177983 PPM1G 
NM_003075 SMARCC2 
NM_032907 UBL7 
NM_031921 ATAD3B 
NM_177973 SULT2B1 
NM_003975 SH2D2A 
NM_033274 ADAM19 
NM_032375 AKT1S1 
NM_002274 KRT13 
NM_006086 TUBB3 
NM_052906 KIAA1904 
NM_003125 SPRR1B 
NM_001324 CSTF1 
NM_004751 GCNT3 
NM_144569 SPOCD1 
NM_002701 POU5F1 
NM_203464 AK3L1 
NM_002521 NPPB 
NM_001031682 GPR30 
NM_004926 ZFP36L1 
NM_001717 BNC1 
NM_000602 SERPINE1 
NM_201282 EGFR 
Genbank ID Symbol 
NM_004040 RHOB 
NM_006718 PLAGL1 
NM_018660 ZNF395 
NM_005228 EGFR 
NM_152288 MGC13024 
NM_001198 PRDM1 
NM_007361 NID2 
NM_020436 SALL4 
NM_014755 SERTAD2 
NM_001025598 ARHGAP30 
NM_024607 PPP1R3B 
NM_054034 FN1 
NM_014356 C6orf123 
NM_012118 CCRN4L 
NM_005401 PTPN14 
NM_003220 TFAP2A 
NM_194278 C14orf43 
NM_003749 IRS2 
NM_017527 LY6K 
NM_003612 SEMA7A 
NM_198390 CMIP 
NM_003842 TNFRSF10B 
NM_005239 ETS2 
NM_001397 ECE1 
NM_004093 EFNB2 
NM_001024809 RARA 
NM_005450 NOG 
NM_002648 PIM1 
NM_181720 ARHGAP30 
NM_005263 GFI1 
NM_003028 SHB 
NM_001004431 METRNL 
NM_001005619 ITGB4 
NM_024633 C14orf139 
NM_001018136 NME1-NME2 
NM_199203 Kua-UEV 
NM_000295 SERPINA1 
NM_006589 C1orf2 
NM_018378 FBXL8 
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Genbank ID Symbol 
NM_005368 MB 
NM_000359 TGM1 
NM_178569 CEI 
NM_173503 EFCAB3 
NM_004089 TSC22D3 
NM_006147 IRF6 
NM_052864 TIFA 
NM_022162 CARD15 
NM_025058 TRIM46 
NM_030824 ZNF442 
NM_001004349 FLJ45422 
NM_003976 ARTN 
NM_018089 ANKZF1 
NM_153271 SH3PX3 
NM_199054 MKNK2 
NM_030765 B3GNT4 
NM_004527 MEOX1 
NM_018498 PPP4R1L 
NM_030936 RNF32 
NM_021168 RAB40C 
NM_207371 FLJ45187 
NM_032701 SUV420H2 
NM_181717 HCG27 
NM_138372 LOC91661 
NM_033025 SYDE1 
NM_033634 SCAND2 
NM_052818 CG018 
NM_001031735 C19orf36 
NM_001013702 LOC440258 
NM_004864 GDF15 
NM_007021 C10orf10 
NM_001124 ADM 
NM_020801 ARRDC3 
NM_002610 PDK1 
NM_001033506 CSTF3 
NM_019058 DDIT4 
NM_002928 RGS16 
NM_145343 APOL1 
NM_033633 SCAND2 
Genbank ID Symbol 
NM_003714 STC2 
NM_004428 EFNA1 
NM_004417 DUSP1 
NM_022066 UBE2O 
NM_003992 CLK3 
NM_015714 G0S2 
NM_033640 SCAND2 
NM_181802 UBE2C 
NM_022081 HPS4 
NM_000188 HK1 
NM_004711 SYNGR1 
NM_057157 CYP26A1 
NM_001206 KLF9 
NM_145176 SLC2A12 
NM_000254 MTR 
NM_024787 RNF122 
NM_201283 EGFR 
NM_019593 KIAA1434 
NM_001731 BTG1 
NM_001011664 CSNK1G1 
NM_018293 ZNF654 
NM_001706 BCL6 
NM_152556 FLJ31818 
NM_032373 PCGF5 
NM_001020825 NR3C1 
NM_004004 GJB2 
NM_020472 PIGA 
NM_153693 HOXC6 
NM_134264 WSB1 
NM_153255 MCMDC1 
NM_000522 HOXA13 
NM_032551 KISS1R 
NM_153361 MGC42105 
NM_032379 SYTL2 
NM_199327 SPRY1 
NM_170600 SH2D3C 
NM_018354 C20orf46 
NM_001671 ASGR1 
NM_080743 SRrp35 
Appendix A 
213 
Genbank ID Symbol 
NM_153350 FBXL16 
NM_178012 TUBB2B 
NM_001005353 AK3L1 
NM_014367 C3orf28 
NM_022073 EGLN3 
NM_001001701 LOC401152 
NM_015689 DENND2A 
NM_004753 DHRS3 
NM_014584 ERO1L 
NM_130439 MXI1 
NM_001002921 AK3L2 
NM_005238 ETS1 
NM_006653 FRS3 
NM_178519 C17orf55 
NM_207443 FLJ45244 
NM_004112 FGF11 
NM_000189 HK2 
NM_153449 SLC2A14 
NM_015053 PPFIA4 
NM_001122 ADFP 
NM_173540 FUT11 
NM_001975 ENO2 
NM_016133 INSIG2 
NM_173642 FAM80A 
NM_001005404 YPEL2 
NM_021983 HLA-DRB4 
NM_005398 PPP1R3C 
NM_013332 HIG2 
NM_181726 ANKRD37 
NM_139314 ANGPTL4 
NM_004567 PFKFB4 
NM_001002914 KCTD11 
NM_006931 SLC2A3 
NM_005384 NFIL3 
NM_006096 NDRG1 
NM_004354 CCNG2 
NM_052880 MGC17330 
NM_018433 JMJD1A 
NM_003155 STC1 
Genbank ID Symbol 
NM_003831 RIOK3 
NM_130807 MOBKL2A 
NM_018948 ERRFI1 
NM_000381 MID1 
NM_005224 ARID3A 
NM_004566 PFKFB3 
NM_144497 AKAP12 
NM_000180 GUCY2D 
NM_006516 SLC2A1 
NM_017817 RAB20 
NM_138445 GPR146 
NM_174919 LOC201175 
NM_018689 KIAA1199 
NM_184231 NCKIPSD 
NM_003864 SAP30 
NM_022047 DEF6 
NM_153836 CREG2 
NM_019021 FLJ20010 
NM_014353 RAB26 
NM_004915 ABCG1 
NM_178145 RASSF4 
NM_001010919 LOC441168 
NM_002943 RORA 
NM_001008541 MXI1 
NM_003561 PLA2G10 
NM_173678 FLJ40722 
NM_022355 DPEP2 
NM_030567 PRR7 
NM_152353 MGC33839 
NM_078626 CDKN2C 
NM_005165 ALDOC 
NM_003116 SPAG4 
NM_080660 MGC14289 
NM_014562 OTX1 
NM_152361 EID-3 
NM_030817 APOLD1 
NM_005223 DNASE1 
NM_014883 FAM13A1 
NM_016150 ASB2 
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Genbank ID Symbol 
NM_004721 MAP3K13 
NM_207453 FLJ35934 
NM_019052 CCHCR1 
NM_001452 FOXF2 
NM_173639 C1orf104 
NM_004861 GAL3ST1 
NM_182494 FAM26A 
NM_004286 GTPBP1 
NM_020959 TMEM16H 
NM_177551 GPR109A 
NM_014143 CD274 
NM_006018 GPR109B 
NM_058193 TRIM29 
NM_170713 RASSF1 
NM_173624 FLJ40504 
NM_006995 BTN2A2 
NM_021914 CFL2 
NM_003419 ZNF345 
NM_005899 NBR1 
NM_174910 TCTE3 
NM_001001664 LOC339745 
NM_203282 ZNF539 
NM_152772 TCP11L2 
NM_058241 CCNT2 
NM_147128 ZNRF2 
NM_031296 RAB33B 
NM_198182 GRHL1 
NM_015358 MORC3 
NM_002031 FRK 
NM_005086 SSPN 
NM_001013398 IGFBP3 
NM_032626 RBBP6 
NM_014670 BZW1 
NM_001821 CHML 
NM_007054 KIF3A 
NM_001013689 LOC401622 
NM_058230 ZNF354B 
NM_181077 GOLGA8A 
NM_003441 ZNF141 
Genbank ID Symbol 
NM_152791 ZNF555 
NM_198845 SIGLEC6 
NM_144995 DHX57 
NM_001012960 C1orf84 
NM_024336 IRX3 
NM_001561 TNFRSF9 
NM_006317 BASP1 
NM_003027 SH3GL3 
NM_021244 RRAGD 
NM_007000 UPK1A 
NM_001013646 LOC388799 
NM_018027 FRMD4A 
NM_006301 MAP3K12 
NM_006133 C11orf11 
NM_002048 GAS1 
NM_004821 HAND1 
NM_080833 C20orf151 
NM_133367 PAQR8 
NM_001014380 KATNAL1 
NM_052820 CORO2A 
NM_170773 RASSF2 
NM_024760 TLE6 
NM_001033719 ZNF404 
NM_006480 RGS14 
NM_138350 THAP3 
NM_015180 SYNE2 
NM_024509 LRFN3 
NM_002456 MUC1 
NM_002826 QSCN6 
NM_003857 GALR2 
NM_003970 MYOM2 
NM_130783 TSPAN18 
NM_032735 MGC13168 
NM_020183 ARNTL2 
NM_005084 PLA2G7 
NM_012292 HMHA1 
NM_207336 ZNF467 
NM_001719 BMP7 
NM_020989 CRYGC 
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Genbank ID Symbol 
NM_032892 FRMD5 
NM_153262 SYT14 
NM_199205 KIAA1967 
NM_002145 HOXB2 
NM_001936 DPP6 
NM_001005505 CACNA2D2 
NM_018226 RNPEPL1 
NM_001033515 LOC389833 
NM_207354 ANKRD13D 
NM_004473 FOXE1 
NM_006907 PYCR1 
NM_153609 TMPRSS6 
NM_004071 CLK1 
NM_080736 WFDC2 
NM_139317 BIRC7 
NM_015478 L3MBTL 
NM_001005914 SEMA3B 
NM_000201 ICAM1 
NM_198452 PNCK 
NM_013304 ZDHHC1 
NM_001647 APOD 
NM_006182 DDR2 
NM_052924 RHPN1 
NM_006760 UPK2 
NM_000203 IDUA 
NM_133455 EMID1 
NM_001606 ABCA2 
NM_005166 APLP1 
NM_004416 DTX1 
NM_175873 ANKRD43 
NM_024682 TBC1D17 
NM_016335 PRODH 
NM_016632 ARL17P1 
NM_001029997 ZNF181 
NM_022367 SEMA4A 
NM_000526 KRT14 
NM_024909 C6orf134 
NM_152326 ANKRD9 
NM_033557 YIF1B 
Genbank ID Symbol 
NM_002466 MYBL2 
NM_145696 BRF1 
NM_001032279 RCE1 
NM_005432 XRCC3 
NM_001453 FOXC1 
NM_003656 CAMK1 
NM_145262 GLYCTK 
NM_001687 ATP5D 
NM_003935 TOP3B 
NM_138387 G6PC3 
NM_020196 XAB2 
NM_006949 STXBP2 
NM_030973 MED25 
NM_015949 C7orf20 
NM_006578 GNB5 
NM_022107 GPSM3 
NM_006712 FASTK 
NM_138334 JOSD2 
NM_173527 FLJ38964 
NM_181334 LOC553158 
NM_019103 ZMAT5 
NM_004357 CD151 
NM_031300 MXD3 
NM_005674 ZNF239 
NM_182944 NIN 
NM_018275 FLJ10925 
NM_004954 MARK2 
NM_003378 VGF 
NM_145040 PRKCDBP 
NM_001014832 PAK4 
NM_001421 ELF4 
NM_000883 IMPDH1 
NM_025129 FLJ22688 
NM_030930 UNC93B1 
NM_000597 IGFBP2 
NM_198589 BSG 
NM_012267 HSPBP1 
NM_015997 C1orf66 
NM_017980 LIMS2 
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Genbank ID Symbol 
NM_021210 TRAPPC1 
NM_022772 EPS8L2 
NM_018956 C9orf9 
NM_006019 TCIRG1 
NM_001031731 YIF1B 
NM_006942 SOX15 
NM_006465 ARID3B 
NM_130787 AP2A1 
NM_007188 ABCB8 
NM_007219 RNF24 
NM_138442 LOC115098 
NM_199444 COPE 
NM_178335 CCDC50 
NM_138393 REEP6 
NM_004257 TGFBRAP1 
NM_201398 FLAD1 
NM_138386 LOC92345 
NM_005850 SF3B4 
NM_000444 PHEX 
NM_144620 LRRC39 
NM_020182 TMEPAI 
NM_004445 EPHB6 
NM_002501 NFIX 
NM_001017965 LOC150223 
NM_153813 ZFPM1 
NM_001001890 RUNX1 
NM_079834 SCAMP4 
NM_005630 SLCO2A1 
NM_198042 PDLIM2 
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Table A.2: List of the 1178 genes responding 
to live WT N. lactamica from 0 to 7 hours 
with respect to mock-infected controls  
The order of the genes is as shown in the heat 
map in Figure 4.4. 
 
Genbank ID Symbol 
NM_007172 NUP50 
NM_000461 THRB 
NM_020808 SIPA1L2 
NM_001010899 C1orf120 
NM_000444 PHEX 
NM_002985 CCL5 
NM_000433 NCF2 
NM_024639 ZNF322A 
NM_001306 CLDN3 
NM_020713 GM632 
NM_003586 DOC2A 
NM_003311 PHLDA2 
NM_018262 IFT122 
NM_172109 KCNQ2 
NM_024519 FAM65A 
NM_022464 SIL1 
NM_025161 C17orf70 
NM_018009 TAPBPL 
NM_024650 FLJ22531 
NM_001667 ARL2 
NM_021976 RXRB 
NM_014593 CXXC1 
NM_024407 NDUFS7 
NM_133644 GTPBP3 
NM_181897 PPP2R3A 
NM_015896 ZMYND10 
NM_006262 PRPH 
NM_139016 LOC128439 
NM_002699 POU3F1 
NM_177951 PPM1A 
NM_006449 CDC42EP3 
NM_181892 UBE2D3 
NM_197957 MAX 
Genbank ID Symbol 
NM_032435 KIAA1804 
NM_018841 GNG12 
NM_032341 DDI2 
NM_001226 CASP6 
NM_153809 TAF1L 
NM_002547 OPHN1 
NM_006045 ATP9A 
NM_002508 NID1 
NM_178169 RASSF3 
NM_014292 CBX6 
NM_015392 NPDC1 
NM_177939 PH-4 
NM_198150 ARSK 
NM_003488 AKAP1 
NM_006559 KHDRBS1 
NM_001010927 TIAM2 
NM_020409 MRPL47 
NM_023915 GPR87 
NM_001225 CASP4 
NM_019071 ING3 
NM_153042 AOF1 
NM_023931 MGC2474 
NM_024944 CHODL 
NM_020038 ABCC3 
NM_019596 C21orf62 
NM_014789 ZNF623 
NM_000765 CYP3A7 
NM_015154 MESDC2 
NM_000373 UMPS 
NM_015059 TLN2 
NM_032199 ARID5B 
NM_006399 BATF 
NM_002243 KCNJ15 
NM_145025 C6orf199 
NM_032782 HAVCR2 
NM_002982 CCL2 
NM_032587 CARD6 
NM_013360 ZNF222 
NM_020423 SCYL3 
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Genbank ID Symbol 
NM_003234 TFRC 
NM_178497 FLJ23657 
NM_001010877 ZNF311 
NM_014061 MAGEH1 
NM_021826 FLJ13149 
NM_170725 PGBD2 
NM_173582 PGM2L1 
NM_015025 MYT1L 
NM_002614 PDZK1 
NM_000396 CTSK 
NM_001004125 TUSC1 
NM_207326 LOC149134 
NM_145014 HYLS1 
NM_006472 TXNIP 
NM_013376 SERTAD1 
NM_152504 FLJ25067 
NM_001033059 AMD1 
NM_004234 ZNF235 
NM_001015072 LOC402682 
NM_001010911 C10orf114 
NM_023921 TAS2R10 
NM_173660 FLJ33718 
NM_024654 NOL9 
NM_001007538 TMEM46 
NM_032974 CASP10 
NM_024105 ALG12 
NM_033261 IDI2 
NM_020989 CRYGC 
NM_152765 C8orf46 
NM_199186 BPGM 
NM_025209 EPC1 
NM_021988 UBE2V1 
NM_014935 PLEKHA6 
NM_207331 LOC153561 
NM_000804 FOLR3 
NM_020967 NCOA5 
NM_017453 STAU 
NM_212460 ARL4 
NM_005738 ARL4 
Genbank ID Symbol 
NM_033086 FGD3 
NM_002118 HLA-DMB 
NM_006454 MXD4 
NM_005279 GPR1 
NM_181703 GJA5 
NM_004549 NDUFC2 
NM_006705 GADD45G 
NM_001724 BPGM 
NM_203374 LOC147808 
NM_018372 C1orf103 
NM_015139 SLC35D1 
NM_032487 ARPM1 
NM_001008708 CHAC2 
NM_017866 TMEM70 
NM_003918 GYG2 
NM_012242 DKK1 
NM_198267 ING3 
NM_001007214 CACYBP 
NM_032382 COG8 
NM_170753 PGBD3 
NM_153345 FLJ90586 
NM_020886 USP28 
NM_024780 TMC5 
NM_005236 ERCC4 
NM_003431 ZNF124 
NM_024636 STEAP4 
NM_001634 AMD1 
NM_006470 TRIM16 
NM_021216 ZNF71 
NM_001007245 IFRD1 
NM_015156 RCOR1 
NM_022065 THADA 
NM_001013439 FXR1 
NM_003603 SORBS2 
NM_153367 C10orf56 
NM_198562 C3orf62 
NM_001032297 ZNF658B 
NM_013354 CNOT7 
NM_005914 MCM4 
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Genbank ID Symbol 
NM_015474 SAMHD1 
NM_205768 ZNF238 
NM_006247 PPP5C 
NM_139121 YY1AP1 
NM_003106 SOX2 
NM_001025357 LOC441376 
NM_021133 RNASEL 
NM_000909 NPY1R 
NM_003438 ZNF137 
NM_003421 ZNF37A 
NM_001004328 ZNF705A 
NM_001395 DUSP9 
NM_000951 PRRG2 
NM_000445 PLEC1 
NM_032043 BRIP1 
NM_000947 PRIM2A 
NM_144972 LDHAL6A 
NM_152417 TMEM68 
NM_175882 IMP5 
NM_018279 TMEM19 
NM_203307 MGC35402 
NM_016488 PPHLN1 
NM_000662 NAT1 
NM_152289 ZNF561 
NM_003356 UCP3 
NM_024323 MGC11271 
NM_153034 ZNF488 
NM_021220 OVOL2 
NM_016499 MGC13379 
NM_174942 GAS2L3 
NM_021915 ZNF69 
NM_002235 KCNA6 
NM_032826 SLC35B4 
NM_003268 TLR5 
NM_012276 LILRA4 
NM_024335 IRX6 
NM_006933 SLC5A3 
NM_022344 C17orf75 
NM_017759 FLJ20309 
Genbank ID Symbol 
NM_002184 IL6ST 
NM_017993 PIG38 
NM_000312 PROC 
NM_032256 TMEM117 
NM_145312 ZNF485 
NM_032181 FLJ13391 
NM_152709 STOX1 
NM_203462 MRFAP1L1 
NM_199421 SOCS4 
NM_032890 DISP1 
NM_024689 CXorf36 
NM_178509 STXBP4 
NM_152517 FLJ30990 
NM_016245 DHRS8 
NM_032230 C12orf26 
NM_025243 SLC19A3 
NM_014959 CARD8 
NM_002048 GAS1 
NM_001024596 DKFZp686I1569 
NM_145796 POGZ 
NM_021205 RHOU 
NM_173826 C3orf23 
NM_173039 AQP11 
NM_032601 MCEE 
NM_201269 ZNF644 
NM_173666 DTWD2 
NM_024641 MANEA 
NM_003219 TERT 
NM_206922 CRIP3 
NM_013269 CLEC2D 
NM_000224 KRT18 
NM_207483 FLJ45964 
NM_175873 ANKRD43 
NM_033311 KCNK4 
NM_138424 KIF12 
NM_032501 ACSS1 
NM_152509 FLJ31568 
NM_152595 PGBD4 
NM_004058 CAPS 
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Genbank ID Symbol 
NM_153263 ZNF549 
NM_172107 KCNQ2 
NM_022034 CUZD1 
NM_001012973 PLAC9 
NM_017771 PXK 
NM_153376 FLJ90575 
NM_130396 WISP3 
NM_145258 LRRC44 
NM_153200 EDF1 
NM_000409 GUCA1A 
NM_020895 GRAMD1A 
NM_032682 FOXP1 
NM_005995 TBX10 
NM_001004695 OR2T33 
NM_152745 NXPH1 
NM_178233 OTOP3 
NM_001313 CRMP1 
NM_002998 SDC2 
NM_005392 PHF2 
NM_003247 THBS2 
NM_032529 KIAA1875 
NM_002978 SCNN1D 
NM_004070 CLCNKA 
NM_017636 TRPM4 
NM_021170 HES4 
NM_000422 KRT17 
NM_032592 PHACS 
NM_016243 CYB5R1 
NM_001013719 LOC441136 
NM_032207 FLJ21742 
NM_015725 RDH8 
NM_014249 NR2E3 
NM_012315 KLK9 
NM_017539 DNAH3 
NM_005396 PNLIPRP2 
NM_012282 KCNE1L 
NM_014710 GPRASP1 
NM_013391 DMGDH 
NM_019046 ANKRD16 
Genbank ID Symbol 
NM_022094 CIDEC 
NM_020373 TMEM16B 
NM_033201 C16orf45 
NM_006163 NFE2 
NM_205864 CAGE1 
NM_005822 DSCR1L1 
NM_001008224 UACA 
NM_054111 IHPK3 
NM_001012277 PRAMEF7 
NM_138277 C6orf25 
NM_178568 RTN4RL1 
NM_004959 NR5A1 
NM_005413 SIX3 
NM_020987 ANK3 
NM_001007542 FLJ40453 
NM_006446 SLCO1B1 
NM_020402 CHRNA10 
NM_173807 C1orf101 
NM_153425 TRADD 
NM_207317 FLJ32921 
NM_203348 MGC50722 
NM_001001686 FLJ43870 
NM_198471 ANKRD47 
NM_020193 C11orf30 
NM_014112 TRPS1 
NM_145812 PDCD8 
NM_020638 FGF23 
NM_007148 ZNF179 
NM_004750 CRLF1 
NM_007368 RASA3 
NM_016204 GDF2 
NM_001362 DIO3 
NM_152868 KCNJ4 
NM_002022 FMO4 
NM_006884 SHOX2 
NM_002029 FPR1 
NM_031291 SLC25A31 
NM_004503 HOXC6 
NM_004171 SLC1A2 
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Genbank ID Symbol 
NM_001004323 LOC402573 
NM_153835 GPR113 
NM_178828 C9orf79 
NM_138612 HAS3 
NM_001148 ANK2 
NM_000054 AVPR2 
NM_001010980 C1orf130 
NM_199296 THSD3 
NM_001013626 LOC286187 
NM_031468 CALN1 
NM_014253 ODZ1 
NM_022123 NPAS3 
NM_173663 NY-REN-7 
NM_015993 TM4SF11 
NM_138294 PATE 
NM_152742 GPC2 
NM_005623 CCL8 
NM_000554 CRX 
NM_001024858 SPTB 
NM_203474 PORCN 
NM_152554 C6orf195 
NM_000440 PDE6A 
NM_016161 A4GNT 
NM_005978 S100A2 
NM_017742 ZCCHC2 
NM_001033082 MYCL1 
NM_002990 CCL22 
NM_004535 MYT1 
NM_002747 MAPK4 
NM_021200 PLEKHB1 
NM_003841 TNFRSF10C 
NM_207509 FLJ46836 
NM_014240 LIMD1 
NM_052882 ZIM3 
NM_145663 DBF4B 
NM_145350 SCARF1 
NM_178121 SBP1 
NM_213605 ZNF517 
NM_000209 IPF1 
Genbank ID Symbol 
NM_001005366 FBXL10 
NM_012458 TIMM13 
NM_002338 LSAMP 
NM_006898 HOXD3 
NM_152498 WDR65 
NM_001012717 C14orf165 
NM_032269 C16orf50 
NM_015912 C8ORFK32 
NM_001001502 SNCB 
NM_133343 RAD17 
NM_173092 KCNH6 
NM_199183 TESSP5 
NM_001001891 TMEM16G 
NM_170600 SH2D3C 
NM_022160 DMRTA1 
NM_003948 CDKL2 
NM_001033521 CSTF1 
NM_000898 MAOB 
NM_003370 VASP 
NM_014718 CLSTN3 
NM_014608 CYFIP1 
NM_002674 PMCH 
NM_152690 DPM2 
NM_032597 NYD-SP21 
NM_207348 SLC25A34 
NM_000214 JAG1 
NM_145805 ISL2 
NM_001033517 SERINC4 
NM_025235 TNKS2 
NM_032037 TSSK6 
NM_006492 ALX3 
NM_001004744 OR5R1 
NM_021069 SORBS2 
NM_173682 FLJ40288 
NM_032099 PCDHGB5 
NM_014767 SPOCK2 
NM_138460 CMTM5 
NM_000627 LTBP1 
NM_001001668 FLJ26175 
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Genbank ID Symbol 
NM_032518 COL25A1 
NM_033129 SCRT2 
NM_198232 RNASE1 
NM_021708 LAIR1 
NM_001460 FMO2 
NM_022789 IL17E 
NM_173477 USH1G 
NM_033054 MYO1G 
NM_148570 MRPL27 
NM_032432 ABLIM2 
NM_001945 HBEGF 
NM_005078 TLE3 
NM_033184 KRTAP2-4 
NM_178836 LOC201164 
NM_152288 MGC13024 
NM_012323 MAFF 
NM_032995 ARHGEF4 
NM_003023 SH3BP2 
NM_178520 TMEM105 
NM_031478 FAM57B 
NM_022465 ZNFN1A4 
NM_001014291 SPRR2G 
NM_031459 SESN2 
NM_144779 FXYD5 
NM_032108 SEMA6B 
NM_033133 CNP 
NM_198452 PNCK 
NM_001013665 LOC399744 
NM_178226 FBXW5 
NM_018411 HR 
NM_014895 C6orf84 
NM_183238 ZNF605 
NM_033557 YIF1B 
NM_033238 PML 
NM_170696 ALDH1A2 
NM_004311 ARL3 
NM_031300 MXD3 
NM_182562 FLJ39743 
NM_019103 ZMAT5 
Genbank ID Symbol 
NM_198563 TMEM110 
NM_012236 SCMH1 
NM_001012753 ZNF440L 
NM_138454 TXNL6 
NM_001013688 LOC401620 
NM_013396 USP25 
NM_017654 SAMD9 
NM_004954 MARK2 
NM_153033 KCTD7 
NM_173619 MGC34761 
NM_015577 RAI14 
NM_001029999 MGC26718 
NM_004257 TGFBRAP1 
NM_144684 ZNF480 
NM_001029997 ZNF181 
NM_025129 FLJ22688 
NM_014903 NAV3 
NM_016562 TLR7 
NM_152761 FLJ25444 
NM_001606 ABCA2 
NM_020812 DOCK6 
NM_015481 ZNF385 
NM_024909 C6orf134 
NM_182552 WDR27 
NM_080647 TBX1 
NM_152326 ANKRD9 
NM_152600 ZNF579 
NM_007186 CEP250 
NM_001029882 AHDC1 
NM_139034 MAPK7 
NM_022367 SEMA4A 
NM_007219 RNF24 
NM_001009944 PKD1 
NM_130787 AP2A1 
NM_007188 ABCB8 
NM_004943 DMWD 
NM_145262 GLYCTK 
NM_006949 STXBP2 
NM_030973 MED25 
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Genbank ID Symbol 
NM_020196 XAB2 
NM_005564 LCN2 
NM_016246 DHRS10 
NM_002502 NFKB2 
NM_079834 SCAMP4 
NM_020360 PLSCR3 
NM_138442 LOC115098 
NM_173548 ZNF584 
NM_018231 FLJ10815 
NM_021210 TRAPPC1 
NM_000120 EPHX1 
NM_000883 IMPDH1 
NM_015997 C1orf66 
NM_178335 CCDC50 
NM_182705 FAM101B 
NM_001453 FOXC1 
NM_138386 LOC92345 
NM_138334 JOSD2 
NM_005432 XRCC3 
NM_003935 TOP3B 
NM_001017965 LOC150223 
NM_145696 BRF1 
NM_003656 CAMK1 
NM_024958 C20orf98 
NM_006578 GNB5 
NM_030930 UNC93B1 
NM_001001890 RUNX1 
NM_004445 EPHB6 
NM_152727 CPNE2 
NM_016240 SCARA3 
NM_005739 RASGRP1 
NM_018334 LRRN3 
NM_024111 CHAC1 
NM_013304 ZDHHC1 
NM_172139 IL28B 
NM_006250 PRH1 
NM_153341 IBRDC3 
NM_005850 SF3B4 
NM_001007559 SS18 
Genbank ID Symbol 
NM_003075 SMARCC2 
NM_205545 LYPD2 
NM_177983 PPM1G 
NM_006201 PCTK1 
NM_004395 DBN1 
NM_178518 TMEM102 
NM_058237 KIAA1622 
NM_006019 TCIRG1 
NM_017980 LIMS2 
NM_022772 EPS8L2 
NM_002145 HOXB2 
NM_005899 NBR1 
NM_004821 HAND1 
NM_022780 FLJ13910 
NM_203464 AK3L1 
NM_032937 C9orf37 
NM_014883 FAM13A1 
NM_018354 C20orf46 
NM_015015 JMJD2B 
NM_019900 ABCC1 
NM_030629 CMIP 
NM_002141 HOXA4 
NM_004753 DHRS3 
NM_004915 ABCG1 
NM_130807 MOBKL2A 
NM_033120 NKD2 
NM_207336 ZNF467 
NM_016270 KLF2 
NM_004051 BDH 
NM_152527 SLC16A14 
NM_004286 GTPBP1 
NM_000228 LAMB3 
NM_005902 SMAD3 
NM_030952 NUAK2 
NM_000201 ICAM1 
NM_003125 SPRR1B 
NM_018273 FLJ10922 
NM_021055 TSC2 
NM_005632 SOLH 
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Genbank ID Symbol 
NM_197941 ADAMTS6 
NM_002983 CCL3 
NM_006018 GPR109B 
NM_177551 GPR109A 
NM_021006 CCL3L1 
NM_052815 IER3 
NM_001511 CXCL1 
NM_004591 CCL20 
NM_000575 IL1A 
NM_006290 TNFAIP3 
NM_005438 FOSL1 
NM_000594 TNF 
NM_000576 IL1B 
NM_005988 SPRR2A 
NM_014143 CD274 
NM_002575 SERPINB2 
NM_000584 IL8 
NM_000600 IL6 
NM_199423 WWP2 
NM_174917 LOC197322 
NM_002521 NPPB 
NM_004861 GAL3ST1 
NM_016424 CROP 
NM_001013398 IGFBP3 
NM_181802 UBE2C 
NM_019058 DDIT4 
NM_001033506 CSTF3 
NM_020801 ARRDC3 
NM_015714 G0S2 
NM_003714 STC2 
NM_175617 MT1E 
NM_001031735 C19orf36 
NM_033025 SYDE1 
NM_024796 FLJ22639 
NM_181717 HCG27 
NM_080735 WFDC2 
NM_080736 WFDC2 
NM_015478 L3MBTL 
NM_033633 SCAND2 
Genbank ID Symbol 
NM_005398 PPP1R3C 
NM_033634 SCAND2 
NM_003976 ARTN 
NM_004721 MAP3K13 
NM_018089 ANKZF1 
NM_005223 DNASE1 
NM_021983 HLA-DRB4 
NM_025045 BAIAP2L2 
NM_199054 MKNK2 
NM_002205 ITGA5 
NM_001004349 FLJ45422 
NM_006147 IRF6 
NM_015589 SAMD4A 
NM_005936 MLLT4 
NM_022066 UBE2O 
NM_003155 STC1 
NM_022162 CARD15 
NM_005238 ETS1 
NM_002133 HMOX1 
NM_144497 AKAP12 
NM_139314 ANGPTL4 
NM_181726 ANKRD37 
NM_006931 SLC2A3 
NM_013332 HIG2 
NM_001124 ADM 
NM_007021 C10orf10 
NM_018498 PPP4R1L 
NM_018433 JMJD1A 
NM_001002914 KCTD11 
NM_153350 FBXL16 
NM_030817 APOLD1 
NM_130439 MXI1 
NM_001005404 YPEL2 
NM_173642 FAM80A 
NM_002943 RORA 
NM_001975 ENO2 
NM_015053 PPFIA4 
NM_018689 KIAA1199 
NM_006096 NDRG1 
Appendix A 
225 
Genbank ID Symbol 
NM_001122 ADFP 
NM_004567 PFKFB4 
NM_016133 INSIG2 
NM_006516 SLC2A1 
NM_004112 FGF11 
NM_173540 FUT11 
NM_018660 ZNF395 
NM_005434 MALL 
NM_004566 PFKFB3 
NM_153449 SLC2A14 
NM_000189 HK2 
NM_005228 EGFR 
NM_005100 AKAP12 
NM_000602 SERPINE1 
NM_004093 EFNB2 
NM_014584 ERO1L 
NM_199327 SPRY1 
NM_032379 SYTL2 
NM_134423 RAD52 
NM_052880 MGC17330 
NM_030567 PRR7 
NM_025058 TRIM46 
NM_032854 CORO6 
NM_017514 PLXNA3 
NM_006238 PPARD 
NM_030665 RAI1 
NM_004209 SYNGR3 
NM_207309 UAP1L1 
NM_144691 CAPN12 
NM_003632 CNTNAP1 
NM_021168 RAB40C 
NM_020210 SEMA4B 
NM_153271 SH3PX3 
NM_173678 FLJ40722 
NM_178519 C17orf55 
NM_030761 WNT4 
NM_173503 EFCAB3 
NM_020959 TMEM16H 
NM_205843 NFIC 
Genbank ID Symbol 
NM_006885 ATBF1 
NM_001004431 METRNL 
NM_032899 FAM83A 
NM_003028 SHB 
NM_001005619 ITGB4 
NM_145735 ARHGEF7 
NM_020322 ACCN3 
NM_178120 DLX1 
NM_005204 MAP3K8 
NM_000067 CA2 
NM_024786 ZDHHC11 
NM_003749 IRS2 
NM_194278 C14orf43 
NM_003220 TFAP2A 
NM_003670 BHLHB2 
NM_001109 ADAM8 
NM_181720 ARHGAP30 
NM_001008490 KLF6 
NM_001300 KLF6 
NM_005450 NOG 
NM_002648 PIM1 
NM_181339 IL24 
NM_005239 ETS2 
NM_000758 CSF2 
NM_001717 BNC1 
NM_020436 SALL4 
NM_001024809 RARA 
NM_014755 SERTAD2 
NM_000391 TPP1 
NM_145739 OSBPL6 
NM_005397 PODXL 
NM_004354 CCNG2 
NM_134264 WSB1 
NM_001731 BTG1 
NM_005384 NFIL3 
NM_018948 ERRFI1 
NM_153836 CREG2 
NM_006670 TPBG 
NM_000381 MID1 
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Genbank ID Symbol 
NM_004064 CDKN1B 
NM_018293 ZNF654 
NM_020940 KIAA1600 
NM_033300 LRP8 
NM_019593 KIAA1434 
NM_020338 RAI17 
NM_001430 EPAS1 
NM_018027 FRMD4A 
NM_001206 KLF9 
NM_054034 FN1 
NM_000227 LAMA3 
NM_001017373 SAMD3 
NM_173551 ANKS6 
NM_000188 HK1 
NM_022081 HPS4 
NM_017634 KCTD9 
NM_018240 KIRREL 
NM_032869 NUDCD1 
NM_001004441 DP58 
NM_003107 SOX4 
NM_013352 SART2 
NM_012089 ABCB10 
NM_000254 MTR 
NM_006469 IVNS1ABP 
NM_173552 C3orf58 
NM_012290 TLK1 
NM_014637 MTFR1 
NM_032373 PCGF5 
NM_006520 DYNLT3 
NM_002245 KCNK1 
NM_018003 UACA 
NM_014607 UBXD2 
NM_032626 RBBP6 
NM_001723 DST 
NM_212479 ZMYND11 
NM_153267 MAMDC2 
NM_001012665 DYNC2LI1 
NM_152731 C6orf65 
NM_178815 ARL5B 
Genbank ID Symbol 
NM_014258 SYCP2 
NM_138270 ATRX 
NM_147166 AKAP9 
NM_014373 GPR160 
NM_018710 TMEM55A 
NM_198945 NBEAL1 
NM_006635 ZNF272 
NM_152995 NFXL1 
NM_182625 FLJ40869 
NM_021914 CFL2 
NM_016955 SLA/LP 
NM_002127 HLA-G 
NM_153255 MCMDC1 
NM_002610 PDK1 
NM_181077 GOLGA8A 
NM_003441 ZNF141 
NM_014395 DAPP1 
NM_145307 PLEKHK1 
NM_004864 GDF15 
NM_006734 HIVEP2 
NM_052996 PRDM7 
NM_016556 TBPIP 
NM_018026 PACS1 
NM_022739 SMURF2 
NM_032374 C14orf153 
NM_005524 HES1 
NM_002228 JUN 
NM_003394 WNT10B 
NM_001001701 LOC401152 
NM_001023567 GOLGA8B 
NM_001013702 LOC440258 
NM_004926 ZFP36L1 
NM_007361 NID2 
NM_004040 RHOB 
NM_001198 PRDM1 
NM_001956 EDN2 
NM_003692 TMEFF1 
NM_003612 SEMA7A 
NM_001018008 TPM1 
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Genbank ID Symbol 
NM_024607 PPP1R3B 
NM_194292 SASS6 
NM_022444 SLC13A1 
NM_144995 DHX57 
NM_024891 FLJ11783 
NM_015425 POLR1A 
NM_173084 TRIM59 
NM_153363 ZNF679 
NM_024669 FLJ11795 
NM_032205 PHF20L1 
NM_018833 TAP2 
NM_025069 ZNF703 
NM_032779 FLJ14397 
NM_175065 HIST2H2AB 
NM_018382 FLJ11292 
NM_005621 S100A12 
NM_021030 ZNF14 
NM_014713 LAPTM4A 
NM_001014972 ZNF638 
NM_144689 ZNF420 
NM_002963 S100A7 
NM_173629 C18orf26 
NM_152496 MANEAL 
NM_130791 WWOX 
NM_001663 ARF6 
NM_007054 KIF3A 
NM_007034 DNAJB4 
NM_004253 PLAA 
NM_133645 MTO1 
NM_015630 EPC2 
NM_005610 RBBP4 
NM_006305 ANP32A 
NM_032315 MGC4399 
NM_030920 ANP32E 
NM_000713 BLVRB 
NM_000990 RPL27A 
NM_001024916 CBWD5 
NM_018509 LRRC59 
NM_001444 FABP5 
Genbank ID Symbol 
NM_007278 GABARAP 
NM_003973 RPL14 
NM_199161 SAA1 
NM_001025780 C9orf77 
NM_001881 CREM 
NM_001008390 CGGBP1 
NM_173803 FLJ39599 
NM_003523 HIST1H2BE 
NM_001005269 C15orf21 
NM_145203 CSNK1A1L 
NM_001012989 UBE2NL 
NM_016312 WBP11 
NM_006107 CROP 
NM_014518 ZNF229 
NM_018396 METTL2B 
NM_001012321 RPSA 
NM_006004 UQCRH 
NM_016059 PPIL1 
NM_001003 RPLP1 
NM_015450 POT1 
NM_004264 SURB7 
NM_018443 ZNF302 
NM_014384 ACAD8 
NM_024615 PARP8 
NM_015115 DCUN1D4 
NM_152261 C12orf23 
NM_152284 CHMP4C 
NM_032992 CASP6 
NM_004365 CETN3 
NM_001515 GTF2H2 
NM_207418 FAM72A 
NM_017847 C1orf27 
NM_012343 NNT 
NM_006948 STCH 
NM_018479 ECHDC1 
NM_001730 KLF5 
NM_022550 XRCC4 
NM_018221 MOBK1B 
NM_033515 ARHGAP18 
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Genbank ID Symbol 
NM_130798 SNAP23 
NM_001412 EIF1AX 
NM_021229 NTN4 
NM_145802 SEPT6/SEP2 
NM_176869 PPA2 
NM_020729 ODF2L 
NM_001032393 HNRPH2 
NM_139164 STARD4 
NM_020685 C3orf14 
NM_000786 CYP51A1 
NM_014155 BTBD15 
NM_007080 LSM6 
NM_145036 MGC33887 
NM_178814 AP1S3 
NM_004902 RNPC2 
NM_004757 SCYE1 
NM_030780 SLC25A32 
NM_016217 HECA 
NM_005499 UBA2 
NM_022874 SMN1 
NM_138730 HMGN3 
NM_004622 TSN 
NM_016037 UTP11L 
NM_014283 C1orf9 
NM_145342 MAP3K7IP2 
NM_016141 DYNC1LI1 
NM_080422 PTPN2 
NM_015420 WDSOF1 
NM_000971 RPL7 
NM_004236 COPS2 
NM_005872 BCAS2 
NM_173060 CAST 
NM_153332 THEX1 
NM_014597 DNTTIP2 
NM_000251 MSH2 
NM_016946 F11R 
NM_182762 7A5 
NM_031208 FAHD1 
NM_001023570 IQCB1 
Genbank ID Symbol 
NM_198530 MXRA7 
NM_022365 DNAJC1 
NM_032833 PPP1R15B 
NM_013341 PTD004 
NM_198449 EMB 
NM_024005 DDX3X 
NM_001010856 LOC147804 
NM_002310 LIFR 
NM_032047 B3GNT5 
NM_019092 FAM63B 
NM_005054 RANBP2L1 
NM_024745 SHCBP1 
NM_017423 GALNT7 
NM_024725 FLJ23518 
NM_002128 HMGB1 
NM_006333 C1D 
NM_016301 ATPBD1C 
NM_005000 NDUFA5 
NM_004483 GCSH 
NM_173671 FLJ37396 
NM_017922 PRPF39 
NM_003051 SLC16A1 
NM_006135 CAPZA1 
NM_016470 C20orf111 
NM_018352 FLJ11184 
NM_032325 MGC11102 
NM_004505 USP6 
NM_024857 C17orf41 
NM_032328 EFCAB2 
NM_021820 C6orf75 
NM_004859 CLTC 
NM_173468 MOBKL1A 
NM_001153 ANXA4 
NM_006218 PIK3CA 
NM_000112 SLC26A2 
NM_006016 CD164 
NM_001011553 SEPT7/CDC3 
NM_016614 TTRAP 
NM_015275 KIAA1033 
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NM_001017420 ESCO2 
NM_013943 CLIC4 
NM_004768 SFRS11 
NM_001031850 PSG6 
NM_002823 PTMA 
NM_030754 SAA2 
NM_032753 RAXL1 
NM_020954 KIAA1618 
NM_176815 DHFRL1 
NM_001029950 DKFZp434K191 
NM_005665 EVI5 
NM_001010915 PTPLAD2 
NM_013361 ZNF223 
NM_178231 ALS2CR14 
NM_003931 WASF1 
NM_001032283 TMPO 
NM_006607 PTTG2 
NM_199144 UBE2V1 
NM_004547 NDUFB4 
NM_014367 C3orf28 
NM_002336 LRP6 
NM_001005751 LOC387680 
NM_001018158 LOC401623 
NM_033402 LRRCC1 
NM_020307 CCNL1 
NM_020861 ZBTB2 
NM_145284 LOC159090 
NM_007166 PICALM 
NM_182707 PSG8 
NM_015335 THRAP2 
NM_001024457 RGPD2 
NM_012403 ANP32C 
NM_182515 ZNF714 
NM_153689 FLJ38973 
NM_147128 ZNRF2 
NM_031438 NUDT12 
NM_024930 ELOVL7 
NM_198182 GRHL1 
NM_015058 KIAA0564 
Genbank ID Symbol 
NM_016570 ERGIC2 
NM_012096 APPL 
NM_005509 DMXL1 
NM_017645 FAM29A 
NM_006620 HBS1L 
NM_000534 PMS1 
NM_001931 DLAT 
NM_144632 FLJ30294 
NM_006379 SEMA3C 
NM_020841 OSBPL8 
NM_018284 GBP3 
NM_194314 ZBTB41 
NM_178566 ZDHHC21 
NM_007139 ZNF92 
NM_003338 UBE2D1 
NM_058230 ZNF354B 
NM_178587 PPP2R5C 
NM_014702 KIAA0408 
NM_198795 TDRD1 
NM_004482 GALNT3 
NM_017861 PIGX 
NM_018379 FAM63A 
NM_145111 DKFZp727G131 
NM_001030288 SPN 
NM_032121 DKFZp564K142 
NM_001031744 LOC158160 
NM_016371 HSD17B7 
NM_198271 LMOD3 
NM_024311 ET 
NM_005950 MT1G 
NM_198542 MGC4728 
NM_138687 PIP5K2B 
NM_152411 DKFZp762I137 
NM_173669 FLJ34047 
NM_018561 USP49 
NM_005687 FARSLB 
NM_022129 MAWBP 
NM_198457 ZNF600 
NM_001012391 LOC400509 
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NM_145913 SLC5A8 
NM_020462 ERGIC1 
NM_198309 TTC8 
NM_024640 YRDC 
NM_002920 RFX4 
NM_001008218 AMY1B 
NM_014670 BZW1 
NM_006817 C12orf8 
NM_006028 HTR3B 
NM_000293 PHKB 
NM_001821 CHML 
NM_016108 AIG1 
NM_138408 C6orf51 
NM_017830 OCIAD1 
NM_203287 PSG11 
NM_015633 FGFR1OP2 
NM_001025303 LOC440686 
NM_014415 ZBTB11 
NM_001033560 DYX1C1 
NM_005066 SFPQ 
NM_002182 IL1RAP 
NM_174908 CCDC50 
NM_001533 HNRPL 
NM_020943 KIAA1604 
NM_006267 RANBP2 
NM_005034 POLR2K 
NM_015939 CGI-09 
NM_018339 RFK 
NM_021127 PMAIP1 
NM_130440 PTPRF 
NM_006589 C1orf2 
NM_014673 KIAA0103 
NM_015200 SCC-112 
NM_001305 CLDN4 
NM_006622 PLK2 
NM_001001664 LOC339745 
NM_004735 LRRFIP1 
NM_173455 PDE8A 
NM_024672 THAP9 
Genbank ID Symbol 
NM_021269 ZNF708 
NM_145204 SENP8 
NM_173872 CLCN3 
NM_172164 NASP 
NM_153691 FLJ90036 
NM_198991 KCTD1 
NM_004282 BAG2 
NM_001014444 CRYM 
NM_001054 SULT1A2 
NM_001420 ELAVL3 
NM_001015050 LOC200810 
NM_014211 GABRP 
NM_001015047 DDX19-DDX19L 
NM_002908 REL 
NM_030979 PABPC3 
NM_007067 MYST2 
NM_012084 GLUD2 
NM_020040 TUBB4Q 
NM_175886 PRPS1L1 
NM_014706 SART3 
NM_199290 NACAL 
NM_003545 HIST1H4E 
NM_003415 ZNF268 
NM_016816 OAS1 
NM_152309 PIK3AP1 
NM_058241 CCNT2 
NM_006850 IL24 
NM_002867 RAB3B 
NM_198845 SIGLEC6 
NM_148896 NPB 
NM_006792 MORF4 
NM_005487 HMG2L1 
NM_001018136 NME1-NME2 
NM_181314 TAZ 
NM_198692 KRTAP10-11 
NM_173624 FLJ40504 
NM_021574 BCR 
NM_012446 SSBP2 
NM_052916 RNF157 
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Genbank ID Symbol 
NM_178174 TREML1 
NM_152871 FAS 
NM_001631 ALPI 
NM_080833 C20orf151 
NM_005374 MPP2 
NM_133378 TTN 
NM_013440 PILRB 
NM_173793 LOC128977 
NM_207393 IGFL3 
NM_032372 MGC16186 
NM_005017 PCYT1A 
NM_022641 CSH1 
NM_012164 FBXW2 
NM_178272 PILRA 
NM_021794 ADAM30 
NM_201380 PLEC1 
NM_017609 C10orf92 
NM_012309 SHANK2 
NM_138809 LOC134147 
NM_152450 FAM81A 
NM_024949 WWC2 
NM_152314 MGC34830 
NM_144695 C1orf58 
NM_018843 MCFP 
NM_031919 FSD1NL 
NM_032335 PHF6 
NM_133494 NEK7 
NM_003111 SP3 
NM_175767 IL6ST 
NM_152622 DKFZP781I1119 
NM_153188 TNPO1 
NM_001030316 C4orf13 
NM_032581 DRCTNNB1A 
NM_001025595 ARFIP1 
NM_005406 ROCK1 
NM_003286 TOP1 
NM_003816 ADAM9 
NM_139169 TRUB1 
NM_001329 CTBP2 
Genbank ID Symbol 
NM_002641 PIGA 
NM_003104 SORD 
NM_032943 SYTL2 
NM_001024948 FNBP1L 
NM_005968 HNRPM 
NM_006457 PDLIM5 
NM_003588 CUL4B 
NM_004318 ASPH 
NM_145005 C9orf72 
NM_138625 BCL2L11 
NM_007207 DUSP10 
NM_178313 SPTBN1 
NM_021230 MLL3 
NM_020310 MNT 
NM_015472 WWTR1 
NM_020164 ASPH 
NM_173075 APBB2 
NM_201545 LGALS8 
NM_182960 MGC21644 
NM_004235 KLF4 
NM_144728 DUSP10 
NM_005084 PLA2G7 
NM_001024630 RUNX2 
NM_006186 NR4A2 
NM_002089 CXCL2 
NM_000963 PTGS2 
NM_152328 ADSSL1 
NM_000791 DHFR 
NM_198974 PTK9 
NM_014827 ZC3H11A 
NM_006756 TCEA1 
NM_033001 GTF2I 
NM_177926 CSRP2BP 
NM_030972 ZNF611 
NM_017752 FLJ20298 
NM_015350 LRRC8B 
NM_177965 C8orf37 
NM_182765 HECTD2 
NM_203282 ZNF539 
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Genbank ID Symbol 
NM_194247 HNRPA3 
NM_003536 HIST1H3H 
NM_205847 GMPPA 
NM_017804 DERPC 
NM_100264 WAC 
NM_020445 ACTR3B 
NM_153485 NUP155 
NM_004346 CASP3 
NM_002894 RBBP8 
NM_001184 ATR 
NM_005178 BCL3 
NM_003143 SSBP1 
NM_002249 KCNN3 
NM_001008910 STK16 
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Table A.3: List of the 125 genes specifically responding to live WT N. meningitidis at 3 hours post 
infection  
This table also shows how the expression of these genes is affected by the absence of the capsule and pili 
using the N. meningitidis cap- and pilE- mutants, respectively. Fold change values with respect to mock-
infected controls at 3 hours are shown. The order of the genes is as shown in the heat map in Figure 4.5. 
NM: N. meningitidis, NS: not significantly expressed with respect to mock-infected controls.  
 
Genbank ID Symbol Fold change values at 3 hours 
  WT NM NM cap- NM pilE- 
NM_001615 ACTG2 4.3 -17.4 NS 
NM_139314 ANGPTL4 2.5 NS NS 
NM_013332 HIG2 3.0 2.8 1.6 
NM_144497 AKAP12 2.2 1.7 NS 
NM_004567 PFKFB4 2.8 2.0 1.8 
NM_005398 PPP1R3C 3.9 1.8 NS 
NM_004724 ZW10 2.0 1.5 NS 
NM_001803 CD52 2.6 NS NS 
NM_057157 CYP26A1 2.8 NS NS 
NM_000758 CSF2 2.0 NS NS 
NM_001936 DPP6 2.1 NS NS 
NM_004503 HOXC6 3.0 2.7 NS 
NM_032735 MGC13168 2.8 NS NS 
NM_004171 SLC1A2 2.4 1.6 NS 
NM_020989 CRYGC 2.5 2.1 1.6 
NM_144605 FLJ25410 2.2 1.6 1.4 
NM_194294 INDOL1 2.1 3.6 NS 
NM_014373 GPR160 2.1 1.9 2.5 
NM_016150 ASB2 2.1 2.1 NS 
NM_001013702 LOC440258 2.0 1.9 1.4 
NM_058241 CCNT2 4.7 NS NS 
NM_006931 SLC2A3 2.1 2.4 1.7 
NM_002610 PDK1 2.1 3.3 2.1 
NM_001008699 IL4R 2.5 2.6 2.9 
NM_012309 SHANK2 2.1 2.2 2.2 
NM_002928 RGS16 2.5 4.3 3.2 
NM_033087 ALG2 -2.5 -1.3 NS 
NM_014716 CENTB1 -2.9 NS NS 
NM_001710 CFB -2.2 -1.3 NS 
NM_022572 PNKD -2.0 NS NS 
NM_002908 REL -2.1 NS NS 
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Genbank ID Symbol Fold change values at 3 hours 
  WT NM NM cap- NM pilE- 
NM_005418 ST5 -2.1 NS NS 
NM_033294 CASP1 -3.6 -1.6 NS 
NM_002310 LIFR -3.9 -1.5 NS 
NM_016488 PPHLN1 -2.1 NS NS 
NM_002155 HSPA6 -2.3 1.4 NS 
NM_014405 CACNG4 -3.8 NS NS 
NM_152246 CPT1B -2.7 NS NS 
NM_182757 IBRDC2 -2.2 NS NS 
NM_001932 MPP3 -2.2 NS NS 
NM_016816 OAS1 -2.1 NS NS 
NM_032405 TMPRSS3 -3.3 NS NS 
NM_001647 APOD -2.1 3.0 2.3 
NM_080645 COL12A1 -2.0 1.8 1.5 
NM_001012301 ARSI -2.8 NS 1.7 
NM_000050 ASS -2.3 NS NS 
NM_002185 IL7R -2.1 1.3 1.5 
NM_018700 TRIM36 -2.3 1.3 NS 
NM_018334 LRRN3 -9.7 1.6 1.8 
NM_004995 MMP14 -2.0 NS NS 
NM_002456 MUC1 -2.0 1.5 NS 
NM_002780 PSG4 -2.3 1.5 NS 
NM_153214 FLJ37440 -2.0 NS NS 
NM_001024457 RGPD2 -2.2 NS NS 
NM_005621 S100A12 -2.2 NS NS 
NM_017922 PRPF39 -2.1 NS NS 
NM_006760 UPK2 -2.7 NS NS 
NM_006472 TXNIP -2.5 -1.8 NS 
NM_000373 UMPS -2.2 -1.7 1.5 
NM_006817 C12orf8 -2.0 NS -1.5 
NM_199161 SAA1 -2.1 NS -1.7 
NM_030754 SAA2 -2.1 NS -1.7 
NM_013341 PTD004 -2.1 NS -1.8 
NM_002982 CCL2 -2.7 NS NS 
NM_001001435 CCL4L1 -2.2 NS NS 
NM_177963 SYT12 -3.2 NS NS 
NM_153609 TMPRSS6 -2.6 -1.5 NS 
NM_024111 CHAC1 -4.6 -6.2 -1.6 
NM_005166 APLP1 -2.2 -1.7 -1.8 
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Genbank ID Symbol Fold change values at 3 hours 
  WT NM NM cap- NM pilE- 
NM_032836 FLJ14768 -2.1 -1.8 -1.7 
NM_004630 SF1 -2.2 -1.9 -1.7 
NM_030756 TCF7L2 -2.3 -2.3 -2.7 
NM_014784 ARHGEF11 -2.0 -1.5 -1.4 
NM_003488 AKAP1 -2.0 -1.4 -1.5 
NM_014731 ProSAPiP1 -2.5 -1.6 -1.7 
NM_024005 DDX3X -2.5 -1.4 -1.6 
NM_004819 SYMPK -2.0 -1.4 -1.4 
NM_014518 ZNF229 -2.4 -1.3 -1.5 
NM_015018 DOPEY1 -2.3 -1.5 -1.5 
NM_001734 C1S -2.2 -1.8 -1.4 
NM_000041 APOE -2.0 -1.5 -1.4 
NM_012153 EHF -2.7 -1.8 -1.6 
NM_004914 RAB36 -2.5 -1.8 -1.5 
NM_181777 UBE2A -2.7 -1.5 NS 
NM_017541 CRYGS -2.2 -1.6 NS 
NM_173547 TRIM65 -2.1 -1.5 NS 
NM_013360 ZNF222 -2.2 -1.7 NS 
NM_032885 ATG4D -2.4 -2.5 -1.6 
NM_183376 ARRDC4 -3.1 -2.8 -1.6 
NM_153263 ZNF549 -2.8 -2.3 -1.5 
NM_014707 HDAC9 -2.5 -2.6 -1.5 
NM_006298 ZNF192 -2.0 -2.1 NS 
NM_014994 MAPKBP1 -5.7 -3.0 -1.6 
NM_025209 EPC1 -2.6 -2.1 -1.4 
NM_033396 TNKS1BP1 -2.2 -1.8 -1.4 
NM_012398 PIP5K1C -2.0 -1.8 -2.5 
NM_001031698 PRPF40B -2.2 -1.6 -2.3 
NM_001759 CCND2 -2.1 -2.3 -2.2 
NM_005108 XYLB -2.4 -2.3 -2.2 
NM_005729 PPIF -2.0 -2.0 -1.7 
NM_016151 TAOK2 -2.1 -1.8 -1.7 
NM_015117 ZC3H3 -2.1 -1.7 -1.7 
NM_020754 CDGAP -8.8 -13.1 NS 
NM_022034 CUZD1 -3.5 -3.8 -1.6 
NM_023942 LRRC61 -2.3 -2.7 -1.6 
NM_025201 PLEKHQ1 -3.1 -3.4 -1.5 
NM_002923 RGS2 -2.0 -2.1 NS 
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Genbank ID Symbol Fold change values at 3 hours 
  WT NM NM cap- NM pilE- 
NM_002964 S100A8 -2.7 -2.3 NS 
NM_022086 ELMO2 -2.1 -2.1 -1.6 
NM_004225 MFHAS1 -2.2 -2.0 -1.5 
NM_005070 SLC4A3 -2.4 -2.0 -1.6 
NM_015260 SIN3B -2.2 -1.7 -1.7 
NM_001946 DUSP6 -8.8 -175.7 NS 
NM_014632 MICAL2 -2.4 -4.9 -1.8 
NM_024509 LRFN3 -2.4 -26.1 -2.5 
NM_005012 ROR1 -2.1 -18.2 NS 
NM_032664 FUT10 -2.1 -5.2 -2.5 
NM_005764 PDZK1IP1 -4.4 -76.9 -14.2 
NM_144964 RG9MTD3 -2.0 -4.5 -1.8 
NM_005564 LCN2 -3.0 -5.2 -2.6 
NM_002638 PI3 -3.4 -4.6 -2.4 
NM_025189 ZNF430 -2.5 -3.1 -1.8 
NM_014903 NAV3 -3.8 -15.2 -4.0 
NM_015246 MGRN1 -2.0 -2.4 -1.7 
NM_017728 TMEM104 -2.1 -3.1 -1.7 
 
 
 
